Page last updated: 2024-08-23

ursodeoxycholic acid and Biliary Cirrhosis

ursodeoxycholic acid has been researched along with Biliary Cirrhosis in 971 studies

Research

Studies (971)

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (2.47)	18.7374
1990's	238 (24.51)	18.2507
2000's	240 (24.72)	29.6817
2010's	288 (29.66)	24.3611
2020's	181 (18.64)	2.80

Authors

Authors	Studies
Amaral-González, C; Chico, I; Díaz-Flores, F; Eirás, P; Hernández-Guerra de Aguilar, MN; Hernández-Pérez, M; Llorente, S; Molina-Pérez, E; Morales-Arráez, D; Olveira-Martín, A; Rodríguez, R; Spigarelli-de Rábago, I; Suárez-Cabredo, C; Suárez-Ferrer, C; Tejedor, M; Yebra-Carmona, J	1
Anderson, H; Boscarino, JA; Bowlus, CL; Daida, YG; Gordon, SC; Haller, IV; Li, J; Lindor, K; Lu, M; Melkonian, C; Rodriguez-Watson, C; Romanelli, RJ; Rupp, LB; Sahota, A; Schmidt, MA; Trudeau, S; VanWormer, JJ; Vincent, J; Wu, KH; Zhou, Y	1
Assis, DN; Barbier, O; Boyer, JL; Gallucci, GM; Ghonem, NS; Hemme, C; Trottier, J	1
Avagnina, A; Barreyro, FJ; Carballo, P; Daruich, J; González Ballerga, E; Paes de Lima, A; Sorda, JA	1
Parés, A	4
Dohmen, K; Harada, S; Onohara, SY	1
Chen, Q; Dong, K; Jin, Q; Kui, Y; Ma, B; Wang, Y; Wen, X; Zhong, R	1
Han, W; Hou, J; Hu, X; Huang, C; Jiang, R; Liu, Y; Tao, S; Xu, B; Xu, J; Zhang, Q	1
Alrubaiy, L; Lambert, JA; Mak, S; Patel, R; Portone, G	1
Marcantonio, O; March-Rodriguez, A; Olmos-Alpiste, F; Pujol, RM	1
Abe, M; Alvaro, D; Bernasconi, DP; Carbone, M; Cazzagon, N; Corpechot, C; Cristoferi, L; Floreani, A; Gerussi, A; Hansen, BE; Hirschfield, G; Inao, M; Invernizzi, P; Komori, A; Lindor, K; Marzioni, M; Mochida, S; Muselli, M; Namisaki, T; Pares, A; Tanaka, A; Valsecchi, MG; Verda, D; Vespasiani-Gentilucci, U; Yoshiji, H	1
Barreyro, FJ; Daruich, J; González Ballerga, E; Sorda, JA	1
Banales, JM; Rodrigues, PM	1
Mankongpaisarnrung, C; McCashland, TM; Olivera-Martinez, MA; Rajendiran, G	1
Chen, S; Duan, W; Jia, J; Jin, H; Li, M; Li, S; Lv, T; Ma, H; Ou, X; Shan, S; Sun, G; Tian, D; You, H; Zhang, C; Zhang, D	1
Chen, X; Huang, Y; Li, L; Liu, H; Song, Y	1
Areia, AL; Melo, D; Moura, P	1
Chazouillères, O; Corpechot, C; Soret, PA	1
Mayo, MJ	4
Chen, L; Ding, D; Guo, G; Han, Y; Hu, Y; Liu, Y; Ma, G; Ma, S; Shang, Y; Tian, S; Xuan, G; Yang, F; Yu, J; Zhou, X	1
Asghari, S; Ebadi, M; Ip, S; Lytvyak, E; Mason, A; Montano-Loza, AJ; Rider, E	1
Abrahamyan, L; Aziz, B; Cheung, A; Flemming, JA; Grbic, D; Gulamhusein, AF; Hansen, BE; Hirschfield, GM; Janssen, HLA; Ko, HH; Lytvyak, E; Mason, AL; Montano-Loza, AJ; Peltekian, K; Qumosani, K; Roberts, SB; Selzner, N; Swain, M; Tirona, K; Vincent, C; Worobetz, LJ	1
Feng, B; Jin, R; Liu, ZC; Song, KM; Wang, YQ; Wang, ZL; Xie, YD	1
Aspinall, RJ; Berg, CP; Boudes, P; Bowlus, CL; Choi, YJ; Dörffel, Y; Galambos, MR; Goel, A; Gordon, SC; Harrison, SA; Hirschfield, GM; Jones, DEJ; Kremer, AE; Levy, C; Mayo, MJ; McWherter, CA; Neff, GW; Sheridan, DA; Shiffman, ML; Stanca, CM; Steinberg, A; Swain, MG; Thuluvath, PJ; Vierling, JM	1
Mishra, AK; Singh, SP	1
Barron-Millar, B; Brain, J; Brotherston, S; Dyson, JK; Flack, S; Hirschfield, G; Jones, DEJ; Jones, R; Jopson, L; Kirby, J; Mells, G; Ogle, L; Palmer, J; Rushbrook, S; Rushton, S; Ryder, SD; Sandford, R; Smith, GR; Thorburn, D; Wetten, A	1
Abenavoli, L; Cinaglia, P; Grazie, CD; Libicherova, P; Longhitano, Y; Luzza, F; Procopio, AC; Zanza, C	1
Chen, R; Chen, Y; Fang, J; Gershwin, ME; Helleday, T; Huang, B; Li, B; Li, Y; Lian, M; Lian, Z; Liang, J; Liu, Q; Lyu, Z; Ma, X; Miao, Q; Qian, Q; Tang, R; Wang, Q; Xiao, X; You, Z; Zhang, J	1
Lleo, A	1
Gao, Y; Liu, Q; Ma, H; Niu, J; Shi, Y; Wang, C; Wang, X	1
Delija, B; Filipec Kanizaj, T; Lalovac, M; Martincevic, D; Mijic, M; Radetic, E; Saric, I; Sobocan, N	1
Abbas, N; Aspinall, R; Chimakurthi, CR; Crothers, H; Culver, EL; Dyson, JK; Halliday, N; Hegade, V; Hirschfield, G; Jones, D; Jones, R; Kallis, Y; Khakoo, SI; McCune, A; Mells, G; Orrell, M; Patanwala, I; Phaw, A; Smith, B; Thain, C; Thain, RM; Thorburn, D; Trivedi, PJ	1
Dyson, J; Er, C; Jones, D; Sayer, J	1
Bittencourt, PL; Braga, MH; Cançado, ELR; Cançado, GGL; Codes, L; Coral, GP; Couto, CA; Cunha-Silva, M; da Cunha, SMCF; de Almeida E Borges, VF; de Faria Gomes, NM; de Lima Pace, FH; Faria, LC; Ferraz, MLG; Guedes, LV; Ivantes, CAP; Levy, C; Mendes, LSC; Nardelli, MJ; Oliveira, EMG; Oliveira, MB; Pessoa, MG; Rotman, V; Signorelli, IV; Terrabuio, DRB; Villela-Nogueira, CA	1
Henriksson, I; Marschall, HU; Nilsson, E; Nyhlin, N; Önnerhag, K; Rorsman, F; Udumyan, R; Wahlin, S; Werner, M	1
Liu, BD; Qureshi, K	1
Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; de Veer, RC; Floreani, A; Gatselis, NK; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van Buuren, HR; van der Meer, AJ; Verhelst, X	1
Abramczyk, J; Adamowicz, M; Banales, JM; Kempinska-Podhorodecka, A; Milkiewicz, M; Milkiewicz, P	1
Adekunle, F; Battezzati, PM; Bowlus, CL; Bruns, T; Carbone, M; Cazzagon, N; Corpechot, C; Dalekos, GN; Fisher, H; Flack, S; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hirschfield, GM; Hiu, S; Invernizzi, P; Janssen, HLA; Jones, D; Kareithi, D; Kowdley, KV; Lammers, WJ; Lindor, KD; Lleo, A; Londoño, MC; Malecha, E; Mason, AL; Mayne, T; Mayo, MJ; Mells, G; Mulcahy, V; Murillo Perez, CF; Ness, E; Nevens, F; Parés, A; Smith, R; Thorburn, D; Trauner, M; Trivedi, PJ; van der Meer, AJ; Verhelst, X; Wason, J	1
Díaz-González, Á; Londoño, MC	1
Khakoo, NS; Levy, C; Reynolds, JM; Sultan, S	1
Deng, J; Ding, D; Guo, C; Guo, G; Han, Y; Jia, G; Liu, Y; Shang, Y; Sun, R; Wang, X; Zheng, L	1
John, BV; Mansour, N; Shaker, M	1
Hussain, N; Trivedi, PJ	1
Corpechot, C	7
Ferreira, RD; John, BV; Sy, AM	1
Bowlus, CL; Liu, CH	1
Buchanan-Peart, KA; Levy, C	1
Martin, EF	1
John, BV	1
Manns, MP; Nevens, F; Trauner, M	1
Cipullo, M; Dallio, M; Federico, A; Gravina, AG; Iadanza, G; Olivieri, S; Panarese, I; Pellegrino, R; Romeo, M	1
Isanbaeva, AR; Sakhautdinova, GM	1
Beuers, U; Trampert, DC	1
Cui, L; Deng, J; Gershwin, ME; Guo, C; Guo, G; Han, Y; Jia, G; Leung, PSC; Li, B; Shang, Y; Sun, R; Wang, X; Yang, C; Zheng, L; Zhou, X	1
Feng, Y; Li, S; Xie, B; Zhang, H; Zhang, Q	1
Chen, H; Gao, X; Hong, X; Hu, S; Jin, X; Qiao, Z; Xia, C; Xiang, X; Xu, Y; Zhang, P	1
Feng, B; Hao, M; Jin, R; Liu, ZC; Wang, XX; Wang, ZL; Xie, YD	1
Carbone, M; Drazilova, S; Gazda, J; Gazda, M; Janicko, M; Jarcuska, P; Koky, T; Macej, M	1
Gershwin, ME; Han, Y; Leung, PSC; Shang, Y	1
Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; de Veer, RC; Floreani, A; Gatselis, NK; Goet, JC; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, AJ; van Hooff, MC; Verhelst, X	1
Deng, J; Ding, D; Guo, G; Han, Y; Jia, G; Liu, Y; Ren, P; Shang, Y; Sun, R; Wang, X; Yang, C; Zheng, L; Zhou, X	1
Bowlus, CL; Kowdley, KV; Levy, C; Mayo, MJ; Pratt, DS; Vuppalanchi, R; Younossi, ZM	1
Cichoz-Lach, H; Kasztelan-Szczerbinska, B; Rycyk-Bojarzynska, A; Szczerbinska, A	1
Carbone, M; Invernizzi, P; Jones, D; Levy, C; Little, N; Nevens, F; Swain, MG; Wiesel, P	1
Hirschfield, G; Levy, C; Manns, M	1
Kim, KA	1
Barba Bernal, R; Bonder, A; Castro, CM; Ferrigno, B; Goyes, D; Medina Morales, E; Patwardhan, VR; Trivedi, H	1
Cui, L; Deng, J; Guo, C; Guo, G; Han, Y; Jia, G; Liu, Y; Shang, Y; Sun, R; Wang, X; Yang, C; Zheng, L	1
Balkovec, V; Tomše, P	1
Andersen, AH; Becker, S; Bossen, L; Eivindson, M; Glerup, H; Grønbæk, H; Jepsen, P; Kjeldsen, NB; Kornerup, L; Lau, TS; Møller, HJ; Neumann, A; Nielsen, MB; Nielsen, MC; Ott, P; Svenningsen, L	1
Chang, JI; Cho, JY; Choi, MS; Goh, MJ; Gwak, GY; Kang, W; Kim, JH; Kim, KM; Koh, KC; Lee, JH; Oh, JH; Paik, SW; Paik, YH; Park, Y; Sinn, DH; Sohn, W	1
Bastaich, D; Brevini, T; Chao, HH; Chin, AM; Dahman, B; Deng, Y; Ferreira, RD; John, BV; Kaplan, DE; Mahmud, N; Moon, A; Sampaziotis, F; Serper, M; Taddei, TH; Webb, G	1
Badrock, J; Clark, G; Cordell, HJ; Hirschfield, GM; Jones, DE; Jones, RL; Kotagiri, P; Liaskou, E; Martin, JE; Mells, GF; Mulcahy, V; Rushbrook, SM; Ryder, SD; Sandford, RN; Taylor-Robinson, SD; Thorburn, D	1
Bogdanos, DP; Rigopoulou, EI	1
Ben Azouz, S; Boukriba, S; Cherif, D; Debbabi, H; Ghayeb, F; Hassine, H; Kchir, H; Maamouri, N; Yacoub, H	1
Chen, Y; Lin, L	1
Battezzati, PM; Bruns, T; Carbone, M; Cazzagon, N; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hassanally, I; Hirschfield, GM; Invernizzi, P; Ioannou, S; Janssen, HLA; Kowdley, KV; Lammers, WJ; Levy, C; Lindor, KD; Lleo, A; Londoño, MC; Mason, AL; Mayo, MJ; Murillo Perez, CF; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, AJ; Verhelst, X; Vuppalanchi, R	1
Carbone, M; Invernizzi, P; Jones, D; Levy, C; Little, N; Nevens, F; Wiesel, P	1
Choi, HY; Jang, ES; Jeong, SH; Ki, M; Kim, KA	1
Cheng, L; Huang, Y; Li, H; Li, X; Li, Y; Liu, Y; Wang, L; Yan, S; Zhan, H	1
John, BV; Levy, C; Trivella, J	1
Gao, L; He, X; Leung, PSC; Rojas, M; Yang, Y	1
Andreone, P; Aspinall, RJ; Boudes, PF; Bowlus, CL; Choi, YJ; Corpechot, C; Dalekos, GN; Drenth, JPH; Fassio, E; Forman, L; Gonzalez-Huezo, MS; Gordon, SC; Gulamhusein, A; Heneghan, MA; Hinrichsen, H; Hirschfield, GM; Invernizzi, P; Janczewska, E; Jeong, SH; Jones, DEJ; Kowdley, KV; Kremer, AE; Ladrón de Guevara, AL; Lawitz, EJ; Leggett, BA; Levy, C; Mayo, MJ; McWherter, CA; Nevens, F; Pratt, DS; Raikhelson, K; Ryder, SD; Shiffman, ML; Steinberg, A; Swain, MG; Trivedi, PJ; Vargas, V; Vierling, JM; Zigmond, E; Zuckerman, E	1
Azzolina, D; Cittone, MG; De Benedittis, C; Giannini, EG; Labanca, S; Manfredi, GF; Morgando, A; Pirisi, M; Rigamonti, C; Saracco, GM; Vanni, E	1
Hou, C; Li, S; Luan, L; Ren, C	1
Cattaneo, M; Hurtado, C; Poniachik, J; Ramírez, F; Roblero, JP; Urzúa, Á	1
Bassi, M; Muzahim, Y; Pyrsopoulos, N; Wakil, A	1
Faisal, MS; Gonzalez, HC; Gordon, SC	1
He, H; Lei, H; Tai, W; Yang, J; Zheng, M; Zhu, H	1
Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Goet, JC; Hansen, BE; Harms, MH; Hirschfield, G; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Lygoura, V; Mason, AL; Mayo, MJ; Nevens, F; Pares, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; Verhelst, X; Zachou, K	1
Chazouillères, O; Corpechot, C	2
Beuers, U; Hohenester, S	1
Shah, N; Yik, B	1
Beuers, U; de Vries, E	2
Efe, C; Montano-Loza, AJ; Taşçilar, K; Wahlin, S; Yoshida, EM	1
Fickert, P; Wagner, M	1
Adams, D; Alpini, G; Banales, JM; Beuers, U; Björnsson, E; Bowlus, C; Carbone, M; Chazouillères, O; Dalekos, G; De Gottardi, A; Gershwin, ME; Harada, K; Hirschfield, G; Invernizzi, P; Jones, D; Krawitt, E; Lanzavecchia, A; Lian, ZX; Ma, X; Manns, M; Mavilio, D; Mieli-Vergani, G; Quigley, EM; Sallusto, F; Shimoda, S; Strazzabosco, M; Swain, M; Tanaka, A; Terziroli Beretta-Piccoli, B; Trauner, M; Tsuneyama, K; Vergani, D; Vierling, JM; Zigmond, E	1
Bedossa, P; Bowlus, CL; Drenth, JPH; Forman, LM; Iloeje, U; Jin, Y; Kremer, AE; Liberman, A; MacConell, L; Parés, A; Pencek, R; Pockros, PJ; Ryder, SD; Terracciano, L	1
Bruns, T; Carbone, M; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Maria Battezzati, P; Mason, AL; Mayo, MJ; Murillo Perez, CF; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, A; Verhelst, X	1
Amano, K; Hidaka, A; Ishida, J; Ishikawa, T; Mizuno, Y; Nakano, M; Oikawa, T; Saeki, C; Saruta, M; Takakura, K; Takano, K; Torisu, Y; Tsubota, A; Zeniya, M	1
Bowlus, C; Gao, L; Gershwin, ME; He, X; Leung, PSC; Wang, L; Woo, E; Yang, G	1
Kowdley, KV; Shah, RA	1
Fan, X; Lu, C; Ma, Y; Men, R; Ni, P; Si, T; Yang, L	1
Nakanuma, Y; Sasaki, M; Sato, Y	1
Gulamhusein, AF; Hirschfield, GM	1
Battezzati, PM; Buuren, HRV; Corpechot, C; de Veer, RC; Floreani, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Pares, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, AJ	1
Gulamhusein, AF; Jackson, ND	1
Carbone, M; D'Amato, D; Hirschfield, GM; Jones, DEJ; Mells, GF	1
Bowlus, CL; Levy, C	1
Galle, PR; Grambihler, A; Kaps, L; Labenz, C; Michel, M; Nagel, M; Ploch, P; Schattenberg, JM; Wörns, MA; Yemane, B	1
Biloglav, Z; Božin, T; Filipec Kanižaj, T; Grgurević, I; Lucijanić, I; Lucijanić, M; Madir, A; Mijić, M; Mikolašević, I; Milić, S; Štimac, D	1
Chascsa, DMH; Lindor, KD	1
Anderson, H; Boscarino, JA; Bowlus, CL; Daida, YG; Gordon, SC; Haller, IV; Li, J; Lindor, K; Lu, M; Rodriguez, CV; Romanelli, RJ; Rupp, LB; Sahota, A; Schmidt, MA; Trudeau, S; VanWormer, JJ; Vincent, J; Wu, KH; Zhang, T	1
Böttler, T; Käser, R; Mayer, LS	1
Chazouillères, O; Corpechot, C; Rousseau, A	1
Schattenberg, JM	1
Harms, MH; van Buuren, HR; van der Meer, AJ	1
Dyson, JK; Jones, D; Phaw, NA	1
Belnou, P; Boillot, O; Bosch, A; Bruns, T; Carrat, F; Cazzagon, N; Chazouillères, O; Chopra, S; Conti, F; Corpechot, C; Donato, MF; Dumortier, J; Ebadi, M; Eurich, D; Floreani, A; Gerussi, A; Giostra, E; Goet, J; Hansen, B; Harms, M; Hirschfield, G; Jacob, D; Malinverno, F; Mason, A; McDowell, P; Montano-Loza, AJ; Nevens, F; Parés, A; Poupon, R; Rauchfuss, F; Reig, A; Reuken, P; Roccarina, D; Russo, FP; Schramm, C; Sterneck, M; Thorburn, D; Trivedi, P; van Buuren, H; Verhelst, X	1
de Veer, RC; Laschtowitz, A; Schramm, C; Van der Meer, AJ	1
Qian, JD; Wang, GQ; Wang, Y; Yao, TT	1
Abe, M; Aiso, M; Arakawa, M; Arizumi, T; Asaoka, Y; Fujii, H; Hashimoto, N; Honda, A; Inao, M; Itakura, J; Joshita, S; Kakisaka, K; Kaneko, A; Kang, JH; Kawada, N; Kawata, K; Kikuchi, K; Komori, A; Masaki, T; Matsumoto, K; Miura, R; Mochida, S; Namisaki, T; Ninomiya, M; Nomura, T; Ohira, H; Sato, K; Takahashi, A; Takamura, M; Takikawa, H; Takikawa, Y; Tamura, Y; Tanaka, A; Umemura, T; Yagi, M; Yoshiji, H	1
Ahn, DW	1
Bentow, C; Garcia, M; Mahler, M; Norman, GL; Pares, A; Reig, A; Romera, MA; Ruiz-Gaspà, S; Shums, Z; Vinas, O	1
Assis, DN; Auclair, AM; Boyer, JL; de la Rosa Rodriguez, R; Gallucci, GM; Ghonem, NS; Hemme, CL	1
Castro Limo, JD; Romero-Gutiérrez, M; Ruiz Martín, J	1
Babinska, I; Cekanova, A; Drazilova, S; Gazda, J; Halanova, M; Janicko, M; Jarcuska, P; Kucinsky, B; Martinkova, D; Safcak, D; Tarbajova, L	1
Dyson, JK; Jones, DEJ	1
Qian, JD; Wang, GQ; Yao, TT	1
Corpechot, C; Montano-Loza, AJ	1
Chai, J; Li, Q; Li, X; Liao, M; Pan, Q; Peng, Y; Qu, J; Xie, Q; Yang, H	1
Majee, C; Mishra, R; Sahu, R	1
Erickson, M; Frisch, K; Hofmann, AF; Horsager, J; Keiding, S; Kjærgaard, K; Munk, OL; Schacht, AC; Shapiro, D; Sørensen, M	1
Chang, Q; Chen, JDZ; Duan, Z; Lin, X; Liu, B; Shi, H; Wang, L; Yang, H	1
El-Serag, HB; Emologu, K; Kanwal, F; Natarajan, Y; Patel, P; Qureshi, Z; Shukla, R; Tansel, A; Thrift, AP	1
Alvaro, D; Carpino, G; Craxi, A; Floreani, A; Invernizzi, P; Moschetta, A	1
Cançado, ELR; Carrilho, FJ; Chaves, CE; Fossaluza, V; Katayose, JT; Liting, Z; Madeira, MCV; Nabeshima, MA; Nakano, LA; Ono, SK; Pinto, VB; Uhrigshardt, GG	1
Carbone, M; Gerussi, A; Invernizzi, P; Mulinacci, G; Palermo, A	1
Deeb, M; Hirschfield, GM; Leung, KK	1
Dyson, JK; Jones, D; Mells, G; Phaw, NA	1
Han, Y; Liu, Y; Ma, S; Sun, K; Tian, S; Wang, L; Zhang, M; Zhou, X	1
Fejfar, T; Hůlek, P; Vaňásek, T	1
Bergquist, A; Beuers, U; Drebber, U; Färkkilä, M; Greinwald, R; Hirschfield, GM; Kupcinskas, L; Manns, MP; Ott, P; Parés, A; Poupon, R; Pröls, M; Spengler, U; Stiess, M; Wendum, D	1
Chung, K; Davidson, M; Gunson, B; Haldar, D; Hansen, B; Hirschfield, GM; Janmohamed, A; Norman, H; Plant, T; Qamar, K; Richter, A; Russell, E; Serevina, O; Trivedi, PJ	1
Chen, X; He, T; Li, H; Li, J; Liu, H; Ma, X; Wang, L; Wang, M; Wang, R; Wei, S; Zhao, Y	1
Arora, S; Greenan, G; Mayo, MJ; Murali, AR; Pedersen, MR	1
Cerny, A; Costantini, S; Di Bartolomeo, C; Kolbus, N; Mazzucchelli, L; Merlo, E; Mertens, J; Messina, P; Mieli-Vergani, G; Semela, D; Stirnimann, G; Terziroli Beretta-Piccoli, B; Vergani, D; Voreck, A; Zen, Y	1
Fan, X; Hu, Z; Men, R; Ni, P; Shen, Y; Wen, M; Yang, L	1
Arpurt, JP; Causse, X; Chazouilleres, O; Corpechot, C; Garioud, A; Hanslik, B; Henrion, J; Pariente, A; Renou, C; Rosa, I	1
Tanaka, A	2
Ampuero, J; Arenas, JI; Berenguer, M; Carrión, JA; Casado, M; Conde, I; Costa-Moreira, P; De Carvalho, A; Fernández-Rodríguez, CM; Garcia Buey, L; Gomez, E; Hernández-Guerra, M; Jorquera, F; Luisa Gutiérrez, M; Macedo, G; Manuel Sousa, J; Mesquita, M; Molina, E; Morillas, RM; Olveira, A; Pérez-Fernández, E; Presa, J; Santos, A; Simón, MA; Uriz, J	1
Battezzati, PM; Bruns, T; Carbone, M; Cazzagon, N; Chazouillères, O; Corpechot, C; Dalekos, GN; Floreani, A; Gatselis, NK; Gulamhusein, A; Hansen, BE; Hirschfield, GM; Invernizzi, P; Janssen, H; Kowdley, KV; Lammers, WJ; Lindor, KD; Lleo, A; Mason, AL; Mayo, MJ; Murillo Perez, CF; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; Trivedi, PJ; van der Meer, AJ; Verhelst, X	1
Li, X; Lin, H; Ouyang, R; Peng, J; Yang, Y; Yu, C	1
Levy, C; Sultan, S	1
Birman, P; Bonder, A; Caldwell, S; Hanf, R; Heneghan, MA; Hirschfield, GM; Jones, D; Kowdley, KV; Levy, C; Luketic, V; Magrez, D; Megnien, S; Pares, A; Pratt, D; Schattenberg, JM; Staels, B; Tailleux, A; Vierling, J	1
Cazzagon, N; Floreani, A	1
Gao, Y; Li, B; Li, L; Zhan, Y	1
Fan, X; Huang, C; Liu, Y; Shen, M; Xiang, X; Yang, L; Yang, X	1
Ahmed, F; Shahini, E	1
Chida, T; Gershwin, ME; Kawata, K; Kobayashi, Y; Kurono, N; Leung, PSC; Ohta, K; Shimoda, S; Shimoyama, S; Suda, T; Suzuki, T; Tsuneyama, K	1
Arab, JP; Candia, R; Kulkarni, AV; Kumar, P; Padaki, NR; Premkumar, M; Reddy, DN; Sharma, M; Tevethia, HV	1
Usami, J	1
Hirai, F; Irie, M; Iwashita, H; Shakado, S; Tanabe, T; Yamaguchi, M; Yasuda, H	1
Carrion, AF; Levy, C; Lindor, KD	1
Alric, L; Anty, R; Berg, T; Bureau, C; Carbone, M; Carrat, F; Cazzagon, N; Cervoni, JP; Chazouillères, O; Corpechot, C; Dumortier, J; Heurgué, A; Invernizzi, P; Lam, L; Larrey, D; Leroy, V; Levy, C; Nevens, F; Pares, A; Potier, P; Rosa-Hezode, I; Roux, O; Schramm, C; Silvain, C; Smets, L; Soret, PA; Trivedi, P; Weiler-Normann, C	1
Abe, H; Arao, Y; Kamimura, H; Kamimura, K; Kimura, N; Sakamaki, A; Setsu, T; Takamura, M; Takatsuna, M; Takeda, N; Takeuchi, S; Terai, S; Tsuchiya, A; Watanabe, Y	1
Bruns, T; Carbone, M; Cazzagon, N; Dalekos, GN; Floreani, A; Gatselis, NK; Goet, JC; Gulamhusein, A; Hansen, BE; Harms, MH; Hirschfield, GM; Lammers, WJ; Lindor, KD; Murillo Perez, CF; Nevens, F; Parés, A; Prechter, F; Reig, A; van Buuren, HR; van der Meer, AJ; Verhelst, X	1
Han, Y; Liu, Y; Sun, K; Tian, A; Wang, L; Zhang, M; Zhou, X	1
Aitchenson, G; Dahman, B; Deng, Y; Goldberg, DS; John, BV; Kaplan, DE; Khakoo, NS; Levy, C; Martin, P; Schwartz, KB; Taddei, TH	1
Chen, L; Han, W; Jin, J; Li, W; Qu, L; Shi, X	1
Angus, P; French, J; Gow, PJ; Ng, J; Simpson-Yap, S; van der Mei, I	1
He, D; Hübscher, SG; Lytvyak, E; Mason, AL; Niazi, M; Pai, R; Zhang, G	1
Hu, JY; Huang, DS; Liang, L; Sun, LY; Tong, XM; Yang, T	1
Alomari, M; Chadalavada, P; Khoudari, G; Padbidri, V; Pinyopornpanish, K; Romero-Marrero, C; Talal Sarmini, M	1
Agostinho, C; Alexandrino, G; Alves, AL; Andreozzi, V; Banhudo, A; Calinas, F; Carvalho, J; Coelho, M; Cortez-Pinto, H; Cotrim, I; Dias, T; Figueiredo, P; Gomes, MV; Gouveia, C; Leal, C; Liberal, R; Lopes, S; Loureiro, R; Machado, MV; Maia, L; Martins, A; Mesquita, M; Nunes, J; Oliveira, J; Pedroto, I; Pinto, JS; Presa, J; Santos, A; Vale, AHE	1
Dyson, JK; Jones, DEJ; Wetten, A	1
Badrock, J; Barron-Millar, B; Brain, J; Dyson, JK; Flack, S; Hegade, VS; Hirschfield, G; Jones, DEJ; Jones, R; Jopson, L; Kirby, J; Mells, G; Ogle, L; Palmer, J; Rushbrook, S; Rushton, S; Ryder, S; Sandford, R; Smith, GR; Thorburn, D	1
Bittencourt, PL; Braga, MH; Cançado, ELR; Cançado, GGL; Codes, L; Coral, GP; Couto, CA; Cunha-Silva, M; da Cunha, SMCF; de Almeida E Borges, VF; de Faria Gomes, NM; de Lima Pace, FH; Faria, LC; Ferraz, MLG; Ivantes, CAP; Levy, C; Mendes, LSC; Nardelli, MJ; Oliveira, EMG; Oliveira, MB; Pessoa, MG; Rotman, V; Signorelli, IV; Terrabuio, DRB; Villela-Nogueira, CA	1
Bodorovska, B; Drazilova, S; Gazda, J; Gazda, M; Grgurevic, I; Janicko, M; Jarcuska, P; Kanizaj, TF; Koller, T; Kucinsky, B; Mijic, M; Mikolasevic, I; Stromar, IK	1
Di Giorgio, A; Mieli-Vergani, G; Vergani, D	1
Miao, H; Pan, J; Shen, N; Xing, L; Yu, X; Zhang, H	1
Barbier, O; Cieślak, A; Gobeil, S; Perreault, M; Thérien, A; Trottier, J; Verreault, M; Vohl, MC	1
Gaete, PV; Guatibonza-García, V; Gutiérrez-Romero, SA; Mendivil, CO; Pérez-Londoño, A; Puerto-Baracaldo, DK; Tapias, M	1
Bowlus, C; Floreani, A; Gershwin, ME; Tanaka, A	1
Gershwin, ME; Tanaka, A	1
Carey, EJ; Chascsa, D; Lindor, KD	1
Hegade, VS; Jones, DEJ; Wong, LL	1
Floreani, A; Mangini, C	1
Lemoinne, S; Marteau, P	1
Lindor, KD; Silveira, MG	3
Dalekos, GN; Gatselis, NK; Lygoura, V; Polychronopoulou, E	1
Burman, BE; Jhaveri, MA; Kowdley, KV	1
Bernuzzi, F; Carbone, M; Gershwin, ME; Invernizzi, P; Malinverno, F; Mousa, HS; Ronca, V	1
Parés, A; Reig, A; Sesé, P	1
Boscarino, JA; Bowlus, CL; Daida, YG; Gordon, SC; Haller, IV; Li, J; Lindor, K; Lu, M; Raebel, MA; Rodriguez, CV; Romanelli, RJ; Rupp, LB; Sahota, A; Schmidt, MA; VanWormer, JJ; Vincent, J	1
Strassburg, CP	1
Baserga, A; Bihl, F; Carbone, M; Cerny, A; Filipowicz Sinnreich, M; Giostra, E; Helbling, B; Hessler, R; Invernizzi, P; Kalid-de Bakker, C; Mertens, J; Oneta, C; Semela, D; Stickel, F; Stirnimann, G; Terziroli Beretta-Piccoli, B	1
Battezzati, PM; Bruns, T; Carbone, M; Corpechot, C; Dalekos, GN; Floreani, A; Goet, JC; Gulamhusein, A; Hansen, BE; Hirschfield, G; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; LaRusso, NF; Lindor, KD; Mason, A; Mayo, MJ; Murillo Perez, CF; Nevens, F; Pares, A; Ponsioen, CY; Poupon, R; Thorburn, D; Trivedi, PJ; van Buuren, HR; Verhelst, X; Zachou, K	1
Levy, C	1
Battezzati, PM; Bruns, T; Corpechot, C; Dalekos, GN; Floreani, A; Goet, JC; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; Verhelst, X	1
Jeong, SH	1
Levy, C; Lindor, KD	1
Dixon, P; Ferraro, E; Gorelik, J; Ibrahim, E; Vasavan, T; Williamson, C	1
Duan, WJ; Jia, JD	1
Li, YM; Ma, X; Wang, QX	1
Abe, K; Fujita, M; Hayashi, M; Nozawa, Y; Ohira, H; Okai, K; Takahashi, A	1
Ansari, AA; Bian, Z; Chen, W; Coppel, RL; Fang, J; Gershwin, ME; Jiang, X; Leung, PSC; Li, Y; Lian, M; Ma, X; Miao, Q; Qiu, D; Tang, R; Wang, Q; Wei, Y; Xiao, X; Zhang, J; Zhang, W	1
Jin, J; Yan, X	1
Bossen, L; Grønbæk, H; Hamberg, O; Jepsen, P; Ott, P; Ytting, H	1
Alexander, GJM; Chapman, MH; Collier, J; Dyson, JK; Hirschfield, GM; Hübscher, S; Jones, DEJ; Patanwala, I; Pereira, SP; Thain, C; Thorburn, D; Tiniakos, D; Walmsley, M; Webster, G	1
Kremer, AE; Vetter, M	1
Corrigan, M; Jones, D; Jopson, L; Khanna, A; Peterson, P; Rudell, E	1
Duan, W; Jia, J; Ma, H; Ou, X; Wang, Q; Wang, X; Wang, Y; Wu, X; You, H; Zhang, W; Zhao, X	1
Gonzalez, RS; Washington, K	1
Goldstein, J; Levy, C	1
Abergel, A; Admane, FH; Boursier, J; Bronowicki, JP; Chazouillères, O; Chollet-Martin, S; Corpechot, C; de Chaisemartin, L; de Ledinghen, V; Debette-Gratien, M; Gaouar, F; Goria, O; Habersetzer, F; Heurgue-Berlot, A; Humbert, L; Larrey, D; Le Gruyer, A; Lefèvre, G; Lemoinne, S; Mathurin, P; Minello, A; Nguyen-Khac, E; Nkontchou, G; Ollivier-Hourmand, I; Potier, P; Poupon, R; Rainteau, D; Rousseau, A; Roux, O; Silvain, C; Simon, T; Zarski, JP; Zoulim, F	1
Chen, J; Gao, F; Li, Y; Liu, Y; Niu, S; Sun, L; Tao, L; Wang, R; Wang, X; Xue, D; Yang, X; Zhang, Q; Zhu, B	1
Fan, Y; Huang, X; Li, M; Lu, B; Zhang, L	1
Díaz Ramírez, GS; Donado Gómez, JH; Marín Zuluaga, JI; Martínez Casas, OY; Muñoz Maya, O; Restrepo Gutiérrez, JC; Santos, Ó	1
Marschall, HU	1
Ainsworth, HF; Alexander, GJ; Alvaro, D; Badrock, J; Bathgate, A; Battezzati, PM; Bernuzzi, F; Bonato, G; Carbone, M; Cardinale, V; Carpino, G; Cordell, HJ; Cristoferi, L; Donato, MF; Flack, S; Floreani, A; Gaudio, E; Gavrila, C; Gerussi, A; Giannini, E; Heneghan, MA; Hirschfield, GM; Invernizzi, P; Jones, DE; Jones, R; Kirby, J; Malinverno, F; Marra, F; Marzioni, M; Mells, GF; Miele, L; Mitchell-Thain, R; Muratori, L; Nardi, A; Neuberger, JM; Ronca, V; Sampaziotis, F; Sandford, RN; Spicer, A; Stocken, DD; Taylor-Robinson, S; Thorburn, D; Varvaropoulou, N; Zuin, M	1
Bonetto, S; Durazzo, M; Fagoonee, S; Morgando, A; Pellicano, R	1
Chapman, RW	1
Fan, X; Lu, C; Men, R; Shen, Y; Wen, M; Yang, L; Zhu, Y	1
Aubert, V; Fraga Christinet, M; Moradpour, D; Sciarra, A; Sempoux, C; Vieira Barbosa, J; Vionnet, J	1
Hegade, VS; Jones, DE	1
Barbier, O; Krawczyk, M; Milkiewicz, M; Milkiewicz, P; Raszeja-Wyszomirska, J; Wunsch, E	1
Bahar, R; Bowlus, CL; Liu, CH; Wong, KA	1
Goel, A; Kim, WR	1
Silveira, M; To, U	1
Aguilar, MT; Carey, EJ	1
Brunet, E; Casas, M; Dalmau, B; Hernández, L; Miquel, M; Sánchez-Delgado, J; Valero, O; Vergara, M	1
Ben Mansour, W; Bouhlel, W; Guediche, A; Jemmali, D; Loghmari, MH; Safer, L	1
Korula, J	1
Klose, G; Nitschmann, S	1
Chen, S; Duan, W; Jia, J; Kong, Y; Li, M; Li, S; Lv, T; Ma, H; Ou, X; Tian, Q; Wang, Q; Wang, X; Wang, Y; Wu, X; You, H; Zhao, X	1
Carbone, M; Cristoferi, L; Invernizzi, P; Mells, G; Nardi, A; Ronca, V	1
Dong, KH; Fang, YN; Jin, QL; Wen, XY	1
Adam, R; Bennet, W; Duvoux, C; Hansen, BE; Harms, MH; Hidalgo, E; Isoniemi, H; Janssen, QP; Karam, V; Klempnauer, JL; Metselaar, HJ; Mirza, D; Pinzani, M; Pratschke, J; van Buuren, HR; Watson, C; Wigmore, SJ; Zieniewicz, K	1
Fan, X; Hu, Z; Men, R; Ni, P; Yang, L	1
Abu Backer, F; Abu Mouch, S; Mari, A	1
Alvaro, D; Bassanelli, C; Marzioni, M; Ripellino, C; Urbinati, D	1
Chazouillères, O; Corpechot, C; Lemoinne, S; Rousseau, A	1
Han, Y; Jia, G; Yuan, Z	1
Goodyear, BG; Kaplan, G; MacQueen, G; Mosher, V; Pang, J; Sharkey, K; Swain, M	1
Beuers, U; Herta, T	1
Bancel, B; Brunel, T; Goubault, P; Mabrut, JY; Mohkam, K; Rode, A	1
Eaton, JE; Gores, GJ	1
Battezzati, PM; Corpechot, C; Floreani, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HLA; Kowdley, KV; Lammers, WJ; Lindor, KD; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Thorburn, D; van Buuren, HR; van der Meer, AJ	1
D'Adda, A; D'Antiga, L; Di Giorgio, A; Licini, L; Marseglia, A; Nicastro, E; Sonzogni, A	1
Bergmann, OM; Björnsson, ES; Lund, SH; Olafsson, S; Örnolfsson, KT	1
Feng, BL; Shen, W; Yu, HH	1
Chen, GY; Chen, S; Duan, WJ; Jia, JD; Kong, YY; Li, M; Li, SX; Lv, TT; Ma, H; Ou, XJ; Su, JR; Sun, GY; Tian, D; Wang, TQ; Wang, Y; You, H; Zhang, CP; Zhang, D; Zhao, XY	1
Beck, G; Onuorah, NK; Wayde, M	1
Gaspar, R; Liberal, R; Macedo, G	1
Chang, Y; Cho, EJ; Chung, SW; Kim, MA; Kim, SW; Kim, YJ; Lee, HY; Lee, JH; Lee, YB; Leem, G; Park, JY; Yoon, JH; Yoon, JS; Yu, SJ	1
Aladağ, M; Alalkim, F; Beretta-Piccoli, BT; Berg, T; Bonder, A; Calişkan, AR; Chayanupatkul, M; Coppo, C; Demir, N; Efe, C; Eliasson, J; Eren, F; Fischer, J; Gönen, C; Günşar, F; Güzelbulut, F; Henriksson, I; Heurgué-Berlot, A; Kiyici, M; Lytvyak, E; Marschall, HU; Montano-Loza, AJ; Muratori, L; Muratori, P; Nilsson, E; Önnerhag, K; Ozaslan, E; Purnak, T; Rorsman, F; Schiano, TD; Semela, D; Taşçilar, K; Trivedi, H; Wahlin, S; Werner, M; Yoshida, EM; Ytting, H	1
Fan, X; Huang, C; Men, R; Ni, P; Shen, M; Wang, T; Yang, L	1
Amano, N; Genda, T; Harada, K; Iijima, K; Matsumoto, K; Murata, A; Sato, S; Shimada, Y; Tomishima, K; Tsuzura, H	1
Bian, ZL; Hao, YL; Ju, LL; Liu, Y; Qin, G	1
Chen, H; Cui, QC; Fei, YY; Gao, LX; Han, SM; Han, W; Kong, F; Li, YZ; Liu, B; Shen, M; Shi, TY; Shi, XH; Shuai, ZW; Wang, L; Wang, Q; Xu, D; Yang, YJ; Zhang, FC; Zhang, LN; Zhang, W; Zhang, X; Zheng, WJ	1
Chen, H; Shen, M; Shi, TY; Wang, L; Zhang, FC; Zhang, LN; Zhang, X	1
Bourikas, L; Drygiannakis, I; Kolios, G; Koulentaki, M; Kouroumalis, E; Manousou, P; Notas, G; Papadaki, HA; Pyrovolaki, K; Voumvouraki, A	1
Czul, F; Levy, C; Peyton, A	1
Burak, KW; Lee, SS; Myers, RP; Shaheen, AA; Swain, MG	1
Hagymási, K; Tulassay, Z	1
Harada, K; Kakuda, Y; Nakamura, M; Nakanuma, Y; Shimoda, S	1
Chen, L; Fu, J; Li, B; Li, J; Li, Y; Lin, H; Liu, H; Lv, S; Shi, M; Sun, Y; Wang, FS; Wang, L; Wang, S; Xu, R; Zhang, Z; Zou, Z	1
Genda, T	1
Imam, MH; Lindor, KD; Talwalkar, JA	1
Czaja, AJ	1
Boberg, KM; Kjøllesdal, KS; Kristiansen, IS; Støvring, H; Wisløff, T	1
Burroughs, AK; Carpenter, JR; Feudjo, M; Rigamonti, C; Tsochatzis, EA; Vlachogiannakos, J	1
Bruguera, M; Lens, S; Leoz, M; Nazal, L; Parés, A	1
Fan, D; Han, Y; Han, Z; Huang, X; Li, T; Li, Z; Shi, Y; Wang, J; Wang, L; Wang, M; Wang, R; Wang, X; Zhou, X	1
Abiru, S; Aiba, Y; Harada, K; Ishibashi, H; Ito, M; Kawashima, M; Komori, A; Migita, K; Nagaoka, S; Nakamura, H; Nakamura, M; Nakanuma, Y; Nishida, N; Shimoda, S; Tokunaga, K; Yatsuhashi, H	1
Bresson-Hadni, S; Efe, C; Heurgué-Berlot, A; Kav, T; Masi, C; Muratori, L; Muratori, P; Ozaslan, E; Purnak, T; Schiano, TD; Thiéfin, G; Ustündag, Y; Wahlin, S	1
Arvaniti, V; Burroughs, AK; Germani, G; Karatapanis, S; Manousou, P; Papastergiou, V; Pieri, G; Rigamonti, C; Rodriguez-Peralvarez, M; Rodriquez-Peralvarez, M; Thalassinos, E; Tsochatzis, EA	1
Alhaji, M; Sadikot, RT	1
Baldo, V; Canesso, F; Cazzagon, N; Floreani, A; Franceschet, I; Salmaso, L	1
Atkinson, EJ; Chan, LL; de Andrade, M; Juran, BD; Lammert, C; Lazaridis, KN; Schlicht, E	1
Mason, AL; Montano-Loza, AJ; Saxinger, L	1
Bhamidimarri, KR; Giordano, C; Levy, C; Mandalia, A; Martin, P; Naik, J; O'Brien, C; Schiff, ER	1
Boberg, KM; Karlsen, TH; Vesterhus, M	1
Gershwin, ME; Invernizzi, P	1
Dohmen, K; Haruno, M; Tanaka, H	1
Acarsu, U; Al-Harthy, N; Bruns, T; Cheung, A; Coltescu, C; Corbett, C; Hirschfield, GM; Janssen, HL; Kittler, C; Kumagi, T; Li, KK; Neuberger, J; Shah, H; Stallmach, A; Tripathi, D; Trivedi, PJ	1
Lindor, KD; Momah, N	1
Bresson-Hadni, S; Efe, C; Heurgué-Berlot, A; Kav, T; Masi, C; Muratori, L; Muratori, P; Ozaslan, E; Purnak, T; Schiano, TD; Thiéfin, G; Torgutalp, M; Wahlin, S	1
Cuperus, FJ; Halilbasic, E; Trauner, M	1
Flores, A; Mayo, MJ	1
Cassani, F; Fabbri, A; Granito, A; Lalanne, C; Lenzi, M; Masi, C; Menichella, R; Muratori, L; Muratori, P; Pappas, G; Quarneti, C	1
Bogdanos, DP; Elias, E; Haas, T; Kempińska-Podhorodecka, A; Kopycińska, J; Milkiewicz, M; Milkiewicz, P	1
Bi, YL; Chen, H; Dong, F; Han, Q; Hu, ZJ; Keating, A; Kong, F; Li, YZ; Shan, GL; Wang, K; Wang, L; Wang, Q; Wang, SH; Xu, D; Yang, YJ; Zhang, FC; Zhang, X; Zhao, RC	1
Efe, C; Kahramanoğlu-Aksoy, E; Kav, T; Ozaslan, E; Ozseker, B; Purnak, T; Roach, EC; Takci, S; Wahlin, S; Yilmaz, B	1
Wada, T; Zeniya, M	1
Ando, M; Harada, K; Hirohata, M; Miyake, Y; Moriya, A; Nakanuma, Y; Takemoto, R; Yamamoto, K	1
Chen, L; Ding, J; Gershwin, ME; Jia, Y; Jin, L; Li, B; Li, Y; Li, Z; Lv, S; Sun, Y; Wang, FS; Wang, L; Xu, X; Yang, T; Zhang, JY; Zhang, Z; Zou, Z	1
Imam, MH; Lindor, KD	1
Cazzagon, N; Floreani, A; Franceschet, I	1
Paul, S; Roper, J; Sepehr, GJ; Weinstein, B	1
Bruns, T; Hirschfield, GM; Li, KK; Trivedi, PJ	1
Joshita, S; Ota, M; Tanaka, E; Umemura, T	2
Battezzati, PM; Boonstra, K; Burroughs, AK; Caballeria, L; Cazzagon, N; Cheung, A; Corpechot, C; Floreani, A; Franceschet, I; Hansen, BE; Hirschfield, GM; Imam, MH; Invernizzi, P; Janssen, HL; Kanwar, PS; Kowdley, KV; Kumagi, T; Lammers, WJ; Lindor, KD; Lleo, A; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Pieri, G; Ponsioen, CY; Poupon, R; Trivedi, PJ; van Buuren, HR	1
Chen, G; Deng, G; Lu, L; Peng, Z; Tang, M; Wang, S; Wang, Z; Xing, T; Xu, J; Zhong, L	1
Hirohara, J; Nakanuma, Y; Takikawa, H; Tanaka, A; Tsubouchi, H	1
Foroncewicz, B; Habior, A; Mucha, K; Pączek, L; Pawełas, A; Raczyńska, J	1
Mac-Namara, M; Rada, G	1
Deng, YQ; Fang, YQ; Jia, W; Li, J; Lv, DX; Wang, GQ; Wang, Y; Yu, M	1
Ali, AH; Carey, EJ; Lindor, KD	1
Chen, RR; Cui, LN; Fan, DM; Han, S; Han, Y; Han, ZY; Li, YJ; Shi, YQ; Wang, L; Wu, KC; Xing, J; Zheng, LH; Zhou, XM	1
Harada, K; Kakuda, Y; Nakanuma, Y	1
Bunchorntavakul, C; Reddy, KR	1
Adorini, L; Beecher-Jones, T; Bodhenheimer, HC; Böhm, O; Castelloe, E; Gordon, SC; Hirschfield, GM; Kowdley, KV; Lindor, K; Luketic, V; Marschall, HU; Mason, A; Mayo, M; Parés, A; Sciacca, C; Shapiro, D; Trauner, M; Vincent, C	1
Bowlus, CL; Gershwin, ME; Invernizzi, P; Lleo, A; Mousa, HS	1
Adinolfi, LE; Alfieri, G; Dalla Mora, L; Lus, G; Marrone, A; Rainone, I; Rinaldi, L; Signoriello, E	1
Battezzati, PM; Burroughs, AK; Caballeria, L; Corpechot, C; Floreani, A; Hansen, BE; Hirschfield, GM; Invernizzi, P; Janssen, HL; Kowdley, KV; Lammers, WJ; Lindor, KD; Lleo, A; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Poupon, R; Trivedi, PJ; van Buuren, HR	1
Poupon, R	6
Abudumijiti, H; Chen, K; Dai, W; Guo, C; Li, J; Li, S; Liu, T; Lu, J; Lu, W; Wang, C; Wang, F; Wang, J; Xia, Y; Yang, J; Zhang, H; Zheng, Y; Zhou, Y; Zhou, Z; Zhu, R	1
Adams, DH; Beuers, U; Dyson, JK; Hirschfield, GM; Jones, DE; Lindor, KD; Mann, DA	1
Assis, DN; Boyer, JL; Ghonem, NS	1
Laudenbach, K; Seese, B	1
Kang, YZ; Liu, YH; Shen, ZY; Sun, XY	1
Hashizume, H; Horiguchi, N; Hosonuma, K; Kakizaki, S; Kusano, M; Sato, K; Yamada, M; Yamazaki, Y; Yanagisawa, M	1
Cazzagon, N; Colloredo, G; Del Ross, T; Floreani, A; Franceschet, I; Invernizzi, P; Lleo, A; Mescoli, C; Motta, R; Roncalli, M; Rosina, F	1
Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Zheng, MH; Zhou, ZR; Zhu, GQ	1
Cai, Y; Chen, RR; Fan, DM; Guo, GY; Han, Y; Han, ZY; Li, Q; Ren, XL; Shi, YQ; Wang, JB; Wang, L; Yang, Q; Zhang, JW; Zhou, X; Zhou, XM	1
Joshita, S; Kimura, T; Komatsu, M; Matsumoto, A; Ota, M; Sekiguchi, T; Shibata, S; Tanaka, E; Umemura, T; Usami, Y	1
Fu, DC; Guo, XY; Hua, Z; Huang, JZ; Li, YG; Wu, HY	1
Cai, Y; Cui, LN; Fan, DM; Guo, CC; Guo, GY; Han, Y; Han, ZY; Ren, X; Shi, YQ; Wang, JB; Wang, L; Wang, N; Zhang, J; Zhou, XM; Zhu, J	1
Chen, K; Guo, C; He, L; Li, J; Li, S; Liu, T; Lu, J; Lu, W; Wang, F; Wang, J; Xia, Y; Yin, Q; Zhang, Y; Zheng, Y; Zhou, Y	1
Vetter, C	1
Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, JT; Wang, LR; Wu, YM; Zheng, MH; Zhou, MT; Zhou, ZR; Zhu, GQ	1
Castellaneta, NM; Di Leo, A; Facciorusso, A; Licinio, R	1
Hosonuma, K; Kusano, M; Sato, K; Yamada, M	1
Cho, EJ; Cho, Y; Kim, YJ; Park, Y	1
Lindor, KD; Tabibian, JH	1
Imai, T; Isoda, N; Miki, A; Nagata, D; Nakagawa, S; Okada, M; Saito, O; Sato, R; Takeda, S; Yamamoto, H	1
Bruns, T; Kittler, C; Stallmach, A; Stengel, S; Trivedi, PJ	1
Guo, G; Han, Y; Shi, Y; Zhou, X	1
Battezzati, PM; Burroughs, AK; Caballeria, L; Cheung, A; Corpechot, C; Floreani, A; Hansen, BE; Harms, MH; Hirschfield, GM; Invernizzi, P; Janssen, HL; Kowdley, KV; Kumagi, T; Lammers, WJ; Lindor, KD; Lleo, A; Mason, AL; Mayo, MJ; Nevens, F; Parés, A; Ponsioen, CY; Poupon, R; Trivedi, PJ; van Buuren, HR	1
Abenavoli, L; Boillot, O; Bosch, A; Calmus, Y; Chazouillères, O; Conti, F; Corpechot, C; Dumortier, J; Giostra, E; Maucort-Boulch, D; Morard, I; Poupon, R; Radenne, S; Rubbia-Brandt, L; Scoazec, JY; Terris, B; Wendum, D	1
Abudumijiti, H; Chen, K; Chen, R; Guo, C; Li, J; Li, S; Liu, T; Lu, J; Lu, W; Wang, F; Wang, J; Xia, Y; Yin, Q; Zhang, R; Zheng, Y; Zhou, Y	1
Gershwin, ME; Hirschfield, GM; Trivedi, PJ	1
Cheung, AC; Feld, JJ; Hirschfield, GM; Janssen, HL; Kowgier, M; Lapointe-Shaw, L; Meza-Cardona, J	1
Peña-Irún, Á	1
Czul, F; Levy, C	1
Borjas-Almaguer, OD; Bosques-Padilla, FJ; Cortez-Hernandez, CA; Cruz-Moreno, MA; Garcia-Compean, D; Garza, AA; Gonzalez-Gonzalez, JA; Gonzalez-Moreno, EI; Maldonado-Garza, HJ; Martinez-Cabriales, SA; Ocampo-Candiani, J	1
Hansen, BE; Harms, MH; Lammers, WJ; van Buuren, HR	1
Liang, Y; Ma, N; Qin, B; Tang, Q; Wang, L; Wei, T; Yang, Z; Zhong, R; Zhou, L	1
Hansen, BE; Jones, DE	1
Cheung, AC; Feld, JJ; Kowgier, M	1
Wang, L; Zhang, FC; Zhang, X	1
Ali, AH; Carey, EJ; Lindor, KD; Tabibian, JH	1
Ishida, K; Kakisaka, K; Koeda, N; Miyamoto, Y; Suzuki, A; Suzuki, Y; Takahashi, H; Takikawa, Y	1
Palmer, RH	1
Bruno, S; Carbone, M; Invernizzi, P; Mells, GF; Ronca, V	1
Carbone, M; Gershwin, ME; Invernizzi, P; Malinverno, F; Mousa, HS; Ronca, V	1
Keam, SJ; Markham, A	1
Dong, Y; Gao, ZH; Han, YX; Huang, CY; Li, HM; Li, N; Li, ZM; Tan, YG; Wang, XF; Wang, YQ; Wu, XL; Yan, HP; Zhang, HP; Zhang, M; Zhu, HM; Zhu, SD	1
Alexander, GJ; Corrigan, M; Dobbins, RL; Dukes, G; Gilchrist, K; Hegade, VS; Hirschfield, GM; Jones, DE; Kendrick, SF; Miller, SR; Richards, D; Storey, J; Vallow, S	1
Dyson, JK; Hegade, VS; Jones, DEJ; Khanna, A; Walker, LJ; Wong, LL	1
Li, G; Li, L; Li, Y; Xu, P; Yu, C	1
Ali, AH; Lindor, KD	1
Himoto, T; Iwama, H; Masaki, T; Miyoshi, H; Morishita, A; Nomura, T; Sakamoto, T; Tani, J; Yoneyama, H	1
Dobbins, RL; O'Connor-Semmes, RL; Young, MA; Zuo, P	1
Harinck, F	1
Boonstra, K; Brouwer, JT; Drenth, JP; Erkelens, GW; Hansen, BE; Koek, GH; Kuyvenhoven, JP; Lammers, WJ; Leeman, M; Poen, AC; Ponsioen, CI; Ter Borg, F; van der Spek, BW; van Ditzhuijsen, TJ; van Erpecum, KJ; van Nieuwkerk, CM; van Tuyl, SA; Verhagen, MA; Vrolijk, JM; Witteman, BJ; Witteman, EM; Wolfhagen, FH	1
Thomas, H	1
Alexander, G; Bathgate, A; Ducker, SJ; Dyson, JK; Heneghan, MA; Hirschfield, GM; Jones, DE; Jopson, L; Mells, G; Neuberger, J; Sandford, R; Stocken, D; Wilkinson, N	1
Abbas, Z; Abe, M; Amarapurkar, DN; Chang, ML; Efe, C; Han, KH; Kim, YJ; Ma, X; Mitchell-Thain, R; Ozaslan, E; Payawal, DA; Takikawa, H; Tanaka, A; Vierling, JM; Weltman, M; Yokosuka, O; You, H; Zeniya, M	1
Alawad, AS; Levy, C	1
Furukawa, M; Kaji, K; Kawaratani, H; Kitade, M; Kubo, T; Mashitani, T; Mitoro, A; Moriya, K; Nakanishi, K; Namisaki, T; Nishimura, N; Okura, Y; Saikawa, S; Sato, S; Sawada, Y; Seki, K; Shimozato, N; Takaya, H; Takeda, K; Uejima, M; Yamao, J; Yoshiji, H	1
Erlinger, S	1
Fujimori, N; Ichikawa, Y; Joshita, S; Komatsu, M; Matsumoto, A; Norman, GL; Ota, M; Sekiguchi, T; Shibata, S; Shums, Z; Tanaka, E; Umemura, T; Yamazaki, T	1
Bhanji, RA; Mason, AL; Montano-Loza, AJ; Wasilenko, S	1
Bai, Y; Cui, Y; Wang, Y; Wu, Y; Zheng, Z	1
Battezzati, PM; Crosignani, A; Invernizzi, P; Podda, M; Prina, E; Selmi, C	1
Beuers, U; Rust, C	4
Bacon, BR; Lindor, KD; Mason, AL; Neuberger, JM; Vincent, C; Wasilenko, ST	1
Balmer, ML; Dufour, JF	1
Christensen, E; Gluud, C; Gong, Y; Huang, ZB	1
Boileau, R; Coté, J; Deslaurier, J; Huet, PM; Huet-van Kerckvoorde, J; Matsutami, S; Vincent, C	1
Abenavoli, L; Andréani, T; Chazouillères, O; Chrétien, Y; Corpechot, C; Johanet, C; Poupon, R; Rabahi, N	1
Bassendine, MF; Jones, DE; Newton, J; Walker, LJ	1
Caponi, A; Grenci, C; Lisotti, A; Roda, E	1
Foley, KF; Hornseth, JM; Lindor, KD; McConnell, JP; Silveira, MG	1
de Vries, RA; den Ouden-Muller, JW; Haagsma, EB; Hansen, BE; Houben, MH; Kuiper, EM; van Buuren, HR; van Ditzhuijsen, TJ; van Erpecum, KJ; Witteman, BJ	1
Angulo, P; Charatcharoenwitthaya, P; Gossard, AA; Jorgensen, RA; Keach, JC; Lindor, KD; Petz, JL; Talwalkar, JA	1
Kaplan, MM; Poupon, R	1
Abe, M; Azemoto, N; Hamada, M; Hiasa, Y; Matsuura, B; Murata, Y; Onji, M	1
Krok, KL; Munoz, SJ	1
Betterle, C; Bisconte, MG; Gentile, C; Gentile, M; Leo, P; Lucia, E; Mazzone, C; Morabito, F; Perugini, D; Romeo, F; Verta, M; Vigna, E	1
Beuers, U; Hohenester, S; Oude-Elferink, RP	1
Abe, K; Honma, F; Kanno, Y; Monoe, K; Ohira, H; Saito, H; Sakamoto, N; Takahashi, A; Yokokawa, H; Yokokawa, J	1
Altiparmak, E; Efe, C; Nasiroglu, N; Ozaslan, E; Purnak, T; Tunca, H	1
Burroughs, AK; Gluud, C; Gurusamy, KS; Tsochatzis, EA	1
Abenavoli, L	1
den Ouden-Muller, JW; Kuiper, EM; van Buuren, HR	1
Gu, EL; Yao, GB	1
Kawamura, K; Kawata, K; Kobayashi, Y; Nakamura, H; Noritake, H; Souda, K; Suehiro, T; Sumiyoshi, S; Takahashi, Y; Watanabe, S	1
Abbas, G; Lindor, KD	1
Shi, XH; Tang, M; Zhang, FC	1
Lindor, KD; Zein, CO	1
Abdalian, R; Arenovich, T; Coltescu, C; Fischer, SE; Guindi, M; Heathcote, EJ; Hirschfield, GM; Kumagi, T	1
Akdoğan, A; Altinbaş, A; Arik, G; Ertenli, AI; Kalyoncu, U; Karadağ, O; Kisacik, B	1
Bonder, A; Bonis, PA; Kaplan, MM; Ruthazer, R	1
Ansari, AA; Bowlus, CL; Coppel, RL; Gershwin, ME; Gores, GJ; Invernizzi, P; Lleo, A; Podda, M; Van de Water, J; Worman, HJ; Yang, GX	1
Song, BC	1
Chang, UI; Jeong, SH; Kim, KA; Kwon, SY; Lee, HJ; Lee, JI; Min, HJ; Yeon, JE	1
Brůha, R; Vítek, L; Zelenková, M	1
Shouval, D	1
Al-Rifai, A; Frith, J; Jones, DE; Newton, JL; Patanwala, I	1
Aparicio, MN; Engels, LG; Hansen, BE; Kerbert-Dreteler, MJ; Koek, GH; Kuiper, EM; Lesterhuis, W; Robijn, RJ; Thijs, JC; van Buuren, HR	1
Gershwin, ME; Heathcote, EJ; Hirschfield, GM	1
Ali, AH; Angulo, P; Jorgensen, RA; Lindor, KD; Silveira, MG; Sinakos, E	1
Podda, M; Selmi, C	1
Juran, BD; Lazaridis, KN; Nguyen, DL	1
Antoniazzi, S; Baldo, V; Brombin, C; Caroli, D; Cazzagon, N; Chiaramonte, M; Floreani, A; Rizzotto, ER; Salmaso, L; Variola, A	1
Dong, XY; Han, Y; Han, ZY; Huang, XF; Li, ZS; Shi, YQ; Wang, JH; Wang, RA; Yan, W; Zhou, XM; Zhu, JY	1
Cabrera, R; Clark, V; Firpi, RJ; Keach, J; Levy, C; Lindor, K; Morelli, G; Nelson, DR; Peter, JA; Petz, J; Soldevila-Pico, C	1
Arulprakash, S; Bala, MR; Kumar, SJ; Pugazhendhi, T; Sasi, AD	1
Hansen, BE; Komárek, A; Kuiper, EM; Lesaffre, E; van Buuren, HR	1
de Man, RA; Haagsma, EB; Hansen, BE; Kuiper, EM; Metselaar, HJ; van Buuren, HR; van Hoek, B	1
Ambrosini, YM; Gershwin, ME; Ishibashi, H; Komori, A; Nakamura, M; Shimoda, S	1
Golovanova, EV; Khomeriki, SG; Petrakov, AV; Serova, TI	1
Yeoman, AD; Yousuf, F	1
Kuroda, H; Shizuma, T	1
Altiparmak, E; Efe, C; Karaaslan, Y; Muratori, P; Ozaslan, E; Ozbalkan, Z; Purnak, T; Wahlin, S	1
Adang, RP; Brouwer, HT; Drenth, JP; Hansen, BE; Kuiper, EM; Kuyvenhoven, JP; Spoelstra, P; Timmer, R; van Buuren, HR; van Nieuwkerk, CM	1
Fujioka, S; Ikeda, F; Itoshima, T; Iwasaki, Y; Kobashi, H; Miyake, Y; Osawa, T; Takaki, A; Takaki, T; Takeuchi, Y; Yamamoto, K; Yasunaka, T	1
Murashima, N; Nakayama, S	1
Han, Y; Han, ZY; Huang, XF; Jia, G; Li, ZS; Shi, YQ; Wang, JH; Wang, RA; Zhou, XM; Zhu, JY	1
Abe, K; Kanno, Y; Katsushima, F; Monoe, K; Ohira, H; Saito, H; Takahashi, A; Yokokawa, J	1
Bonis, PA; Kaplan, MM; Leung, J	1
Beuers, U; Lindor, KD	1
Chazouillères, O; Corpechot, C; Poupon, R	1
Kherbèche, H	1
Berg, PA	1
Chapman, RW; Halliday, JS	1
Grattagliano, I; Minerva, F; Palasciano, G; Palmieri, VO; Portincasa, P	1
Bowlus, CL; Gershwin, ME; Lian, ZX; Lindor, K; Moritoki, Y; Nakatani, T; Tsuda, M; Vierling, J; Wakabayashi, K; Yang, GX; Yoshida, K; Zhang, W	1
Jeong, SH; Kim, KA	1
Jorgensen, R; Lindor, KD; Momah, N; Silveira, MG; Sinakos, E	1
Banales, JM; Medina, JF; Prieto, J; Sáez, E; Úriz, M	1
Chen, YJ; He, JS; Tang, HH; Tong, GD; Wei, CS; Zheng, YJ; Zhou, DQ; Zhou, XZ	1
Bjelakovic, G; Gluud, C; Krstic, MN; Poropat, G; Rudic, JS	2
Bastiaansen, BA; Beuers, U; Dilger, K; Hohenester, S; Rust, C; Schaap, FG; Winkler-Budenhofer, U	1
Bian, ZL; Han, XF; Liu, Y; Ma, X; Qiu, DK; Wang, QX; You, ZR	1
Axelsson, TA; Baldursdottir, TR; Bergmann, OM; Björnsson, ES; Jonasson, JG; Ludviksson, BR	1
Golovanova, EV	1
Hayashi, K; Joh, T; Kondo, H; Miyabe, K; Naitoh, I; Nakazawa, T; Nojiri, S; Shimizu, S; Takahashi, S; Yamashita, H; Yoshida, M	1
Baranovskiĭ, AIu; Marchenko, NV; Mitel'glik, UA; Raĭkhel'son, KL; Semenov, NV; Zubareva, AS	1
Hirayama, T; Honda, A; Ikegami, T; Imawari, M; Iwamoto, J; Matsuzaki, Y; Miyazaki, T; Nakamuta, M; Saito, Y; Takikawa, H	1
Bodenheimer, HC; Khan, FM; Komarla, AR; Mendoza, PG; Theise, ND	1
Bartosiewicz, M; Franczuk, M; Jędrych, M; Kuś, J; Langfort, R; Lewandowska, K; Oniszh, K; Radwan-Röhrenschef, P; Siemion-Szcześniak, I	1
Kotb, MA	1
Rautiainen, H	1
Han, Y; Zhu, JY	1
Berg, CP; Klein, R; Nann, D; Preuss, BE	1
Poupon, R; Serfaty, L	1
Boyer, JL; Ghonem, NS	1
Ding, J; Fan, D; Han, Y; Han, Z; Huang, X; Li, Z; Shi, Y; Wang, J; Wang, R; Wu, K; Zhou, X; Zhu, J	1
Chen, YS; Fan, LJ; Huang, CY; Huang, YL; Liao, HY; Lin, W; Liu, YM; Wang, SZ; Yan, HP	1
Choi, JS; Ha, SI; Jo, YG; Jun, HS; Kim, YH; Lee, SH; Lee, WH; Park, SG	1
Alexander, GJ; Carbone, M; Dawwas, MF; Day, DB; Ducker, SJ; Heneghan, MA; Jones, DE; Mells, GF; Neuberger, JM; Newton, JL; Pells, G; Sandford, RN	1
Bugdaci, MS; Dagli, M; Karabagli, P; Korkmaz, H; Temel, T	1
Gao, LX; Liu, B; Wang, L; Zhang, FC; Zhang, X	1
Chen, SX; Deng, AM; Hu, ZD; Huang, YL; Sun, Y; Yao, DK; Zhong, RQ	1
Shi, TY; Zhang, FC	1
Lohse, AW; Weiler-Normann, C	1
Wu, Y; Yao, DK; Zhu, L	1
Jaikishen, JP; Lamarche, MB; Sokol, L; Stueben, ET	1
Ang, L; Davis, T; Hodges, S; Maxwell, JD; Northfield, TC; Pazianas, M; Verma, A; Zaidi, M	1
Deutsch, M; Hadziyannis, ES; Hadziyannis, SJ; Papatheodoridis, GV	1
Ohira, H; Sata, M; Sato, Y; Ueno, T	1
Kreisel, W; Opitz, OG; Thimme, R	1
Löhr, HF	1
Azzaroli, F; Bacchi, L; Colecchia, A; Ferrara, F; Festi, D; Giovanelli, S; Jaboli, F; Liva, S; Mazzella, G; Mazzeo, C; Miracolo, A; Nigro, G; Piazza, F; Roda, A; Roda, E	1
Chazouillères, O; Poupon, R	1
Chetwynd, A; James, OF; Metcalf, JV; Newman, W; Prince, M	1
Angulo, P; Dickson, ER; Jorgensen, R; Lindor, KD	1
Wang, L; Xie, W; Yao, D	1
Talwalkar, JA	1
Makino, I	2
Stiehl, A	4
Ackermann, H; Holtmeier, J; Leuschner, M; Leuschner, U	1
Gisbert, JP; Jones, EA; Moreno-Otero, R; Pajares, JM	1
Goto, J; Kobayashi, K; Kobayashi, N; Kubota, K; Niwa, T; Oiwa, H	1
Fuller, SJ; Kumar, P; Weltman, M; Wiley, JS	1
Brage, A; Montero, C; Rodríguez-Trigo, G; Verea, H	1
Bach, N; Berk, PD; Bodenheimer, H; Bodian, C; Croen, E; Lindor, KD; Schaffner, F; Therneau, T; Thung, SN	1
Kaplan, MM; Lee, YM	2
Benedetti, A; Macarri, G; Marucci, L	1
Hanada, S; Harada, M; Ishii, M; Kawaguchi, T; Koga, H; Kumashiro, R; Sakisaka, S; Sata, M; Taniguchi, E; Ueno, T; Ueno, Y	1
Karvonen, AL	1
Ben Ammar, A; Chaabouni, H; Cheikh, I; Ouerghi, H; Said, Y	2
Baragiotta, A; Floreani, A; Guido, M	1
Chazouillères, O; Heathcote, EJ; Lindor, KD; Parés, A; Poupon, R; Poupon, RE	1
Paumgartner, G	2
Imazeki, F; Kanda, T; Saisho, H; Yokosuka, O	1
Chazouilleres, O; De Leusse, A; Desaint, B; Flejou, JF; Poupon, R; Poupon, RE; Rosmorduc, O; Serfaty, L	1
Zeniya, M	1
Angulo, P; Jorgensen, R; Lindor, KD; Siegel, JL	1
Baisini, O; Benini, F; De Tavonatti, MG; Lanzarotto, F; Lanzini, A; Mora, A; Panarotto, B; Scalia, S	1
Giudetti, AM; Gnoni, GV; Grattagliano, I; Grattagliano, V; Lapadula, G; Palasciano, G; Palmieri, VO; Vendemiale, G	1
Szalay, F	1
Parés, A; Rodés, J	1
Bain, VG; Dahlan, Y; Heathcote, EJ; Jewell, LD; Simmonds, D; Smith, L; Wanless, I	1
Castillo Grau, P; Erdozain Sosa, JC; Hervías Cruz, D; Manceñido Marcos, N; Navajas León, FJ; Pajares Villarroya, R; Segura Cabral, JM	1
Burroughs, AK; Chan, CW; Goulis, J; Papatheodoridis, GV	1
Ishii, H; Kitajima, M; Oda, M; Wakabayashi, G; Yokomori, H	1
Manns, MP; Strassburg, CP	1
Ballot, E; Bandin, O; Chazouilleres, O; Johanet, C; Poupon, R	1
Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C	1
Borras, C; Carretero, J; Cutrin, J; Pallardó, FV; Pereda, J; Poli, G; Sastre, J; Serviddio, G; Vendemiale, G; Viña, J	1
Bergasa, NV	1
Jorgensen, RA; Lindor, KD; Souto, E; Talwalkar, JA	1
Dalekos, GN; Liaskos, C; Makri, E; Patsiaoura, K; Rigopoulou, E; Stathakis, N; Zachou, K	1
Dohmen, K; Ishibashi, H; Mizuta, T; Nakamuta, M; Shimohashi, N; Yamamoto, K	1
Angulo, P; Levy, C	1
Carithers, RL; Combes, B; Flye, N; Garcia-Tsao, G; Lin, D; Luketic, VA; Munoz, SJ; Peters, MG; Zetterman, RK	1
Bonis, PA; Cheng, S; Kaplan, MM; Price, LL	1
Gluud, C; Gong, Y	1
Avezov, SA; Mansurova, FKh	1
Avezov, SA; Mansurov, FKh	1
Chrétien, Y; Corpechot, C; Galotte, M; Poujol-Robert, A; Poupon, R; Poupon, RE; Wendum, D	1
Kayacetin, E; Köklü, S; Temuçin, T	1
Angus, PW; Christie, JM; Gow, PJ; Sood, S	1
El-Husseini, R; Kaplan, MM	1
He, M; Jiang, J	1
Siboni, AH	1
Chazouillères, O; Chrétien, Y; Chwalow, J; Poupon, R; Poupon, RE	1
Chatzicostas, C; Dimoulios, P; Koulentaki, M; Kouroumalis, EA; Moscandrea, J	1
Neuberger, J; Oo, YH	1
Blum, HE	1
Blum, HE; Kreisel, W; Opitz, OG; Thimme, R	1
Kiss, E; Mayer, S; Rogler, G; Schedel, J; Schölmerich, J; Woenckhaus, M	1
Dickson, ER; Kim, WR	1
Angulo, P; Lindor, KD	1
Bueverov, AO	1
Geng, H; Han, YK; Zeng, Z; Zhang, XF	1
Angulo, P; Jorgensen, RA; Keach, JC; Lindor, KD; Petz, JL; Talwalkar, JA	1
Bahr, A; Carrat, F; Chrétien, Y; Corpechot, C; Poupon, R; Poupon, RE	1
Larusso, NF; Lazaridis, KN	1
Burroughs, AK; Carpenter, JR; Chan, CW; Feudjo, M; Gunsar, F; Rigamonti, C; Vlachogiannakos, J	1
Dimoulios, P; Kolios, G; Koulentaki, M; Kouroumalis, A; Kouroumalis, E; Matrella, E; Notas, G; Tsagarakis, N; Xidakis, C	1
Adachi, H; Daikoku, M; Ishibashi, H; Ito, M; Koga, M; Komori, A; Masaki, N; Matsumoto, T; Migita, K; Nakamura, M; Nakamura, Y; Saoshiro, T; Shimizu-Yoshida, Y; Shimoda, S; Sodeyama, T; Takii, Y; Ueki, T; Watanabe, Y; Yano, K; Yatsuhashi, H; Yokoyama, T	1
Chazouillères, O; Chrétien, Y; Poupon, R; Poupon, RE	1
Ditelberg, J; Kaplan, MM; Vallone, TM	1
Hayashida, K; Kadokawa, Y; Kohno, S; Kusakari, C; Mizuta, Y; Murata, I; Nakanuma, Y; Ohba, K; Omagari, K; Takeshima, F	1
Fritzler, MJ; Hasegawa, C; Miyachi, K; Onozuka, Y; Shibata, M	1
Beuers, U; Denk, A; Dilger, K; Heeg, MH	1
Akcan, Y; Belenli, O; Bicik, Z; Kisacik, B; Korkut, E; Yucel, O	1
Färkkilä, M; Kärkkäinen, P; Karvonen, AL; Nurmi, H; Nuutinen, H; Pikkarainen, P; Rautiainen, H	1
Fickert, P; Trauner, M; Wagner, M; Zollner, G	1
Lohse, AW; Schramm, C	1
Shibata, M; Yanagawa, T	1
Lengyel, G; Tulassay, Z	1
Gershwin, ME; Invernizzi, P; Oertelt, S; Podda, M; Selmi, C	1
Binaut, R; Daniel, L; Fakhouri, F; Grünfeld, JP; Knebelmann, B; Lino, M; Noël, LH; Patey, N; Rustin, P; Serpaggi, J; Vanhille, P; Varaut, A	1
Eisebitt, R; Leuschner, U; Manns, MP	1
Vierling, JM	1
Malfertheiner, P; Treiber, G	1
Gershwin, ME; Kaplan, MM	1
Guy, JE; Lowell, JA; Peters, MG; Qian, P	1
Gordon, FD; Keaveny, AP; Khettry, U	1
Copaci, I; Iliescu, L; Micu, L; Voiculescu, M	1
Blendis, L	1
Barnes, DS; Bass, NM; Benner, KG; Bonacini, M; Boyer, JL; Boyer, TD; Carithers, RL; Combes, B; Contos, MJ; Di Bisceglie, AM; Emerson, SS; Flye, NL; Garcia-Tsao, G; Hofmann, AF; Kowdley, KV; Lake, JR; Lindsay, KL; Luketic, VA; Markin, RS; Martinez, EJ; Mayo, MJ; McCashland, TM; Mills, AS; Munoz, SJ; Peters, MG; Rosoff, L; Rubin, R; West, AB; Wheeler, DE; Zetterman, RK	1
Combes, B	2
Bhala, N; Burt, J; Goldblatt, J; Jones, DE; Newton, JL; Prince, M	1
Chazouillères, O; Poupon, R; Rosmorduc, O; Serfaty, L; Wendum, D	1
Christensen, E; Gluud, C; Gong, Y	1
Castiella, A; Fernández, J; Irarreta, A	1
Eun, CS; Jang, HJ; Jang, WY; Kae, SH; Kim, GS; Lee, J	1
Abiru, S; Daikoku, M; Dohmen, K; Ishibashi, H; Komori, A; Nagaoka, S; Ueki, T; Wen, CY; Yano, K; Yatsuhashi, H	1
Bonis, PA; Kaplan, M	2
Bhala, N; Jones, DE; Newton, JL	1
Caballería, L; Parés, A; Rodés, J	1
Ferrara, F; Floreani, A; Guido, M; Ostuni, PA	1
Benderitter, T; Bourlière, M; Calvet, B; Halfon, P; Harafa, A; Igual, JP; Larroque, O; Martini, F; Ouzan, D; Penaranda, G; Renou, C; Sokolowsky, S	1
Brahm B, J; Buckel G, E; Ferrario B, M; Oksenberg R, D; Poniachik T, J; Silva P, G; Smok S, G; Valera M, JM	1
Aboutwerat, A; Pemberton, PW; Smith, A; Warnes, TW	1
Hansen, BE; Schalm, SW; ter Borg, PC; van Buuren, HR	1
Chen, YX; Lin, Y; Shi, J; Wu, C; Xie, WF; Zhu, L	1
Babatin, MA; Sanai, FM; Swain, MG	1
Regev, A; Schreibman, I	1
Gatzen, M; Pausch, J	2
Bernard-Chabert, B; Cadiot, G; Diebold, MD; Frémond, L; Geoffroy, P; Heurgué, A; Louvet, H; Pennaforte, JL; Picot, R; Schmit, JL; Thiéfin, G; Vitry, F; Yaziji, N	1
Erik, C; Gluud, C; Yan, G	1
Brok, J; Gluud, C; Gong, Y; Koretz, RL	1
Angulo, P; Lindor, KD; Silveira, MG; Talwalkar, JA	1
Befeler, AS; Smith, T	1
Irisawa, A; Kanno, Y; Monoe, K; Ohira, H; Rai, T; Saito, H; Takahashi, A	1
Christensen, E; Gluud, C; Gong, Y; Huang, Z	1
Gershwin, ME; Ishibashi, H; Komori, A; Shimoda, S	1
Stiefelhagen, P	2
Fauler, G; Gurakuqi, G; März, W; Putz-Bankuti, C; Scharnagl, H; Stadlbauer, V; Stauber, RE; Stojakovic, T; Trauner, M; Wagner, M	1
Aithal, GP; Card, TR; Jackson, H; Logan, R; Solaymani-Dodaran, M; West, J	1
Charatcharoenwitthaya, P; Enders, FT; Krom, RA; Lindor, KD; Pimentel, S; Talwalkar, JA; Wiesner, RH	1
Gershwin, ME; Williams, R	1
Gossard, AA; Lindor, KD	1
Bella, RM; Cisteró, B; Dalmau, B; Gil, M; Pla, X; Real, J; Vergara, M	1
Doğan, M; Ozenirler, S; Yaşar, DG	1
Corpechot, C; Poupon, R	1
Bach, N; Belanger, A; Doucette, JT; Friedman, S; Lee, J; Stanca, C	1
Lindor, K	1
García-Buey, L; Gisbert, JP; Gómez-Dominguez, E; Jones, EA; Mendoza, J; Moreno-Otero, R; Trapero, M	1
Hashimoto, K; Miyawaki, S; Nishiyama, S; Taniguchi, Y; Yoshinaga, Y	1
Arenas, F; Hervias, I; Joplin, R; Medina, JF; Prieto, J; Uriz, M	1
Heathcote, EJ; Kumagi, T	1
Gao, LX; Liu, B; Shi, XH; Zhang, FC; Zhang, W	1
Pan, MH; Zhou, XJ	1
Beppu, T; Fuke, H; Shiraki, K; Sugimoto, K; Takei, Y; Tanaka, J; Yamamoto, N; Yoneda, K	1
Gossard, AA; Talwalkar, JA	1
Färkkilä, M; Kärkkäinen, P; Karvonen, AL; Niemelä, O; Nurmi, H; Rautiainen, H	1
Fujimura, Y; Inada, N; Kobashi, H; Nishino, K; Sakanoue, R; Suehiro, M; Toshikuni, N; Yamada, G; Yamato, R	1
Borozan, I; Chen, L; Coltescu, C; Edwards, AM; Guindi, M; Heathcote, EJ; McGilvray, ID; Meng, X; Milkiewicz, P; Ostrowski, MA; Sun, J	1
Al-Chalabi, T; Bernal, W; Heneghan, MA; McFarlane, IG; Portmann, BC	1
Levy, C; Michaels, A	1
Hou, MC; Huang, YT; Lee, FY; Lee, KC; Lee, SD; Lee, TY; Lin, HC; Yang, YY	1
Güldütuna, S; Leuschner, U; Sipos, P; Vallent, K	1
Adler, D; Kürktschiev, D; Lehmann, HU; Schentke, KU; Subat, S	2
Anderson, ML; Baldus, WP; Dickson, ER; Gores, GJ; Hofmann, AF; Jorgensen, RA; Lange, SM; Lindor, KD; Rossi, SS; Wiesner, RH	1
Jazrawi, RP; Lim, AG; Northfield, TC	1
de Vries, RA; den Ouden Muller, JW; Eskens, FA; Ferwerda, J; Schalm, SW; ten Kate, FJ; van Buuren, HR; van der Hoek, EW; van Hattum, J; Wolfhagen, FH	1
Dickson, ER; Hofmann, AF; Jorgensen, RA; Lindor, KD; Rossi, SS	1
Carithers, RL; Combes, B; Eigenbrodt, EH; Garcia-Tsao, G; Lin, D; Maddrey, WC; McDonald, MF; Muñoz, SJ; Rubin, R; Wheeler, DE	1
Bilik, R; Edwards, V; Phillips, J; Superina, RA	1
Degott, C; Duclos-Vallée, JC; Erlinger, S; Ganne-Carrié, N; Hadengue, A; Robin, E	1
Färkkilä, M; Friman, C; Karvonen, AL; Lehtola, J; Leino, R; Mäkinen, J; Mattila, J; Seppälä, K; Tuominen, J; Vuoristo, M	1
Lindor, KD	3
Färkkilä, M; Friman, C; Karvonen, AL; Lehtola, J; Leino, R; Miettinen, TA; Seppälä, K; Tuominen, J; Vuoristo, M	1
Bassendine, MF; James, OF; Jones, DE	1
Ammann, R; Meyenberger, C; Wirth, HP; Zala, G	1
Aoshima, M; Makino, I; Nakamura, K	1
Kommerell, B; Raedsch, R; Rudi, J; Waldherr, R	1
Cagnoni, C; Carrara, GC; Castelli, A; Concesi, C; Crippa, G; Girometta, S; Pancotti, D; Pierfranceschi, MG; Sverzellati, E; Tacchini, G	1
Benjaminov, A; Güldütuna, S; Hübner, K; Imhof, M; Leuschner, M; Leuschner, U	1
Henley, KS	1
Sherlock, S	1
Leuschner, U	7
Crippin, JS; Dickson, ER; Janes, CH; Jorgensen, RA; Lindor, KD	1
Adler, D; Kürktschiev, D; Schentke, KU; Subat, S	1
Goddard, CJ; Warnes, TW	1
Enomoto, M; Sadamoto, T; Sato, G; Shibata, M; Tuzimoto, S; Ueno, Y; Watanabe, M; Yamagami, T; Yasushi, T	1
Bateson, MC	3
Lim, AG	1
Palumbo, PJ	1
Balan, V; Dickson, ER; Jorgensen, RA; Lindor, KD	1
Loizeau, E	1
DeSotel, CK; Dickson, ER; Jorgensen, RA; Laurin, JM; Lindor, KD	1
Alvarez, F; Colombato, LA; Côté, J; Huet, PM	1
Stiehl, A; Theilmann, L; Töx, U	1
Montet, JC; Queneau, PE	1
van Berge-Henegouwen, GP; Van de Meeberg, PC; van Erpecum, KJ	1
Luketic, VA; Sanyal, AJ	1
Buscher, HP; Gerok, W; Zietzschmann, Y	1
van Berge Henegouwen, GP; van de Meeberg, PC; van Erpecum, KJ	1
Janardan, SK; Moseley, RH	1
Aikawa, T; Doy, M; Matsuzaki, Y; Nakano, M; Osuga, T; Shoda, J; Tanaka, N	1
Hanada, H; Okita, K	1
Balkau, B; Guéchot, J; Heintzmann, F; Poupon, RE	1
Michael, S; Prego, V; Simko, V	1
Balkau, B; Poupon, R; Poupon, RE	1
Kaplan, MM	4
Anderson, ML; Baldus, WP; Dickson, ER; Harrison, JM; Jorgensen, RA; Lange, SM; Lindor, KD; Ludwig, J; Murtaugh, PA; Wiesner, RH	1
Bailey, RJ; Blendis, LM; Cauch-Dudek, K; Ghent, CN; Heathcote, EJ; Michieletti, P; Minuk, GY; Pappas, SC; Scully, LJ; Walker, V	1
Schalm, SW; van Buuren, HR; Wolfhagen, FH	1
Jansen, PL; van der Lelie, H	1
Altorfer, J; Ammann, R; Blum, HE; Meyenberger, C; Wirth, HP	1
Fennerty, MB	1
Balladur, P; Cogliandolo, A; Coutris, G; de Saint-Laurent, J; Hannoun, L; Hecht, Y; Kieffel, T; Nordlinger, B; Parc, R; Vaubourdolle, M	1
Fleig, WE; Lotterer, E	1
Bernocchi, P; Fedeli, S; Ferri, F	1
Accatino, L; Arrese, M	1
Bhatti, S; Güldütuna, S; Hübner, K; Leuschner, M; Leuschner, U; Nickel, A; Wunderlich, N	1
Britten, AJ; de Caestecker, JS; Goggin, PM; Jazrawi, RP; Joseph, AE; Maxwell, JD; Northfield, TC	1
Chiaramonte, M; Floreani, A; Mazzetto, M; Naccarato, R; Plebani, M; Zappalà, F	1
Wiesner, RH	2
Hart, LL; Pham, NT	1
Battezzati, PM; Bianchi, FB; Manenti, F; Naccarato, R; Orlandi, F; Pagliaro, L; Podda, M; Surrenti, C	1
Chishima, J; Makita, F; Nagamine, T; Nishijima, K; Ojima, T; Saitoh, S; Satoh, K; Takagi, H; Yamada, S; Yamada, T	1
Fehér, J; Gergely, P; Herszényi, L; Schaff, Z; Szalay, L	1
Buniak, B; Holt, J; Leevy, CB	1
Chrétien, Y; Eschwège, E; Magot, T; Ouguerram, K; Poupon, R; Poupon, RE; Verneau, C	1
Chrétien, Y; Paumgartner, G; Poupon, R; Poupon, RE	1
Kaplan, MM; Pratt, DS	1
Abroon, J; Batta, AK; Batta, M; Mirchandani, R; O'Brien, CB; Salen, G; Senior, JR; Shefer, S; Tint, GS	1
Aldini, R; Bazzoli, F; Cipolla, A; Festi, D; Mazzella, G; Parini, P; Polimeni, C; Roda, A; Tonelli, D; Villanova, N	1
Ishibashi, H	1
Beuers, U; Paumgartner, G; Sauter, G	1
Forsberg, L; Hägerstrand, I; Lyttkens, K; Prytz, H	1
Manns, MP; Schmidt, HH	1
Dickson, ER; Jorgensen, RA; Lindor, KD; Malinchoc, M; Therneau, TM	2
Dickson, ER; Hoofnagle, J; Lindor, KD; Mackay, IE; Maddrey, WC	1
Bailey, RJ; Blendis, LM; Cauch-Dudek, K; Ghent, CN; Heathcote, EJ; Kilmurry, MR; Minuk, GY; O'Rourke, K; Pappas, SC; Scully, LJ; Steinbrecher, UP; Sutherland, LR; Williams, CN; Worobetz, LJ	1
Masuda, T; Nakadate, I; Sato, S; Suzuki, K; Yamazaki, K	1
Rudi, J; Schönig, T; Stremmel, W	1
Desmet, V; Fevery, J; Sciot, R; Van Eyken, P; Van Steenbergen, W	1
Crosignani, A; Podda, M; Rodrigues, CM; Setchell, KD	1
Ansari, A; Jones, JW	1
Raedsch, R; Rudi, J; Stremmel, W; Waldherr, R	1
Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H	1
Dingemans, KP; Elferink, RP; Groen, AK; Offerhaus, GJ; Ottenhoff, R; Tytgat, GN; Van Den Bergh Weerman, MA; Van Nieuwkerk, CM	1
Shiraki, K; Tameda, Y	1
Ikeda, T; Kobayashi, F; Marumo, F; Noguchi, O; Sakamoto, S; Sato, C; Tozuka, S	2
Okuaki, Y; Toda, G	1
Färkkilä, M; Inkovaara, J; Karvonen, AL; Kisand, KE; Kisand, KV; Krohn, K; Lehtola, J; Miettinen, T; Uibo, R; Vuoristo, M	1
Guan, R; Kang, JY; Tay, HH; Wee, A; Yap, I	1
Bhatti, S; Güldütuna, S; Hübner, K; Leuschner, M; Leuschner, U; You, T	1
Canga, F; Castellano, G; Colina, F; Dominguez, P; Herruzo, JA; Rodriguez, S; Sánchez-Pobre, P	1
Bonnand, AM; Huet, PM; Nhieu, JT; Poupon, R; Poupon, RE; Zafrani, ES	1
Feeney, SJ; Hara, K; Ikuno, N; Mackay, IR; Matsuo, I; Omagari, K; Shirono, K; Whittingham, S	1
Makino, I; Tanaka, H	1
Breuer, N; Mahl, MA; Uppenkamp, M; von Schönfeld, J	1
Batts, KP; Dickson, ER; Jorgensen, RA; Lindor, KD	1
Császár, A; Karádi, I; Nemesánszky, E; Romics, L; Szalay, F; Tresch, J	1
Bonnand, AM; Poupon, RE	1
Ikegami, H; Miki, T; Niinobu, T; Ogihara, T; Ono, M; Rakugi, H; Yamanaka, Y; Yasuda, O	1
Kaneko, S; Kobayashi, K; Ogino, H; Saeki, R; Unoura, M	1
Salemans, JM; Tangerman, A; Van Berge-Henegouwen, GP; van Buuren, HR; van de Meeberg, PC; van Erpecum, KJ; van Hattum, J; Wolfhagen, FH	1
Befrits, R; Einarsson, K; Eriksson, LS; Glauman, H; Lindgren, S; Olsson, R; Prytz, H; Rydén, BO; Wallerstedt, S; Wedén, M	1
de Caestecker, JS	1
Jazrawi, RP; Levy, JH; Lim, AG; Northfield, TC; Schalm, SW; van Buuren, HR; Verma, A; Wolfhagen, FH	1
Higuchi, K; Kashii, Y; Miyamoto, M; Shimizu, Y; Tsukishiro, T; Watanabe, A	1
Bruguera, M; Caballería, L; Parés, A; Rodés, J; Saló, J	1
DeLellis, RA; Kaplan, MM; Wolfe, HJ	1
Koga, H; Ohishi, M; Sakisaka, S; Sata, M; Tanikawa, K	1
Allocca, M; Battezzati, PM; Crosignani, A; De Valle, G; Invernizzi, P; Larghi, A; Podda, M; Zuin, M	1
Abroon, J; Batta, AK; Salen, G	1
Jakab, L; Kalabay, L; Nemesánszky, E; Romics, L; Szalay, F; Telegdy, L	1
Batts, KP; Dickson, ER; Homburger, HA; Jorgensen, RA; Kim, WR; Krom, RA; Lindor, KD; Poterucha, JJ; Wiesner, RH	1
Brodanová, M; Perlík, F	1
Färkkilä, M; Gylling, H; Karvonen, AL; Lehtola, J; Leino, R; Makinen, J; Mattila, J; Miettinen, TA; Tilvis, R; Vuoristo, M	1
Antezana, C; Brahm, J; Cumsille, MA; González-Koch, A; Smok, G	1
Egawa, I; Kinoshita, H; Kohno, S; Komatsu, K; Matsuo, I; Nakamura, T; Omagari, K; Shirono, K; Yamasaki, Y	1
Cauch-Dudek, K; Dickson, ER; Heathcote, EJ; Lindor, KD; Poupon, R; Poupon, RE	1
Chang, FY; Chen, CY; Chiu, CF; Lee, SD; Lu, CL	1
Beste, M; Breuer, N; Goebell, H; v Schönfeld, J; Zotz, RB	1
Boberg, KM; Schrumpf, E	1
Fiedler, GM; Grunewald, RW; Müller, GA; Schauer, A; Stöckmann, F	1
Beuers, U; Oswald, M	1
Carithers, RL	1
Goto, J; Kobayashi, N; Oiwa, H	1
Hagey, LR; Hofmann, AF; Jorgensen, RA; Lindor, KD; Ricci, P; Rolland Dickson, E	1
Dickson, ER; Jorgensen, RA; Lindor, KD; Zukowski, TH	1
Chazouillères, O; Montembault, S; Poupon, R; Rosmorduc, O; Serfaty, L; Wendum, D	1
Batta, AK; DeSotel, CK; Dickson, ER; Hofmann, AF; Jorgensen, RA; Lacerda, MA; Lindor, KD; Rossi, SS; Salen, G	1
Hay, JE	1
Noguchi, K; Sakisaka, S; Sasatomi, K; Sata, M; Tanikawa, K	1
Breed, JG; De Smet, MB; Den Ouden-Muller, JW; Engels, LG; Hop, WC; Renooij, W; Rijk, MC; Schalm, SW; Smit, AM; van Berge Henegouwen, GP; van Buuren, HR; Van Hoogstraten, HJ; Zwertbroek, R	1
Karvonen, AL; Kisand, KE; Kisand, KV; Mäkinen, J; Mattila, J; Uibo, R; Vuoristo, M	1
Agraou, B; Agraou, H; Asseman, P; Dujardin, JJ; Le Tourneau, T; Leroy, F	1
de Vries, RA; den Ouden, JW; Hop, WC; Kerbert, MJ; Schalm, SW; Smit, AM; ten Kate, FJ; van Berge-Henegouwen, GP; van Buuren, HR; van der Hoek, EW; van Hoogstraten, HJ; van Lijf, HH; van Zanten, RA; Wolfhagen, FH	1
Amital, H; Bar-Dayan, Y; Gershwin, ME; Levi, Y; Shoenfeld, Y	1
Cauch-Dudek, K; Dickson, ER; Gabriel, S; Heathcote, J; Jorgensen, R; Lindor, KD; Pasha, T; Therneau, T	1
Bonnand, AM; Heathcote, EJ; Lindor, KD; Poupon, RE	1
da Silva, JA; de Medeiros, BC; de Medeiros, CR; Lacerda, MA; Telles, JE	1
Battezzati, PM; Crosignani, A; Invernizzi, P; Larghi, A; O'Connell, NC; Podda, M; Setchell, KD	1
Bateson, MC; Gedling, P	1
Angulo, P; Batts, KP; Dickson, ER; Jorgensen, RA; Lindor, KD; Therneau, TM	1
Fujii, T; Goto, T; Imai, H; Komatsu, M; Masamune, O; Meng, XW; Nakane, K; Ohshima, S; Shibuya, T; Yoneyama, K	1
Balkau, B; Callard, P; Degott, C; Poupon, R; Poupon, RE; Zafrani, ES	1
LaRusso, N	1
Angulo, P; Dickson, ER; Jorgensen, RA; Kamath, PS; Lindor, KD; Malinchoc, M; Therneau, TM	1
Kuroki, T; Shiomi, S	1
Bonner, GF; Boyer, JL; Carithers, RL; Combes, B; Garcia-Tsao, G; Hofmann, AF; Luketic, VA; Maddrey, WC; Munoz, S; Peters, MG; Risser, R; Rossi, SS; Shiffman, ML; White, H; Zetterman, RK	1
Bonnand, AM; Chrétien, Y; Poupon, R; Poupon, RE	1
Anderson, ML; Angulo, P; DeSotel, CK; Dickson, ER; Jorgensen, RA; Lange, SM; Lindor, KD; Mahoney, DW; Smith, C; Therneau, TM	1
García, N; Martí-Climent, JM; Medina, JF; Peñuelas, I; Prieto, J; Richter, JA	1
Batts, KP; Gleich, GJ; Kephart, GM; Kita, H; Lindor, KD; Nakamura, A; Sato, S; Suzuki, K; Tarara, JE; Yamazaki, K	1
Neuberger, J	2
Cauch-Dudek, K; Chazouilleres, O; Dickson, ER; Heathcote, EJ; Lindor, KD; Petz, J; Poupon, R; Poupon, RE; Stone, J	1
Benner, KG	1
Angulo, P; Dickson, ER	2
Ciećko-Michalska, I; Garlicka, M; Janas-Skulina, U; Owczarek, D; Skulina, D; Szczepański, W; Tetnowski, J	1
Hansen, BE; Schalm, SW; ten Kate, FJ; van Berge-Henegouwen, GP; van Buuren, HR; van Hoogstraten, HJ	1
Bonner, GF; Boyer, JL; Carithers, RL; Combes, B; Eigenbrodt, EH; Garcia-Tsao, G; Luketic, VA; Maddrey, WC; Markin, RS; Mills, AS; Munoz, SJ; Peters, MG; Rubin, R; Shiffman, ML; West, AB; Wheeler, DE; White, HM; Zetterman, RK	1
Inaba, K; Ishikawa, H; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakashima, T; Okanoue, T; Sakamoto, Y; Sumida, Y; Yoh, T	1
van Berge-Henegouwen, GP; Vleggaar, FP	1
Ackermann, H; Dahm, HH; Happ, J; Herrmann, G; Leuschner, M; Leuschner, U; Maier, KP; Schlichting, J; Strahl, S	1
Burroughs, AK; Goulis, J; Leandro, G	2
Ahmed, HA; Jazrawi, RP; Northfield, TC; Verma, A	1
Assy, N; Baruch, Y; Blendis, LM; Bomzon, A; Enat, R; Reisner, SA; Rinkevich, D; Weisbruch, F	1
Ahmed, HA; Benson, M; Bland, JM; Davis, T; Jazrawi, RP; Maxwell, JD; Northfield, TC; Orchard, RT; Theodossi, A; Verma, A	1
Chamuleau, RA; Houben, M; Jones, EA; Reesink, HW; ten Kate, FJ; ter Borg, F	1
Angulo, P; Batts, KP; Larson, DR; LaRusso, NF; Lindor, KD; Therneau, TM	1
Harihara, Y; Hashizume, K; Hirata, M; Ito, M; Kita, Y; Kubota, K; Makuuchi, M; Sakakura, H; Takayama, T; Tanaka, H; Yoshino, H	1
Toda, G; Zenia, M	1
Ackermann, H; Dietrich, CF; Herrmann, G; Leuschner, M; Leuschner, U; Raedle, J; Seidl, C; You, T	1
Bonis, PA; Kaplan, MM	1
Deguchi, A; Kurokohchi, K; Masaki, T; Nakai, S; Nishioka, M	1
Angulo, P; Dickson, ER; Jorgensen, RA; Keach, JC; Lindor, KD; Smith, C	1
Heathcote, EJ; Lindor, KD; Poupon, R; Therneau, T	1
Burnevich, EZ; Ignatova, TM	1
Harada, M; Kawaguchi, T; Koga, H; Ohishi, M; Sakisaka, S; Sasatomi, K; Sata, M; Taniguchi, E; Tanikawa, K; Uchimura, Y; Ueno, T	1
Heathcote, EJ	1
Kowdley, KV	1
Berenguer, J; Bruguera, M; Caballería, L; García-Plaza, A; Mercader, J; Parés, A; Rodés, J; Rodrigo, L; Rodríguez-Martínez, D; Velicia, R	1
Poupon, RE	1
Fracchia, M; Galatola, G; Pera, A; Secreto, P; Tabone, M; Zaffino, C	1
Altschuler, EL	1
Broomé, U	1
Bar-Dayan, Y; Gershwin, ME; Shapira, S; Shoenfeld, Y	1
Poupon, R; Poupon, RE	3
Franco, J; Saeian, K	1
Lazaridis, KN; Lindor, KD	1
Angulo, P; Jorgensen, RA; Lindor, KD; Patel, T; Therneau, TM	1
Kurihara, T; Maeda, A; Niimi, A; Shigemoto, M; Yamashita, K	1
Aso, K; Makino, I; Miura, T; Nakamura, K	1
Bonnand, AM; Carrat, F; Corpechot, C; Poupon, R; Poupon, RE	1
Almasio, PL; Ballardini, G; Battezzati, P; Bianchi, FP; Chiaramonte, M; Craxì, A; Crosignani, A; Davies, SE; Floreani, A; Manenti, F; Podda, M; Provenzano, G; Rosina, F; Saccoccio, G; Scheuer, PJ; Todros, L	1
Battezzati, PM; Bignotto, M; De Andreis, C; Invernizzi, P; Perego, F; Podda, M; Rossella, F; Simoni, G; Sirchia, SM; Zuin, M	1
Hahn, EG; Schuppan, D	1
Mikhova, A; Nikolovska, D; Vasilev, P	1
Leuschner, M	1
Voigt, M; Weyman, RL	1
Amati, B; Crosignani, A; Del Puppo, M; Galli Kienle, M; Petroni, ML; Podda, M; Zuin, M	1
Aizawa, Y; Toda, G	1
Bernard, O; Bosma, PJ; Burdelski, M; Cresteil, D; De Vree, JM; Dumont, M; Elferink, RP; Hadchouel, M; Jacquemin, E; Paul, M; Scheffer, GL; Sokal, EM; Sturm, E	1
Kakisaka, Y; Mitsuyoshi, H; Nakashima, T; Sumida, Y; Yoh, T	1
Alvelius, G; Broomé, U; Einarsson, C; Marschall, HU; Matern, S; Thomas, HG	1
Gish, RG; Mason, A	1
Mitsui, Y; Ohmoto, K; Yamamoto, S	1
Christensen, E; Gluud, C	2
Allocca, M; Battezzati, PM; Crosignani, A; Invernizzi, P; Podda, M; Selmi, C; Villa, E; Zuin, M	1
Barbu, V; Benlian, P; Chazouillères, O; Corpechot, C; Poupon, R; Poupon, RE	1
Gershwin, ME	1
Angulo, P; Jorgensen, RA; Lindor, KD	1
Holtmeier, J; Leuschner, U	1
Heathcote, EJ; Lilly, L; Tinmouth, J; Tomlinson, G	1
Batts, K; Cauch-Dudek, K; Heathcote, EJ; Jorgensen, R; Joshi, S; Lindor, KD; Wanless, IR	1
Fukuda, Y; Katano, Y	1
Asakura, H; Fuse, I; Honma, T; Ishizuka, K; Takahashi, T	1
Carrat, F; Corpechot, C; Poupon, R; Poupon, RE	1
Lü, W; Sun, G	1
Azzaroli, F; Ferrara, F; Festi, D; Giovanelli, S; Liva, S; Mazzella, G; Nigro, G; Roda, E	1
Angulo, P; Dickson, ER; Haber, J; Jorgensen, R; Katz, G; Lindor, K; Malkiewicz, I; Neuman, M; Shear, N	1
Linares Rodríguez, A	1
Medina, JF	1
Olsson, R	1
Aamar, S; Ackerman, Z; Heyman, SN; Pappo, O; Rubinger, D; Spectre, G	1
Blendis, LM; Cameron, RG; Haber, JA; Katz, GG; Neuman, MG	1
Brandt, KH; de Vries, RA; Kneppelhout, JC; Mulder, CJ; van Berge Henegouwen, GP	1
Berg, CL; Gollan, JL	1
Güldütuna, S; Imhof, M; Leuschner, U; Zimmer, G	1
Kommerell, B; Raedsch, R; Scherrmann, JM; Stiehl, A; Walker, S	1
Reichen, J; Zimmermann, H	1
Seifert, CF; Vondracek, TG	1
Javitt, NB	1
Perdigoto, R; Wiesner, RH	1
Beuers, U; Fischer, S; Pauletzki, J; Paumgartner, G; Spengler, U; Zwiebel, FM	1
Lirussi, F; Okolicsanyi, L	1
Hayashi, H; Higuchi, T; Hishida, N; Isomura, T; Takeshima, H	1
Aldini, R; Bazzoli, F; Festi, D; Mazzella, G; Parini, P; Roda, E	1
Jansen, PL	1
Fukui, H; Ishizaka, S; Kubo, R; Matsumura, K; Matsumura, Y; Tsujii, T; Yamao, J; Yoshikawa, M	1
Balkau, B; Eschwège, E; Poupon, R; Poupon, RE	1
Barreca, T; Carati, L; Cataldi, A; Cicchetti, V; Franceschini, R; Rolandi, E	1
Chen, DS; Kao, JH; Lai, MY; Lin, JT; Sheu, JC; Sung, JL; Wang, TH; Yang, PM	1
Conchillo, F; García González, N; García Villarreal, L; Macías, E; Prieto, J; Quiroga, J; Zozaya, JM	1
Berenguer Lapuerta, J; Nos Mateu, P; Siles Moreno, MS	1
Kolarski, V	1
Calmus, Y; Poupon, R	1
Kobayashi, K; Nakanuma, Y; Ogino, H; Terasaki, S; Unoura, M	1
de Caestecker, JS; Jazrawi, RP; Northfield, TC; Petroni, ML	1
Stiehl, A; Theilmann, L	1
Hopf, U; Stemerowicz, R	1
Battezzati, PM; Bertolini, E; Crosignani, A; Podda, M; Setchell, KD; Watson, D; Zuin, M	1
Aikawa, T; Doi, M; Matsuzaki, Y; Nakano, M; Osuga, T; Shoda, J; Tanaka, N	1
Eschwège, E; Poupon, R; Poupon, RE	1
Hashimoto, N; Hasumura, Y; Hattori, N; Ikeda, Y; Kamimura, T; Namihisa, T; Ohta, Y; Oka, H; Toda, G; Tsuji, T	1
van Berge Henegouwen, GP; van Erpecum, KJ	1
Brodanová, M; Kordac, V; Marecek, Z	1
Borum, M; Fromm, H	2
Held, C	1
Bos, LP; Engels, LG; Wouters, RS	1
Achord, JL	1
Bircher, J; Foelsch, UR; Lotterer, E; Raedsch, R; Stiehl, A	1
Bircher, J; Endele, R; Fölsch, U; Hopf, U; Klaus, J; Lotterer, E; Möller, B; Raedsch, R; Rudolph, G; Stiehl, A	1
Calmus, Y; Gane, P; Poupon, R; Rouger, P	1
Hopf, U; Möller, B; Raedsch, R; Stiehl, A	1
Fischer, H; Hübner, K; Leuschner, U	1
Fischer, H; Gatzen, M; Güldütuna, S; Hellstern, A; Hübner, K; Kurtz, W; Leuschner, M; Leuschner, U	1
Bateson, MC; Diffey, BL; Ross, PE	1
Aikawa, T; Matsuzaki, Y; Osuga, T; Tanaka, N	1
Aldini, R; Bazzoli, F; Festi, D; Mazzella, G; Minutello, A; Poggi, C; Roda, E; Ronchi, M; Simoni, P; Villanova, N	1
Battezzati, PM; Bertolini, E; Crosignani, A; Ghezzi, C; Petroni, ML; Podda, M; Zuin, M	2
Arora, R; Batta, AK; Eskreis, D; Katz, S; Salen, G; Tint, GS	1
Raedsch, R; Stiehl, A	1
Chazouilleres, O; Chretien, Y; Gherardt, MF; Labbe, D; Myara, A; Poupon, R; Trivin, F	1
Gerhardt, MF; Labbé, D; Myara, A; Trivin, F; Vercambre, C	1
Abroon, J; Arora, R; Batta, AK; Eskreis, D; Katz, S; Salen, G; Shefer, S; Tint, GS	1
Ballet, F; Calmus, Y; Chrétien, Y; Darnis, F; Poupon, R; Poupon, RE	1
Hofmann, AF; Popper, H	1
Kurtz, W; Leuschner, U	1
Braunsteiner, H; Judmaier, G; Kathrein, H; Vogel, W	1
Berg, PA; Caselmann, W; Eder, M; Eisenburg, J; Mannes, AG; Muntau, A; Spengler, U	2
Fujiyama, S; Murata, H; Sato, T; Shibata, J; Yoshida, K	1
Doty, JE; Tompkins, RK	1

Reviews

262 review(s) available for ursodeoxycholic acid and Biliary Cirrhosis

Article	Year
Disease-modifying therapies and symptomatic management for primary biliary cholangitis. British journal of hospital medicine (London, England : 2005), 2021, Nov-02, Volume: 82, Issue:11 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2021
Mechanisms and molecules: What are the treatment targets for primary biliary cholangitis? Hepatology (Baltimore, Md.), 2022, Volume: 76, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Fibrosis; Humans; Inflammation; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis. Medicine, 2022, Mar-04, Volume: 101, Issue:9 Topics: Cholagogues and Choleretics; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2022
Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis. Frontiers in immunology, 2022, Volume: 13 Topics: Cholagogues and Choleretics; Fibric Acids; Humans; Liver Cirrhosis, Biliary; PPAR alpha; Pruritus; Ursodeoxycholic Acid	2022
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients. Canadian journal of gastroenterology & hepatology, 2022, Volume: 2022 Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholestasis; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2022
Efficacy and Safety of Bezafibrate Alone or in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis: Systematic Review and Meta-Analysis. Digestive diseases and sciences, 2023, Volume: 68, Issue:4 Topics: Bezafibrate; Cholagogues and Choleretics; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2023
Primary Biliary Cholangitis in Males: Pathogenesis, Clinical Presentation, and Prognosis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Prognosis; Ursodeoxycholic Acid	2022
The Inconvenient Truth of Primary Biliary Cholangitis/Autoimmune Hepatitis Overlap Syndrome. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Disease Progression; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Syndrome; Ursodeoxycholic Acid	2022
Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Fibrosis; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Hepatocellular Carcinoma in Primary Biliary Cholangitis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Ursodeoxycholic Acid	2022
Treatment of Primary Biliary Cholangitis: First-Line and Second-Line Therapies. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Autoimmune Diseases; Bezafibrate; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Novel Therapies in Primary Biliary Cholangitis: What Is in the Pipeline? Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2022
Liver Transplantation for Primary Biliary Cholangitis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Survival Rate; Ursodeoxycholic Acid	2022
Primary biliary cholangitis as a roadmap for the development of novel treatments for cholestatic liver diseases Journal of hepatology, 2023, Volume: 78, Issue:2 Topics: Cholestasis; Humans; Liver Cirrhosis, Biliary; Membrane Transport Proteins; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2023
Efficacy of fibrates in the treatment of primary biliary cholangitis: a meta-analysis. Clinical and experimental medicine, 2023, Volume: 23, Issue:5 Topics: Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Pruritus; Treatment Outcome; Ursodeoxycholic Acid	2023
Treatment response to ursodeoxycholic acid in primary biliary cholangitis: A systematic review and meta-analysis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:10 Topics: Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2023
Selected Aspects of the Intricate Background of Immune-Related Cholangiopathies-A Critical Overview. Nutrients, 2023, Feb-02, Volume: 15, Issue:3 Topics: Bile Acids and Salts; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
New Treatment Paradigms in Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:8 Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Peroxisome Proliferator-Activated Receptors; Pruritus; Quality of Life; Ursodeoxycholic Acid	2023
[Diagnosis and Treatment of Primary Biliary Cholangitis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2023, 02-25, Volume: 81, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2023
Role of autoantibodies in the clinical management of primary biliary cholangitis. World journal of gastroenterology, 2023, Mar-28, Volume: 29, Issue:12 Topics: Antibodies, Antinuclear; Autoantibodies; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis? Frontiers in immunology, 2023, Volume: 14 Topics: Animals; Cholangitis; Cholestasis; Fibrosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Treatment of Primary Biliary Cholangitis including Transplantation. Clinics in liver disease, 2024, Volume: 28, Issue:1 Topics: Cholagogues and Choleretics; Cholangitis; Female; Fibric Acids; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2024
Primary Biliary Cholangitis: Epidemiology, Diagnosis, and Presentation. Clinics in liver disease, 2024, Volume: 28, Issue:1 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2024
Autoconversion of Autoimmune Liver Diseases. Digestive diseases and sciences, 2020, Volume: 65, Issue:1 Topics: Adult; Autoantibodies; Autoimmunity; Azathioprine; Biomarkers; Cholagogues and Choleretics; Diagnostic Errors; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Mitochondria; Predictive Value of Tests; Prednisone; Treatment Outcome; Ursodeoxycholic Acid	2020
Ursodeoxycholic acid in pregnancy? Journal of hepatology, 2019, Volume: 71, Issue:6 Topics: Adult; Breast Feeding; Cholagogues and Choleretics; Clinical Decision-Making; Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Pregnancy Complications; Treatment Outcome; Ursodeoxycholic Acid	2019
Drug Therapies for Chronic Cholestatic Liver Diseases. Annual review of pharmacology and toxicology, 2020, 01-06, Volume: 60 Topics: Animals; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Disease Progression; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2020
The challenges of primary biliary cholangitis: What is new and what needs to be done. Journal of autoimmunity, 2019, Volume: 105 Topics: Antibodies, Antinuclear; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Congresses as Topic; Female; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2019
Clinical Management of Primary Biliary Cholangitis-Strategies and Evolving Trends. Clinical reviews in allergy & immunology, 2020, Volume: 59, Issue:2 Topics: Animals; Bile Acids and Salts; Biomarkers; Chenodeoxycholic Acid; Combined Modality Therapy; Disease Management; Disease Progression; Disease Susceptibility; Fibrosis; Humans; Immunotherapy; Liver Cirrhosis, Biliary; Liver Transplantation; Molecular Targeted Therapy; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Ursodeoxycholic Acid	2020
Current and potential treatments for primary biliary cholangitis. The lancet. Gastroenterology & hepatology, 2020, Volume: 5, Issue:3 Topics: Benzothiazoles; Bezafibrate; Bile Acids and Salts; Budesonide; Case-Control Studies; Chenodeoxycholic Acid; Cholagogues and Choleretics; Clinical Trials as Topic; Cyclosporine; Disease Progression; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Liver Cirrhosis, Biliary; Liver Transplantation; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Rituximab; Treatment Outcome; United States; United States Food and Drug Administration; Ursodeoxycholic Acid	2020
Primary biliary cholangitis: pathogenesis and therapeutic opportunities. Nature reviews. Gastroenterology & hepatology, 2020, Volume: 17, Issue:2 Topics: Adaptive Immunity; Animals; Autoimmunity; Bile Acids and Salts; Chenodeoxycholic Acid; Chloride-Bicarbonate Antiporters; Cholagogues and Choleretics; Dihydrolipoyllysine-Residue Acetyltransferase; Disease Progression; Environmental Exposure; Epigenesis, Genetic; Humans; Immunity, Innate; Liver Cirrhosis; Liver Cirrhosis, Biliary; MicroRNAs; Organic Anion Transporters, Sodium-Dependent; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Symporters; Ursodeoxycholic Acid	2020
Emerging therapies for PBC. Journal of gastroenterology, 2020, Volume: 55, Issue:3 Topics: Chenodeoxycholic Acid; Disease Progression; End Stage Liver Disease; Female; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Ursodeoxycholic Acid	2020
Emerging drugs for the treatment of primary biliary cholangitis. Expert opinion on emerging drugs, 2020, Volume: 25, Issue:2 Topics: Animals; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Drug Development; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2020
Diagnosis and treatment of primary biliary cholangitis. United European gastroenterology journal, 2020, Volume: 8, Issue:6 Topics: Autoantigens; Autoimmune Diseases; Bezafibrate; Biomarkers; Biopsy; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Elasticity Imaging Techniques; End Stage Liver Disease; Fatigue; Female; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Middle Aged; Off-Label Use; Prognosis; Pruritus; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2020
[Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2020, 05-25, Volume: 75, Issue:5 Topics: Alkaline Phosphatase; Chenodeoxycholic Acid; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Prognosis; Risk Factors; Ursodeoxycholic Acid	2020
Efficacy of ursodeoxycholic acid combined with prednisolone and immunosuppressant triple therapy in the treatment of refractory primary biliary cholangitis. Medicina clinica, 2020, 08-28, Volume: 155, Issue:4 Topics: Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Prednisolone; Ursodeoxycholic Acid	2020
Definition and Management of Patients With Primary Biliary Cholangitis and an Incomplete Response to Therapy. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021, Volume: 19, Issue:11 Topics: Bilirubin; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review. European journal of gastroenterology & hepatology, 2020, Volume: 32, Issue:9 Topics: Alanine Transaminase; Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2020
An insight into primary biliary cholangitis and its recent advances in treatment: semi-synthetic analogs to combat ursodeoxycholic-acid resistance. Expert review of gastroenterology & hepatology, 2020, Volume: 14, Issue:10 Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acids; Humans; Liver Cirrhosis, Biliary; Nitrates; Ursodeoxycholic Acid	2020
Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Digestive diseases and sciences, 2021, Volume: 66, Issue:7 Topics: Carcinoma, Hepatocellular; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Ursodeoxycholic Acid	2021
Primary biliary cholangitis management: controversies, perspectives and daily practice implications from an expert panel. Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:11 Topics: Bile Acids and Salts; Cholestasis; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2020
Review article: pathophysiology and management of primary biliary cholangitis. Alimentary pharmacology & therapeutics, 2020, Volume: 52, Issue:7 Topics: Fatigue; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Metabolic Diseases; Pruritus; Ursodeoxycholic Acid	2020
Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta-Analysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2021, Volume: 27, Issue:6 Topics: Cholagogues and Choleretics; Humans; Incidence; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2021
Current understanding of primary biliary cholangitis. Clinical and molecular hepatology, 2021, Volume: 27, Issue:1 Topics: Carcinoma, Hepatocellular; Cholestasis; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Ursodeoxycholic Acid	2021
Risk factors for recurrent primary biliary cirrhosis after liver transplantation: A systematic review and meta-analysis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2021, Volume: 53, Issue:3 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Secondary Prevention; Tacrolimus; Ursodeoxycholic Acid	2021
Primary biliary cholangitis: treatment. Current opinion in gastroenterology, 2021, 03-01, Volume: 37, Issue:2 Topics: Bilirubin; Humans; Liver Cirrhosis, Biliary; Prognosis; Pruritus; Ursodeoxycholic Acid	2021
Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta-Analysis. Canadian journal of gastroenterology & hepatology, 2021, Volume: 2021 Topics: Chenodeoxycholic Acid; Humans; Lipids; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology, 2021, Volume: 45, Issue:3 Topics: Chenodeoxycholic Acid; Cholestasis; Humans; Liver Cirrhosis, Biliary; Non-alcoholic Fatty Liver Disease; Pharmaceutical Preparations; Ursodeoxycholic Acid	2021
The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to "UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis" by Pedersen et al., Liver Transplant, November Clinics and research in hepatology and gastroenterology, 2021, Volume: 45, Issue:3 Topics: Cholagogues and Choleretics; Humans; Incidence; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2021
Safety of fibrates in cholestatic liver diseases. Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:6 Topics: Bezafibrate; Cholagogues and Choleretics; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Cutting edge issues in juvenile sclerosing cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:4 Topics: Child; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Neoplasm Recurrence, Local; Ursodeoxycholic Acid	2022
Fibrates for the treatment of pruritus in primary biliary cholangitis: a systematic review and meta-analysis. Annals of palliative medicine, 2021, Volume: 10, Issue:7 Topics: Bezafibrate; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2021
Geoepidemiology and changing mortality in primary biliary cholangitis. Journal of gastroenterology, 2017, Volume: 52, Issue:6 Topics: Animals; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Models, Animal; Drug Design; Fluorescent Antibody Technique, Indirect; Humans; Liver Cirrhosis, Biliary; Precision Medicine; Ursodeoxycholic Acid	2017
Old and new treatments for primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:4 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
What Comes after Ursodeoxycholic Acid in Primary Biliary Cholangitis? Digestive diseases (Basel, Switzerland), 2017, Volume: 35, Issue:4 Topics: Chenodeoxycholic Acid; Cholangitis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2017
Primary biliary cholangitis: Old and novel therapy. European journal of internal medicine, 2018, Volume: 47 Topics: Budesonide; Chenodeoxycholic Acid; Disease Progression; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2018
Investigational drugs in phase II clinical trials for primary biliary cholangitis. Expert opinion on investigational drugs, 2017, Volume: 26, Issue:10 Topics: Animals; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Drug Design; Drugs, Investigational; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
An Update on the Treatment and Follow-up of Patients with Primary Biliary Cholangitis. Clinics in liver disease, 2017, Volume: 21, Issue:4 Topics: Aftercare; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Disease Management; Disease Progression; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2017
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis. Expert review of clinical immunology, 2017, Volume: 13, Issue:12 Topics: Autoimmunity; Bile Ducts, Intrahepatic; Chenodeoxycholic Acid; Cholangitis; Fibrosis; Humans; Immunotherapy; Liver; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Ursodeoxycholic Acid; Ustekinumab	2017
[Modern treatment of primary biliary cholangitis]. Der Internist, 2018, Volume: 59, Issue:1 Topics: Bezafibrate; Budesonide; Chenodeoxycholic Acid; Cohort Studies; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Multicenter Studies as Topic; PPAR alpha; Pregnancy; Prognosis; Quality of Life; Receptors, Cytoplasmic and Nuclear; Risk Assessment; Treatment Outcome; Ursodeoxycholic Acid	2018
Current epidemiology and clinical characteristics of autoimmune liver diseases in South Korea. Clinical and molecular hepatology, 2018, Volume: 24, Issue:1 Topics: Anti-Inflammatory Agents; Hepatitis, Autoimmune; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Prednisolone; Prevalence; Republic of Korea; Treatment Outcome; Ursodeoxycholic Acid	2018
Heart and bile acids - Clinical consequences of altered bile acid metabolism. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:4 Pt B Topics: Apoptosis; Arrhythmias, Cardiac; Bile Acids and Salts; Cardiomyopathies; Cholagogues and Choleretics; Cholangitis; Cholestasis, Intrahepatic; Female; Heart; Hemodynamics; Humans; Hydrophobic and Hydrophilic Interactions; Liver Cirrhosis, Biliary; Maternal-Fetal Exchange; Myocytes, Cardiac; Pregnancy; Pregnancy Complications; Prevalence; Ursodeoxycholic Acid	2018
[New name and new treatments for primary biliary cholangitits]. Ugeskrift for laeger, 2018, Mar-05, Volume: 180, Issue:10 Topics: Anti-Inflammatory Agents; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2018
[Primary biliary cholangitis-established and novel therapies]. Der Internist, 2018, Volume: 59, Issue:6 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Pruritus; Quality of Life; Ursodeoxycholic Acid	2018
Primary Biliary Cholangitis and Autoimmune Hepatitis. Surgical pathology clinics, 2018, Volume: 11, Issue:2 Topics: Biopsy; Cholangitis; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Prognosis; Ursodeoxycholic Acid	2018
Novel and emerging therapies for cholestatic liver diseases. Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38, Issue:9 Topics: Bile Acids and Salts; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Drug Therapy, Combination; Elasticity Imaging Techniques; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2018
Cost effectiveness of using ursodeoxycholic acid to treat primary biliary cholangitis. British journal of hospital medicine (London, England : 2005), 2018, Aug-02, Volume: 79, Issue:8 Topics: Cholagogues and Choleretics; Dose-Response Relationship, Drug; Drug Monitoring; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Prognosis; Risk Assessment; Ursodeoxycholic Acid	2018
Current Treatment Options for Primary Biliary Cholangitis. Clinics in liver disease, 2018, Volume: 22, Issue:3 Topics: Alkaline Phosphatase; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Comorbidity; Drug Therapy, Combination; Fenofibrate; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Malnutrition; Osteoporosis; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2018
Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems. Clinics in liver disease, 2018, Volume: 22, Issue:3 Topics: Bilirubin; Blood Coagulation Disorders; Cholagogues and Choleretics; Disease Progression; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Models, Statistical; Prognosis; Serum Albumin; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2018
Overlap Syndrome of Autoimmune Hepatitis and Primary Biliary Cholangitis. Clinics in liver disease, 2018, Volume: 22, Issue:3 Topics: Ascites; Cholagogues and Choleretics; Drug Therapy, Combination; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Glucocorticoids; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Mortality; Ursodeoxycholic Acid	2018
Current Status of Liver Transplantation for Primary Biliary Cholangitis. Clinics in liver disease, 2018, Volume: 22, Issue:3 Topics: Cholagogues and Choleretics; Disease Progression; End Stage Liver Disease; Graft Survival; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Recurrence; Ursodeoxycholic Acid	2018
Prognostic models in primary biliary cholangitis. Journal of autoimmunity, 2018, Volume: 95 Topics: Alkaline Phosphatase; Animals; Biomarkers; Cholagogues and Choleretics; Genomics; Humans; Liver Cirrhosis, Biliary; Machine Learning; Metabolomics; Models, Statistical; Precision Medicine; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid; Whole Genome Sequencing	2018
[PRIMARY BILIARY CHOLANGITIS: THERAPEUTIC APPROACH IN THE MODERN ERA]. Harefuah, 2018, Volume: 157, Issue:12 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Quality of Life; Ursodeoxycholic Acid	2018
[Immune-mediated cholangiopathies : Diagnostic and therapeutic challenges]. Der Radiologe, 2019, Volume: 59, Issue:4 Topics: Bile Duct Diseases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2019
Low-Phospholipid Associated Cholelithiasis (LPAC) syndrome: A synthetic review. Journal of visceral surgery, 2019, Volume: 156, Issue:4 Topics: Adult; Age Factors; ATP Binding Cassette Transporter, Subfamily B; Bile; Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis; Cholangitis, Sclerosing; Cholecystectomy; Cholelithiasis; Codon, Nonsense; Diagnosis, Differential; Female; Gallstones; Humans; Lithiasis; Liver Abscess; Liver Cirrhosis, Biliary; Liver Diseases; Mutation; Phosphatidylcholines; Pregnancy; Pregnancy Complications; Recurrence; Syndrome; Ultrasonography; Ursodeoxycholic Acid	2019
[Ursodeoxycholic acid combined with bezafibrate in the treatment of refractory primary biliary cholangitis: a meta-analysis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019, Apr-20, Volume: 27, Issue:4 Topics: Bezafibrate; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2019
Primary biliary cirrhosis: therapeutic advances. Clinics in liver disease, 2013, Volume: 17, Issue:2 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2013
[Review of overlap syndromes in autoimmune liver diseases. Diagnostic and therapeutic difficulties]. Orvosi hetilap, 2013, Jun-16, Volume: 154, Issue:24 Topics: Adrenal Cortex Hormones; Autoantibodies; Autoimmunity; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Syndrome; Ursodeoxycholic Acid	2013
Clinical management of autoimmune biliary diseases. Journal of autoimmunity, 2013, Volume: 46 Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Outcome Assessment, Health Care; Prognosis; Ursodeoxycholic Acid	2013
Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2013, Volume: 27, Issue:7 Topics: Adult; Alkaline Phosphatase; Cholangitis, Sclerosing; Cholestasis; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2013
Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis. Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:3 Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; Humans; Immunosuppression Therapy; Liver Cirrhosis, Biliary; Liver Transplantation; Prognosis; Time Factors; Ursodeoxycholic Acid	2014
Primary biliary cirrhosis in adults. Expert review of gastroenterology & hepatology, 2014, Volume: 8, Issue:4 Topics: Adult; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2014
Fibrate treatment for primary biliary cirrhosis. Current opinion in gastroenterology, 2014, Volume: 30, Issue:3 Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Fibric Acids; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Treatment Failure; Treatment Outcome; Ursodeoxycholic Acid	2014
Pregnancy in women with primary biliary cirrhosis. Autoimmunity reviews, 2014, Volume: 13, Issue:9 Topics: Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Ursodeoxycholic Acid	2014
The natural history of primary biliary cirrhosis. Seminars in liver disease, 2014, Volume: 34, Issue:3 Topics: Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Pregnancy; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2014
Old and novel therapies for primary biliary cirrhosis. Seminars in liver disease, 2014, Volume: 34, Issue:3 Topics: Anti-Inflammatory Agents; Antipruritics; Bile Ducts, Intrahepatic; Bone Density Conservation Agents; Cholagogues and Choleretics; Dietary Supplements; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Osteoporosis; Pruritus; Treatment Outcome; Ursodeoxycholic Acid	2014
Primary biliary cirrhosis: overlaps with other autoimmune disorders. Seminars in liver disease, 2014, Volume: 34, Issue:3 Topics: Animals; Autoimmune Diseases; Autoimmunity; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Prevalence; Treatment Outcome; Ursodeoxycholic Acid	2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. Gastroenterology, 2014, Volume: 147, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; Biomarkers; Cholagogues and Choleretics; Education, Medical, Continuing; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Risk Factors; Survival Analysis; Ursodeoxycholic Acid	2014
Primary biliary cirrhosis in the era of liver transplantation. Annals of transplantation, 2014, Sep-29, Volume: 19 Topics: Cholagogues and Choleretics; Humans; Immunosuppression Therapy; Liver Cirrhosis, Biliary; Liver Transplantation; Recurrence; Risk Factors; Ursodeoxycholic Acid	2014
Diagnosis and management of primary biliary cirrhosis. Expert review of clinical immunology, 2014, Volume: 10, Issue:12 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2014
Diagnosis and management of overlap syndromes. Clinics in liver disease, 2015, Volume: 19, Issue:1 Topics: Autoantibodies; Cholagogues and Choleretics; Cholangitis, Sclerosing; Diagnosis, Differential; Disease Progression; Hepatitis, Autoimmune; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Syndrome; Ursodeoxycholic Acid	2015
Advances in pharmacotherapy for primary biliary cirrhosis. Expert opinion on pharmacotherapy, 2015, Volume: 16, Issue:5 Topics: Autoimmune Diseases; Bile Acids and Salts; Budesonide; Chenodeoxycholic Acid; End Stage Liver Disease; Female; Fibric Acids; Humans; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Treatment Failure; Ursodeoxycholic Acid	2015
Liver alkaline phosphatase: a missing link between choleresis and biliary inflammation. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:6 Topics: Adenosine Triphosphate; Alkaline Phosphatase; Animals; Bile; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Infections; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2015
Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis. Drug design, development and therapy, 2015, Volume: 9 Topics: Budesonide; Chi-Square Distribution; Cholagogues and Choleretics; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Odds Ratio; Randomized Controlled Trials as Topic; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2015
Novel therapeutic targets in primary biliary cirrhosis. Nature reviews. Gastroenterology & hepatology, 2015, Volume: 12, Issue:3 Topics: Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Ursodeoxycholic Acid	2015
Fibrates and cholestasis. Hepatology (Baltimore, Md.), 2015, Volume: 62, Issue:2 Topics: Biomarkers; Cholestasis; Female; Fibric Acids; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; PPAR alpha; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2015
Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis. Medicine, 2015, Volume: 94, Issue:11 Topics: Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2015
Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis. Drug design, development and therapy, 2015, Volume: 9 Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Middle Aged; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2015
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis. Oncotarget, 2015, Sep-15, Volume: 6, Issue:27 Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Bezafibrate; Bile Ducts; Colchicine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Penicillamine; Treatment Outcome; Ursodeoxycholic Acid	2015
Primary biliary cirrhosis: safety and benefits of established and emerging therapies. Expert opinion on drug safety, 2015, Volume: 14, Issue:9 Topics: Adult; Animals; Disease Progression; Drug Design; Fatigue; Humans; Liver Cirrhosis, Biliary; Pruritus; Quality of Life; Ursodeoxycholic Acid	2015
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy. Gastroenterology, 2015, Volume: 149, Issue:7 Topics: Adult; Age Factors; Aged; Biomarkers; Cholagogues and Choleretics; Decision Support Techniques; Disease Progression; Disease-Free Survival; Europe; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; North America; Predictive Value of Tests; Proportional Hazards Models; Reproducibility of Results; Risk Assessment; Risk Factors; Sex Factors; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2015
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis. Drug design, development and therapy, 2015, Volume: 9 Topics: Bezafibrate; Biomarkers; Chi-Square Distribution; Drug Therapy, Combination; Humans; Liver; Liver Cirrhosis, Biliary; Odds Ratio; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2015
Obeticholic acid for the treatment of primary biliary cirrhosis. Expert review of clinical pharmacology, 2016, Volume: 9, Issue:1 Topics: Animals; Chenodeoxycholic Acid; Dose-Response Relationship, Drug; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Pruritus; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2016
Novel Therapies on Primary Biliary Cirrhosis. Clinics in liver disease, 2016, Volume: 20, Issue:1 Topics: Abatacept; Anti-Retroviral Agents; Antibodies, Monoclonal, Humanized; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Fenofibrate; Glucocorticoids; Humans; Hypolipidemic Agents; Immunologic Factors; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Receptors, Cytoplasmic and Nuclear; Rituximab; Ursodeoxycholic Acid; Ustekinumab	2016
Therapeutic advances for primary biliary cholangitis: the old and the new. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:6 Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclosporine; Enzyme Inhibitors; Fibric Acids; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Methotrexate; Mycophenolic Acid; Pyridones; Rituximab; Tacrolimus; Ursodeoxycholic Acid; Ustekinumab	2016
Primary Biliary Cirrhosis Beyond Ursodeoxycholic Acid. Seminars in liver disease, 2016, Volume: 36, Issue:1 Topics: Animals; Cholagogues and Choleretics; Humans; Liver; Liver Cirrhosis, Biliary; Molecular Targeted Therapy; Signal Transduction; Treatment Outcome; Ursodeoxycholic Acid	2016
Emerging drugs for the treatment of Primary Biliary Cholangitis. Expert opinion on emerging drugs, 2016, Volume: 21, Issue:1 Topics: Alkaline Phosphatase; Animals; Autoantibodies; Cholangitis; Chronic Disease; Disease Progression; Drug Design; Female; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Male; Mitochondria; Ursodeoxycholic Acid	2016
Toward precision medicine in primary biliary cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2016, Volume: 48, Issue:8 Topics: Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis; Clinical Trials as Topic; Disease Progression; Elasticity Imaging Techniques; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Precision Medicine; Ursodeoxycholic Acid	2016
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach. Autoimmunity reviews, 2016, Volume: 15, Issue:9 Topics: Animals; Bile Ducts; Cholagogues and Choleretics; Cholangitis; Disease Progression; End Stage Liver Disease; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2016
Obeticholic Acid: First Global Approval. Drugs, 2016, Volume: 76, Issue:12 Topics: Chenodeoxycholic Acid; Drug Approval; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2016
Insight into the natural history of primary biliary cirrhosis: A systemic review of data from placebo-controlled clinical trials. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2016, Volume: 27, Issue:4 Topics: Alkaline Phosphatase; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2016
Obeticholic acid for the treatment of primary biliary cholangitis. Expert opinion on pharmacotherapy, 2016, Volume: 17, Issue:13 Topics: Animals; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; End Stage Liver Disease; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2016
Autoimmune liver diseases in the Asia-Pacific region: Proceedings of APASL symposium on AIH and PBC 2016. Hepatology international, 2016, Volume: 10, Issue:6 Topics: Asia; Congresses as Topic; Disease Management; Female; Hepatitis, Autoimmune; Humans; Japan; Liver Cirrhosis, Biliary; Male; Taiwan; Ursodeoxycholic Acid	2016
FXR Agonists: From Bench to Bedside, a Guide for Clinicians. Digestive diseases and sciences, 2016, Volume: 61, Issue:12 Topics: Animals; Azepines; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholestasis; Drug Evaluation, Preclinical; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Indoles; Isoxazoles; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Diseases; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2016
Systematic review: recurrent autoimmune liver diseases after liver transplantation. Alimentary pharmacology & therapeutics, 2017, Volume: 45, Issue:4 Topics: Adult; Clinical Trials as Topic; Cyclosporine; Female; Graft Survival; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Recurrence; Steroids; Survival Rate; Tacrolimus; Ursodeoxycholic Acid	2017
Management of cholestatic disease in 2017. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37 Suppl 1 Topics: Bile Acids and Salts; Bile Ducts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
Novel Treatment Strategies for Primary Biliary Cholangitis. Seminars in liver disease, 2017, Volume: 37, Issue:1 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Fibric Acids; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2017
Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis. Journal of immunology research, 2017, Volume: 2017 Topics: Alleles; Cholangitis; Disease Susceptibility; Genetic Predisposition to Disease; Genome-Wide Association Study; HLA Antigens; Humans; Liver Cirrhosis, Biliary; Polymorphism, Genetic; Ursodeoxycholic Acid	2017
Clinical features and management of primary biliary cirrhosis. World journal of gastroenterology, 2008, Jun-07, Volume: 14, Issue:21 Topics: Animals; Autoimmune Diseases; Bone Diseases, Metabolic; Cholagogues and Choleretics; Cholestyramine Resin; Disease Progression; Fatigue; Humans; Hyperlipidemias; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Transplantation; Malnutrition; Pruritus; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2008
Overlap syndromes among autoimmune liver diseases. World journal of gastroenterology, 2008, Jun-07, Volume: 14, Issue:21 Topics: Adolescent; Adult; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2008
Treatment of hypercholesterolemia in patients with primary biliary cirrhosis might be more beneficial than indicated. Swiss medical weekly, 2008, Jul-26, Volume: 138, Issue:29-30 Topics: Cardiovascular Diseases; Clofibric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid	2008
Ursodeoxycholic acid for primary biliary cirrhosis. The Cochrane database of systematic reviews, 2008, Jul-16, Issue:3 Topics: Administration, Oral; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2008
Primary biliary cirrhosis. Seminars in immunopathology, 2009, Volume: 31, Issue:3 Topics: Autoantibodies; Autoimmunity; Biomarkers; Clinical Trials as Topic; Female; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Prevalence; Prognosis; Sex Factors; Ursodeoxycholic Acid	2009
The development of autoimmune hepatitis and primary biliary cirrhosis overlap syndrome during the course of connective tissue diseases: report of three cases and review of the literature. Digestive diseases and sciences, 2010, Volume: 55, Issue:8 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Middle Aged; Scleroderma, Systemic; Sjogren's Syndrome; Ursodeoxycholic Acid	2010
[Primary biliary cirrhosis: therapeutic options]. Recenti progressi in medicina, 2009, Volume: 100, Issue:9 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2009
[Primary biliary cirrhosis]. Nederlands tijdschrift voor geneeskunde, 2009, Volume: 153 Topics: Age Factors; Autoantibodies; Fatigue; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Prevalence; Prognosis; Pruritus; Sex Factors; Ursodeoxycholic Acid	2009
[The clinical characteristics of primary biliary cirrhosis in China: a systematic review]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2009, Volume: 17, Issue:11 Topics: Adult; Alanine Transaminase; Autoantibodies; Biomarkers; China; Female; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mitochondria, Liver; Retrospective Studies; Ursodeoxycholic Acid	2009
Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:3 Topics: Drug Administration Schedule; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Mitochondria, Liver; Treatment Outcome; Ursodeoxycholic Acid	2010
Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis. Current gastroenterology reports, 2010, Volume: 12, Issue:1 Topics: Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Clinical Protocols; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2010
Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology, 2010, Volume: 139, Issue:5 Topics: Animals; Apoptosis; Bile; Cholagogues and Choleretics; Cholestasis; Cytokines; Hepatocytes; Humans; Immunity, Cellular; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Prognosis; Risk Factors; Ursodeoxycholic Acid	2010
Primary biliary cirrhosis. Best practice & research. Clinical gastroenterology, 2010, Volume: 24, Issue:5 Topics: Animals; Disease Management; Disease Progression; Environmental Exposure; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Major Histocompatibility Complex; Mitochondria, Liver; Treatment Failure; Ursodeoxycholic Acid	2010
Risk factors and prediction of long-term outcome in primary biliary cirrhosis. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:1 Topics: Autoantibodies; Disease Progression; Genetic Predisposition to Disease; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Liver Cirrhosis, Biliary; Liver Failure; Prognosis; Risk Factors; Ursodeoxycholic Acid	2011
The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis: a conceptual view. Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:7 Topics: Apoptosis; Autoantibodies; Autoantigens; Humans; Immunity, Innate; Liver Cirrhosis, Biliary; Mitochondria; Receptors, Cholinergic; Ursodeoxycholic Acid	2011
The diagnosis and treatment of primary biliary cirrhosis. The Korean journal of hepatology, 2011, Volume: 17, Issue:3 Topics: Autoantibodies; Autoimmunity; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2011
Bezafibrate for primary biliary cirrhosis. The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1 Topics: Alanine Transaminase; Alkaline Phosphatase; Bezafibrate; Bilirubin; Drug Therapy, Combination; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Immunoglobulin M; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2012
[Principles and perspectives of primary biliary cirrhosis therapy]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2012, Issue:3 Topics: Antibodies, Monoclonal; Fatigue; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Practice Guidelines as Topic; Pruritus; Receptors, Cytoplasmic and Nuclear; S-Adenosylmethionine; Treatment Outcome; Ursodeoxycholic Acid	2012
Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. International journal of molecular sciences, 2012, Volume: 13, Issue:7 Topics: Animals; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Coenzyme A; Cyclic AMP; DNA Repair; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Regeneration; Tumor Suppressor Protein p53; Ursodeoxycholic Acid	2012
[Primary biliary cirrhosis (PBC)]. Duodecim; laaketieteellinen aikakauskirja, 2012, Volume: 128, Issue:15 Topics: Alkaline Phosphatase; Biomarkers; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Mitochondria, Liver; Prognosis; Ursodeoxycholic Acid	2012
Primary biliary cirrhosis and bile acids. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Anti-Inflammatory Agents; Bile Acids and Salts; Cholagogues and Choleretics; Humans; Immunologic Factors; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2012
Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Animals; Anti-Inflammatory Agents; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Evidence-Based Medicine; Gastrointestinal Agents; Humans; Immunologic Factors; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Treatment Outcome; Ursodeoxycholic Acid	2012
Ursodeoxycholic acid for primary biliary cirrhosis. The Cochrane database of systematic reviews, 2012, Dec-12, Volume: 12 Topics: Administration, Oral; Cause of Death; Cholagogues and Choleretics; Chronic Disease; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2012
Role of autoimmunity in primary biliary cirrhosis. World journal of gastroenterology, 2012, Dec-28, Volume: 18, Issue:48 Topics: Animals; Autoantibodies; Autoimmunity; B-Lymphocytes; CD4-Positive T-Lymphocytes; Chemokines; Disease Models, Animal; Female; Humans; Immunity, Cellular; Immunity, Humoral; Immunity, Innate; Immunoglobulin M; Interleukin-2 Receptor alpha Subunit; Killer Cells, Natural; Liver Cirrhosis, Biliary; Mice; Ursodeoxycholic Acid	2012
[Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis]. Deutsche medizinische Wochenschrift (1946), 2002, Sep-06, Volume: 127, Issue:36 Topics: Adult; Autoimmune Diseases; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Prognosis; Ursodeoxycholic Acid	2002
[Autoimmune hepatitis and overlap syndrome: therapy]. Praxis, 2002, Aug-21, Volume: 91, Issue:34 Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Haplotypes; Hepatitis, Autoimmune; HLA Antigens; Humans; Liver Cirrhosis, Biliary; Prednisolone; Syndrome; Ursodeoxycholic Acid	2002
[Development of bile acid therapy; from a choleretic to an immunomodulator, and at present time]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2002, Volume: 99, Issue:10 Topics: Apoptosis; Bile Acids and Salts; Histocompatibility Antigens Class II; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2002
Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis)? Alimentary pharmacology & therapeutics, 2003, Volume: 17, Issue:1 Topics: Antibodies; Cholangitis; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Mitochondria, Liver; Treatment Outcome; Ursodeoxycholic Acid	2003
[Cholestasis. Recent diagnostic and therapeutic acquisitions]. Recenti progressi in medicina, 2003, Volume: 94, Issue:1 Topics: Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cholestasis; Cholestasis, Intrahepatic; Clinical Trials as Topic; Endoscopy, Digestive System; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Magnetic Resonance Imaging; Meta-Analysis as Topic; Mutation; Risk Factors; Time Factors; Ursodeoxycholic Acid	2003
[Primary biliary cirrhosis]. Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:3 Pt 1 Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy, Needle; Cholagogues and Choleretics; Female; Gastroscopy; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Middle Aged; Patient Selection; Prednisolone; Rifampin; Ursodeoxycholic Acid	2003
[Treatment of cholestatic liver diseases]. Duodecim; laaketieteellinen aikakauskirja, 2003, Volume: 119, Issue:6 Topics: Adrenal Cortex Hormones; Antimetabolites; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholestasis; Colchicine; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Stents; Ursodeoxycholic Acid	2003
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. Journal of hepatology, 2003, Volume: 39, Issue:1 Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2003
Ursodeoxycholic acid for primary biliary cirrhosis: treat early to slow progression. Journal of hepatology, 2003, Volume: 39, Issue:1 Topics: Cholagogues and Choleretics; Disease Progression; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2003
[Treatment of primary biliary cirrhosis]. Orvosi hetilap, 2003, Sep-07, Volume: 144, Issue:36 Topics: Antioxidants; Cholagogues and Choleretics; Cholestasis; Cholestyramine Resin; Colchicine; Enzyme Inhibitors; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Ursodeoxycholic Acid	2003
Natural history of primary biliary cirrhosis. Clinics in liver disease, 2003, Volume: 7, Issue:4 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Models, Theoretical; Prognosis; Survival Analysis; Ursodeoxycholic Acid	2003
[Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy]. Der Internist, 2004, Volume: 45, Issue:1 Topics: Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Hepatitis, Autoimmune; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Mitochondria, Liver; Prognosis; Syndrome; Ursodeoxycholic Acid	2004
[Autoimmune liver disease: diagnosis and therapy]. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:1 Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Immunoassay; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prognosis; Ultrasonography; Ursodeoxycholic Acid	2004
Colchicine for primary biliary cirrhosis. The Cochrane database of systematic reviews, 2004, Issue:2 Topics: Cholagogues and Choleretics; Colchicine; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2004
Options for treatment of primary biliary cirrhosis. Drugs, 2004, Volume: 64, Issue:20 Topics: Aged; Antipruritics; Cholagogues and Choleretics; Clinical Trials as Topic; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid	2004
[Hepatitis 2004: an update]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Antiviral Agents; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis; Hepatitis A; Hepatitis B; Hepatitis C; Hepatitis D; Hepatitis E; Hepatitis, Alcoholic; Humans; Laparoscopy; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Physical Examination; Ultrasonography; Ursodeoxycholic Acid; Weight Loss	2004
[Cholestatic liver diseases]. Therapeutische Umschau. Revue therapeutique, 2004, Volume: 61, Issue:8 Topics: Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Anticholesteremic Agents; Antipruritics; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiography; Cholangitis; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Clinical Enzyme Tests; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Immunosuppression Therapy; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Naloxone; Naltrexone; Narcotic Antagonists; Ondansetron; Plasmapheresis; Ursodeoxycholic Acid	2004
Predictive models of natural history in primary biliary cirrhosis. Clinics in liver disease, 1998, Volume: 2, Issue:2 Topics: Disease Progression; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis, Biliary; Models, Theoretical; Survival Rate; Ursodeoxycholic Acid	1998
Management of primary biliary cirrhosis and autoimmune cholangitis. Clinics in liver disease, 1998, Volume: 2, Issue:2 Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Cholangitis; Colchicine; Disease Progression; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Penicillamine; Ursodeoxycholic Acid	1998
Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. Alimentary pharmacology & therapeutics, 2005, Feb-01, Volume: 21, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Disease Progression; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome; Ursodeoxycholic Acid	2005
Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis. Digestive diseases and sciences, 2005, Volume: 50, Issue:1 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Cholagogues and Choleretics; Female; gamma-Glutamyltransferase; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Puerperal Disorders; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2005
Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:4 Suppl 2 Topics: Animals; Bile; Bile Acids and Salts; Biliary Tract; Biological Transport, Active; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Humans; Liver; Liver Cirrhosis, Biliary; Mice; Mutation; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2005
Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis. Clinical reviews in allergy & immunology, 2005, Volume: 28, Issue:2 Topics: Autoantibodies; Cholagogues and Choleretics; Cholangitis, Sclerosing; Diagnosis, Differential; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Prevalence; Ursodeoxycholic Acid	2005
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Clinical reviews in allergy & immunology, 2005, Volume: 28, Issue:2 Topics: Adrenal Cortex Hormones; Apoptosis; Cholangitis, Sclerosing; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Prednisolone; Ursodeoxycholic Acid	2005
[Primary biliary cirrhosis (PBC)]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 5 Topics: Adrenal Cortex Hormones; Autoantibodies; Autoimmunity; CD4-Positive T-Lymphocytes; Dihydrolipoyllysine-Residue Acetyltransferase; Humans; Liver Cirrhosis, Biliary; Mitochondria, Liver; Pyruvate Dehydrogenase Complex; Ursodeoxycholic Acid	2005
[Possibilities in the treatment of primary biliary cirrhosis]. Orvosi hetilap, 2005, Jun-05, Volume: 146, Issue:23 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Retroviral Agents; Bezafibrate; Eosinophilia; Humans; Hypolipidemic Agents; Immunologic Factors; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Sulindac; Ursodeoxycholic Acid	2005
Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2005, Volume: 46, Issue:3 Topics: Acidosis, Renal Tubular; Adrenal Cortex Hormones; Aged; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Autoimmune Diseases; Biopsy; Bone Diseases, Metabolic; Calcitriol; Fanconi Syndrome; Female; Humans; Ketoglutarate Dehydrogenase Complex; Kidney; Kidney Failure, Chronic; Liver; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria; Mitochondria, Liver; Nephritis, Interstitial; Phosphates; Pyruvate Dehydrogenase Complex; Ursodeoxycholic Acid	2005
Ursodeoxycholic acid in the therapy for primary biliary cirrhosis: effects on progression and prognosis. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:9 Topics: Disease Progression; Humans; Liver Cirrhosis, Biliary; Prognosis; Recovery of Function; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2005
Overlap syndromes. Seminars in liver disease, 2005, Volume: 25, Issue:3 Topics: Adult; Age of Onset; Aged; Cholagogues and Choleretics; Cholangitis, Sclerosing; Comorbidity; Diagnosis, Differential; Disease Progression; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Failure; Male; Prognosis; Syndrome; Ursodeoxycholic Acid	2005
The natural history of PBC: has it changed? Seminars in liver disease, 2005, Volume: 25, Issue:3 Topics: Cholagogues and Choleretics; Esophageal and Gastric Varices; Humans; Liver Cirrhosis, Biliary; Models, Theoretical; Prognosis; Survival; Ursodeoxycholic Acid	2005
Future Treatment Options in PBC. Seminars in liver disease, 2005, Volume: 25, Issue:3 Topics: Autoimmunity; Cell Movement; Cell Proliferation; Cholagogues and Choleretics; Combined Modality Therapy; Disease Progression; Enzyme Inhibitors; Humans; Immunoglobulins; Immunotherapy; Inflammation; Liver Cirrhosis; Liver Cirrhosis, Biliary; Oxidation-Reduction; T-Lymphocytes; Ursodeoxycholic Acid	2005
Primary biliary cirrhosis. The New England journal of medicine, 2005, Sep-22, Volume: 353, Issue:12 Topics: Antibodies, Antinuclear; Apoptosis; Autoimmune Diseases; Bile Ducts; Cholagogues and Choleretics; Colchicine; Humans; Liver Cirrhosis, Biliary; Methotrexate; Mitochondria; Pyruvic Acid; T-Lymphocytes; Ursodeoxycholic Acid	2005
New therapeutical indications of ursodeoxycholic acid. Romanian journal of gastroenterology, 2005, Volume: 14, Issue:3 Topics: Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Female; Hepatocytes; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Mitochondria, Liver; Oxidative Stress; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid	2005
Development of primary biliary cirrhosis in a patient with Crohn's disease: a case report and review of the literature. Digestive diseases and sciences, 2005, Volume: 50, Issue:12 Topics: Adult; Biopsy, Needle; Cholangiopancreatography, Endoscopic Retrograde; Colonoscopy; Crohn Disease; Follow-Up Studies; Humans; Immunohistochemistry; Liver Cirrhosis, Biliary; Male; Risk Assessment; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2005
Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials. The American journal of gastroenterology, 2006, Volume: 101, Issue:7 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2006
Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets. World journal of gastroenterology, 2006, Jul-28, Volume: 12, Issue:28 Topics: Animals; Apoptosis; Bile; Bile Acids and Salts; Cholestasis, Intrahepatic; Chronic Disease; Hepatocytes; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2006
Recurrent primary biliary cirrhosis after liver transplantation--the disease and its management. MedGenMed : Medscape general medicine, 2006, May-03, Volume: 8, Issue:2 Topics: Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Recurrence; Risk Factors; Ursodeoxycholic Acid	2006
[Treatment of cholestatic hepatic diseases: more than the substitution of fat soluble vitamins?]. Der Internist, 2006, Volume: 47, Issue:12 Topics: Adult; Age Factors; Bile Acids and Salts; Bile Duct Neoplasms; Cholangiocarcinoma; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Infant, Newborn; Liver Cirrhosis, Biliary; Long-Term Care; Middle Aged; Pregnancy; Risk Factors; Ursodeoxycholic Acid	2006
Hepatology may have problems with putative surrogate outcome measures. Journal of hepatology, 2007, Volume: 46, Issue:4 Topics: Antiviral Agents; Bilirubin; Biomarkers; Cholagogues and Choleretics; Gastroenterology; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Liver Cirrhosis, Biliary; Liver Diseases; Outcome Assessment, Health Care; Reproducibility of Results; Ribavirin; Ursodeoxycholic Acid; Viral Load	2007
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Current gastroenterology reports, 2007, Volume: 9, Issue:1 Topics: Animals; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2007
Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses. The American journal of gastroenterology, 2007, Volume: 102, Issue:8 Topics: Bayes Theorem; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Ursodeoxycholic Acid; Weight Gain	2007
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. The New England journal of medicine, 2007, Oct-11, Volume: 357, Issue:15 Topics: Cholagogues and Choleretics; Female; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Practice Guidelines as Topic; Ursodeoxycholic Acid	2007
Primary biliary cirrhosis. Orphanet journal of rare diseases, 2008, Jan-23, Volume: 3 Topics: Aged; Antibodies, Antinuclear; Autoimmune Diseases; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Sex Factors; Ursodeoxycholic Acid	2008
[Pathologic diagnosis of autoimmune liver disease]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2007, Volume: 36, Issue:11 Topics: Autoimmune Diseases; Cholangitis; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Interferon-gamma; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2007
The medical management of primary sclerosing cholangitis. Medscape journal of medicine, 2008, Mar-12, Volume: 10, Issue:3 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Practice Patterns, Physicians'; Ursodeoxycholic Acid	2008
Natural history of primary biliary cirrhosis. Clinics in liver disease, 2008, Volume: 12, Issue:2 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2008
Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents. Clinics in liver disease, 2008, Volume: 12, Issue:2 Topics: Cholagogues and Choleretics; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2008
[Bile acids in liver diseases--current indications]. Therapeutische Umschau. Revue therapeutique, 1995, Volume: 52, Issue:10 Topics: Bile Acids and Salts; Biliary Atresia; Child; Cholangitis, Sclerosing; Female; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Male; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid	1995
Ursodeoxycholic acid therapy in primary biliary cirrhosis. Scandinavian journal of gastroenterology. Supplement, 1994, Volume: 204 Topics: Clinical Trials as Topic; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Ursodeoxycholic Acid	1994
[Ursodeoxycholic acid: hope in the treatment of liver diseases]. Revue medicale de la Suisse romande, 1994, Volume: 114, Issue:9 Topics: Animals; Cholangitis, Sclerosing; Cholelithiasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Postcholecystectomy Syndrome; Rats; Ursodeoxycholic Acid	1994
Hepatoprotection by hydrophilic bile salts. Journal of hepatology, 1994, Volume: 21, Issue:2 Topics: Bile Acids and Salts; Cholangitis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	1994
Therapy with ursodeoxycholic acid in cholestatic liver disease. Scandinavian journal of gastroenterology. Supplement, 1993, Volume: 200 Topics: Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Postoperative Care; Pregnancy; Pregnancy Complications; Recurrence; Ursodeoxycholic Acid	1993
[Ursodeoxycholic acid in the treatment of primary biliary liver cirrhosis]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:2 Pt 3 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease. The Gastroenterologist, 1994, Volume: 2, Issue:1 Topics: Alagille Syndrome; Biliary Atresia; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	1994
Rationale for therapy with ursodeoxycholic acid in patients with cholestatic liver disease. The Netherlands journal of medicine, 1993, Volume: 43, Issue:5-6 Topics: Bile Acids and Salts; Cholestasis; Enterohepatic Circulation; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	1993
[Primary biliary cirrhosis: therapy and prognosis]. Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:1 Topics: Clinical Trials as Topic; Colchicine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Prognosis; Ursodeoxycholic Acid	1994
Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis. The American journal of gastroenterology, 1994, Volume: 89, Issue:3 Topics: Hepatitis, Alcoholic; Hepatitis, Chronic; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Treatment Outcome; Ursodeoxycholic Acid	1994
Primary sclerosing cholangitis and primary biliary cirrhosis. How effective is medical therapy? Postgraduate medicine, 1993, Nov-01, Volume: 94, Issue:6 Topics: Adult; Anti-Bacterial Agents; Cholangitis, Sclerosing; Clinical Trials as Topic; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Methotrexate; Middle Aged; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	1993
[Ursodeoxycholic acid in the treatment of cholestatic liver diseases]. Revista medica de Chile, 1993, Volume: 121, Issue:4 Topics: Bile; Cholestasis; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1993
Use of ursodeoxycholic acid in primary biliary cirrhosis. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:12 Topics: Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1993
[Ursodeoxycholic acid therapy in biliary cirrhosis]. Orvosi hetilap, 1993, Sep-19, Volume: 134, Issue:38 Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Clinical Enzyme Tests; Female; Humans; Immunoglobulin G; Immunologic Tests; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	1993
[Primary biliary cirrhosis--antimitochondrial antibody and the reactive antigens]. Fukuoka igaku zasshi = Hukuoka acta medica, 1995, Volume: 86, Issue:10 Topics: Autoantibodies; Autoantigens; B-Lymphocytes; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Mitochondria; T-Lymphocytes; Ursodeoxycholic Acid	1995
[Primary biliary cirrhosis and ursodeoxycholic acid therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1996, Mar-10, Volume: 85, Issue:3 Topics: Adjuvants, Immunologic; Cholagogues and Choleretics; Clinical Trials as Topic; Diagnosis, Differential; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1996
[Chronic non-suppurative destructive cholangitis (CNSDC)]. Ryoikibetsu shokogun shirizu, 1996, Issue:9 Topics: Autoimmune Diseases; Graft vs Host Disease; Hepatitis C; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1996
[Primary biliary cirrhosis (PBC) (symptomatic, asymptomatic)]. Ryoikibetsu shokogun shirizu, 1995, Issue:7 Topics: Diagnosis, Differential; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Prognosis; Ursodeoxycholic Acid	1995
Primary biliary cirrhosis. The New England journal of medicine, 1996, Nov-21, Volume: 335, Issue:21 Topics: Colchicine; Cyclosporine; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Mitochondria, Liver; Prognosis; Ursodeoxycholic Acid	1996
[Bile acids and immune regulation]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1996, Volume: 93, Issue:10 Topics: Animals; Bile Acids and Salts; Cytokines; Gastrointestinal Agents; Glucocorticoids; Homeostasis; Humans; Liver Cirrhosis, Biliary; Lymphocytes; Major Histocompatibility Complex; Ursodeoxycholic Acid	1996
Ursodeoxycholic acid in primary biliary cirrhosis. Seminars in liver disease, 1997, Volume: 17, Issue:2 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Quality of Life; Randomized Controlled Trials as Topic; Survival Analysis; Ursodeoxycholic Acid	1997
The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Seminars in liver disease, 1997, Volume: 17, Issue:2 Topics: Adjuvants, Immunologic; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Methotrexate; Ursodeoxycholic Acid	1997
[A case of primary biliary cirrhosis associated with fatty liver following delivery]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1997, Volume: 94, Issue:8 Topics: Adult; Cholagogues and Choleretics; Fatty Liver; Female; Humans; Liver Cirrhosis, Biliary; Puerperal Disorders; Ursodeoxycholic Acid	1997
Primary biliary cirrhosis associated with mixed type autoimmune hemolytic anemia and sicca syndrome: a case report and review of literature. The American journal of gastroenterology, 1997, Volume: 92, Issue:9 Topics: Administration, Oral; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Antigens; Autoantibodies; Autoimmune Diseases; Blood Transfusion; Cholagogues and Choleretics; Erythrocyte Transfusion; Erythrocytes; Female; Glucocorticoids; Humans; Isoantibodies; Jaundice; Liver Cirrhosis, Biliary; Methylprednisolone; Middle Aged; Sjogren's Syndrome; Treatment Outcome; Ursodeoxycholic Acid	1997
[Treatment of cholestatic liver diseases with ursodeoxycholic acid]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1997, Sep-30, Volume: 117, Issue:23 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1997
Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection? Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1998, Volume: 4, Issue:5 Suppl 1 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Chronic Disease; Endoscopy; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Patient Selection; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Survival Rate; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	1998
Primary biliary cirrhosis. Is (and how much of) the pathology preventible? Immunologic research, 1998, Volume: 18, Issue:2 Topics: Antibodies; Antibody Specificity; Autoimmune Diseases; Biomarkers; Cholagogues and Choleretics; Chronic Disease; Disease Progression; Humans; Liver Cirrhosis, Biliary; Mitochondria; Risk Factors; Ursodeoxycholic Acid	1998
[Primary biliary cirrhosis: progress in its therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Apr-10, Volume: 88, Issue:4 Topics: Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Plasma Exchange; Ursodeoxycholic Acid	1999
Eosinophils and primary biliary cirrhosis-stoking the fire? Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:1 Topics: Animals; Cell Degranulation; Cholagogues and Choleretics; Eosinophils; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1999
Progress and novel discoveries in biliary tract diseases. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:1 Topics: Animals; Biliary Tract Diseases; Cholangitis, Sclerosing; Cholelithiasis; Cholestasis, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1999
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (London, England), 1999, Sep-25, Volume: 354, Issue:9184 Topics: Evidence-Based Medicine; Female; Gastrointestinal Agents; Humans; Liver; Liver Cirrhosis, Biliary; Male; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Ursodeoxycholic Acid	1999
Ursodeoxycholic acid for primary biliary cirrhosis. Drug and therapeutics bulletin, 1999, Volume: 37, Issue:4 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	1999
[Recent progress in the diagnosis and therapy of autoimmune hepatitis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Sep-10, Volume: 88, Issue:9 Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Genetic Predisposition to Disease; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Prednisolone; Ursodeoxycholic Acid	1999
[Primary biliary cirrhosis and CREST syndrome: a rare classical combination (literature review and case report)]. Terapevticheskii arkhiv, 2000, Volume: 72, Issue:2 Topics: Cholagogues and Choleretics; CREST Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prednisolone; Ursodeoxycholic Acid	2000
URSO-panacea or placebo? Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:4 Topics: Controlled Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary; MEDLINE; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2000
Ursodeoxycholic acid therapy in hepatobiliary disease. The American journal of medicine, 2000, Apr-15, Volume: 108, Issue:6 Topics: Biliary Tract Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Cystic Fibrosis; Female; Graft Rejection; Graft vs Host Disease; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Parenteral Nutrition, Total; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid	2000
[Treatment of primary biliary cirrhosis. The effect of ursodeoxycholic acid is questioned now]. Lakartidningen, 2000, May-24, Volume: 97, Issue:21 Topics: Cholagogues and Choleretics; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2000
[Cholestatic hepatopathy: primary biliary cirrhosis]. Praxis, 2000, Jun-15, Volume: 89, Issue:24 Topics: Adult; Aged; Autoimmune Diseases; Cholestasis, Intrahepatic; Cross-Sectional Studies; Drug Therapy, Combination; Female; Germany; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Ursodeoxycholic Acid	2000
[Is it possible to predict and prevent primary biliary cirrhosis?]. Harefuah, 1999, Volume: 137, Issue:1-2 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1999
Treatment of primary biliary cirrhosis. Bailliere's best practice & research. Clinical gastroenterology, 2000, Volume: 14, Issue:4 Topics: Cholagogues and Choleretics; Colchicine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Methotrexate; Ursodeoxycholic Acid	2000
The timing of liver transplantation in primary biliary cirrhosis. Bailliere's best practice & research. Clinical gastroenterology, 2000, Volume: 14, Issue:4 Topics: Adult; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Models, Biological; Ursodeoxycholic Acid	2000
Biliary tract inflammatory disorders: primary sclerosing cholangitis and primary biliary cirrhosis. Current gastroenterology reports, 1999, Volume: 1, Issue:2 Topics: Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Risk Factors; Ursodeoxycholic Acid	1999
Management of primary biliary cirrhosis: from diagnosis to end-stage disease. Current gastroenterology reports, 2000, Volume: 2, Issue:2 Topics: Adult; Bone Diseases, Metabolic; Cholagogues and Choleretics; Estrogens; Humans; Life Style; Liver Cirrhosis, Biliary; Liver Failure; Liver Transplantation; Quality of Life; Survival Analysis; Ursodeoxycholic Acid	2000
[Diagnosis and treatment of primary biliary cirrhosis of the liver]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2000, Sep-10, Volume: 89, Issue:9 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2000
Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature. The American journal of gastroenterology, 2001, Volume: 96, Issue:2 Topics: Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Recurrence; Ursodeoxycholic Acid	2001
[Primary biliary cirrhosis]. Ryoikibetsu shokogun shirizu, 2000, Issue:31 Topics: Autoantibodies; Bile Ducts; Diagnosis, Differential; Epithelial Cells; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Mitochondria; Prognosis; Ursodeoxycholic Acid	2000
Autoimmune liver disease. Current standards, future directions. Clinics in liver disease, 2001, Volume: 5, Issue:2 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Prednisone; Prognosis; Ursodeoxycholic Acid	2001
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. Digestion, 2001, Volume: 64, Issue:3 Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Osteoporosis; Prednisolone; Pruritus; Tacrolimus; Ursodeoxycholic Acid	2001
[Primary biliary cirrhosis]. Nihon rinsho. Japanese journal of clinical medicine, 2002, Volume: 60 Suppl 1 Topics: Age Factors; Cause of Death; Female; Humans; Japan; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Morbidity; Prognosis; Reference Standards; Severity of Illness Index; Sex Factors; Time Factors; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid for primary biliary cirrhosis. The Cochrane database of systematic reviews, 2002, Issue:1 Topics: Administration, Oral; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2002
[Treatment of cholestatic liver diseases]. Medizinische Klinik (Munich, Germany : 1983), 2002, Mar-15, Volume: 97, Issue:3 Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Cholestasis, Intrahepatic; Chronic Disease; Controlled Clinical Trials as Topic; Cystic Fibrosis; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Infant, Newborn; Liver Cirrhosis, Biliary; Male; Prednisolone; Pregnancy; Pregnancy Complications; Time Factors; Ursodeoxycholic Acid	2002
[Medical treatment of chronic cholestasis: ursodeoxycholic acid]. Gastroenterologia y hepatologia, 2000, Volume: 23 Suppl 1 Topics: Adjuvants, Immunologic; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis; Chronic Disease; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2000
[Pathophysiology of biliary epithelium in primary biliary cirrhosis]. Gastroenterologia y hepatologia, 2000, Volume: 23 Suppl 1 Topics: Anions; Antiporters; Autoimmune Diseases; Autoimmunity; Bicarbonates; Bile; Biliary Tract; Epithelium; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2000
[Ursodeoxycholic acid in the treatment of chronic cholestatic liver disease. Documented delay in disease progress inspires hope]. Lakartidningen, 2002, Mar-21, Volume: 99, Issue:12 Topics: Cholagogues and Choleretics; Cholestasis, Intrahepatic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid for the treatment of cholestatic diseases. Progress in liver diseases, 1992, Volume: 10 Topics: Adult; Child; Cholangitis, Sclerosing; Cholestasis; Cystic Fibrosis; Female; Humans; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Liver Transplantation; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid	1992
Primary biliary cirrhosis: new therapeutic directions. Scandinavian journal of gastroenterology. Supplement, 1992, Volume: 192 Topics: Bone Diseases, Metabolic; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Liver Transplantation; Methotrexate; Pruritus; Ursodeoxycholic Acid	1992
[Pathophysiology of cholestasis: correlation between bile acid metabolism and liver damage]. Zeitschrift fur Gastroenterologie, 1992, Volume: 30 Suppl 1 Topics: Animals; Bile Acids and Salts; Cholestasis; Humans; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Ursodeoxycholic Acid	1992
Use of ursodiol in a patient with biliary cirrhosis. Clinical pharmacy, 1992, Volume: 11, Issue:8 Topics: Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	1992
Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease. The Italian journal of gastroenterology, 1992, Volume: 24, Issue:1 Topics: Bile Acids and Salts; Cell Membrane; Cholestasis, Intrahepatic; Chronic Disease; Hepatitis, Chronic; Humans; In Vitro Techniques; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
Advances in the therapy of cholestatic liver disease. Hepato-gastroenterology, 1992, Volume: 39 Suppl 1 Topics: Cholestasis; Colchicine; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
Antifibrotic therapy of liver cirrhosis, with special reference to primary biliary cirrhosis: promises and limitations. The Netherlands journal of medicine, 1992, Volume: 40, Issue:3-4 Topics: Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
[Therapy of cholestatic liver diseases with ursodeoxycholic acid: a new treatment principle]. Zeitschrift fur Gastroenterologie. Verhandlungsband, 1991, Volume: 26 Topics: Adult; Child; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Ursodeoxycholic Acid	1991
[The treatment of primary biliary cirrhosis. Its current status]. Revista espanola de enfermedades digestivas, 1991, Volume: 80, Issue:5 Topics: Adrenal Cortex Hormones; Colchicine; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Penicillamine; Ursodeoxycholic Acid	1991
Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases. Biochimie, 1991, Volume: 73, Issue:10 Topics: Animals; Cholestasis; Chronic Disease; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Liver Cirrhosis, Biliary; Major Histocompatibility Complex; Ursodeoxycholic Acid	1991
Ursodeoxycholic acid in chronic liver disease. Gut, 1991, Volume: 32, Issue:9 Topics: Animals; Cholestasis; Chronic Disease; Hepatitis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	1991
Recent developments in primary biliary cirrhosis: etiology and treatment. Immunologic research, 1991, Volume: 10, Issue:3-4 Topics: Antigen-Antibody Complex; Autoantibodies; Enterobacteriaceae; Humans; Lipid A; Liver; Liver Cirrhosis, Biliary; Mitochondria, Liver; Models, Biological; Ursodeoxycholic Acid	1991
[Bile acid therapy; new hope for patients with chronic liver diseases]. Nederlands tijdschrift voor geneeskunde, 1991, Apr-20, Volume: 135, Issue:16 Topics: Cholangitis, Sclerosing; Cholelithiasis; Chronic Disease; Hepatitis, Chronic; Humans; Infant, Newborn; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Ursodeoxycholic Acid	1991
[New aspects in therapeutic use of ursodeoxycholic acid]. Zeitschrift fur arztliche Fortbildung, 1990, Volume: 84, Issue:5 Topics: Cholelithiasis; Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1990
[What is guaranteed in the therapy of primary biliary cirrhosis with bile acids?]. Der Internist, 1990, Volume: 31, Issue:11 Topics: Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Ursodeoxycholic Acid	1990
[Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases]. Klinische Wochenschrift, 1989, Feb-15, Volume: 67, Issue:4 Topics: Cholangitis, Sclerosing; Clinical Trials as Topic; Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Pilot Projects; Prospective Studies; Ursodeoxycholic Acid	1989
Medical treatment of primary biliary cirrhosis. Seminars in liver disease, 1989, Volume: 9, Issue:2 Topics: Colchicine; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Penicillamine; Ursodeoxycholic Acid	1989
[Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid]. Fortschritte der Medizin, 1988, Nov-30, Volume: 106, Issue:34 Topics: Animals; Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Ursodeoxycholic Acid	1988
Ursodeoxycholic acid for chronic liver diseases. Journal of clinical gastroenterology, 1988, Volume: 10 Suppl 2 Topics: Chronic Disease; Clinical Trials as Topic; Deoxycholic Acid; Hepatitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1988
Modern management of biliary tract stone disease. Advances in surgery, 1987, Volume: 20 Topics: Chenodeoxycholic Acid; Cholecystectomy; Cholecystitis; Cholelithiasis; Humans; Lithotripsy; Liver Cirrhosis, Biliary; Solvents; Ursodeoxycholic Acid	1987

Trials

145 trial(s) available for ursodeoxycholic acid and Biliary Cirrhosis

Article	Year
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis. Journal of hepatology, 2022, Volume: 77, Issue:2 Topics: Acetates; Adult; Alkaline Phosphatase; Disease Progression; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2022
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls. Gastroenterology, 2022, Volume: 163, Issue:6 Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion. Hepatology international, 2023, Volume: 17, Issue:1 Topics: Aspartate Aminotransferases; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2023
Impact of setanaxib on quality of life outcomes in primary biliary cholangitis in a phase 2 randomized controlled trial. Hepatology communications, 2023, 03-01, Volume: 7, Issue:3 Topics: Fatigue; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2023
Effectiveness of Fenofibrate in Treatment-Naive Patients With Primary Biliary Cholangitis: A Randomized Clinical Trial. The American journal of gastroenterology, 2023, 11-01, Volume: 118, Issue:11 Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2023
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trial. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:7 Topics: Alkaline Phosphatase; Animals; gamma-Glutamyltransferase; Liver Cirrhosis, Biliary; NADPH Oxidase 1; Treatment Outcome; Ursodeoxycholic Acid	2023
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study. Hepatology (Baltimore, Md.), 2023, 08-01, Volume: 78, Issue:2 Topics: Acetates; Alkaline Phosphatase; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2023
Long-Term Obeticholic Acid Therapy Improves Histological Endpoints in Patients With Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:5 Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	2020
Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis. Journal of hepatology, 2021, Volume: 74, Issue:1 Topics: Aged; Alkaline Phosphatase; Bile Acids and Salts; Bile Ducts, Intrahepatic; Biological Transport; Chenodeoxycholic Acid; Double-Blind Method; Female; Gastrointestinal Agents; Hepatocytes; Humans; Liver Cirrhosis, Biliary; Middle Aged; Positron-Emission Tomography; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Ursodeoxycholic Acid	2021
A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC gastroenterology, 2020, Aug-05, Volume: 20, Issue:1 Topics: Cholagogues and Choleretics; Cross-Over Studies; Hospitals; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Ursodeoxycholic Acid	2020
A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA. Journal of hepatology, 2021, Volume: 74, Issue:2 Topics: Alkaline Phosphatase; Anti-Inflammatory Agents; Biopsy; Budesonide; Cholagogues and Choleretics; Disease Progression; Double-Blind Method; Drug Monitoring; Female; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2021
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA. Journal of hepatology, 2021, Volume: 74, Issue:6 Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Bilirubin; Chalcones; Double-Blind Method; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; PPAR delta; Propionates; Pruritus; Quality of Life; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2021
Ursodeoxycholic Acid at 18-22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis. Canadian journal of gastroenterology & hepatology, 2021, Volume: 2021 Topics: Cholagogues and Choleretics; Cholangitis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2021
Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland. Clinical reviews in allergy & immunology, 2018, Volume: 54, Issue:2 Topics: Cholangitis; Cohort Studies; Cross-Sectional Studies; Delayed Diagnosis; Drug Resistance; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Switzerland; Treatment Outcome; Ursodeoxycholic Acid	2018
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. The New England journal of medicine, 2018, Jun-07, Volume: 378, Issue:23 Topics: Adult; Bezafibrate; Bile Acids and Salts; Cholangitis; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Treatment Failure; Ursodeoxycholic Acid	2018
B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid. The American journal of gastroenterology, 2013, Volume: 108, Issue:6 Topics: Adult; Alkaline Phosphatase; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; Cholagogues and Choleretics; Drug Resistance; Fatigue; Female; Humans; Immunoglobulin M; Immunologic Factors; Liver Cirrhosis, Biliary; Longitudinal Studies; Lymphocyte Depletion; Male; Middle Aged; Mitochondria; Pilot Projects; Pruritus; Quality of Life; Rituximab; Severity of Illness Index; Ursodeoxycholic Acid	2013
Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. Journal of gastroenterology and hepatology, 2013, Volume: 28 Suppl 1 Topics: Adult; Cells, Cultured; Cholagogues and Choleretics; Feasibility Studies; Female; Humans; Liver Cirrhosis, Biliary; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Pilot Projects; Quality of Life; Treatment Outcome; Umbilical Cord; Ursodeoxycholic Acid	2013
Cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid. Alimentary pharmacology & therapeutics, 2013, Volume: 38, Issue:7 Topics: Aged; Canada; Cost-Benefit Analysis; Female; Follow-Up Studies; Health Care Costs; Humans; Life Expectancy; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Markov Chains; Middle Aged; Norway; Randomized Controlled Trials as Topic; Survival Analysis; Time Factors; Ursodeoxycholic Acid	2013
Allogeneic bone marrow mesenchymal stem cell transplantation in patients with UDCA-resistant primary biliary cirrhosis. Stem cells and development, 2014, Oct-15, Volume: 23, Issue:20 Topics: Adult; Bone Marrow Transplantation; Cholagogues and Choleretics; Drug Resistance; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Mesenchymal Stem Cell Transplantation; Middle Aged; Ursodeoxycholic Acid	2014
[Effect of post-liver transplantation administration of ursodeoxycholic acid on serum liver tests and biliary complications: a randomized clinical trial]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2014, Volume: 22, Issue:7 Topics: Alanine Transaminase; Aspartate Aminotransferases; Bile; Bile Acids and Salts; Biliary Tract Diseases; gamma-Glutamyltransferase; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Postoperative Complications; Ursodeoxycholic Acid	2014
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. Gastroenterology, 2015, Volume: 148, Issue:4 Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Chenodeoxycholic Acid; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pruritus; Treatment Failure; Treatment Outcome; Ursodeoxycholic Acid	2015
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia. The American journal of gastroenterology, 2015, Volume: 110, Issue:3 Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Myalgia; Prognosis; Renal Insufficiency; Survival Rate; Time; Treatment Outcome; Ursodeoxycholic Acid	2015
[Treatment of early and mid-term primary biliary cirrhosis by Qingying Huoxue Decoction Combined ursodeoxycholic acid: a clinical observation]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2015, Volume: 35, Issue:3 Topics: Alanine Transaminase; Aspartate Aminotransferases; Drug Combinations; Drugs, Chinese Herbal; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2015
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial. BMC gastroenterology, 2016, Jul-19, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Methylamines; Middle Aged; Organic Anion Transporters, Sodium-Dependent; Pruritus; Symporters; Thiazepines; Ursodeoxycholic Acid; Young Adult	2016
Clinical trial: randomized controlled study of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. Alimentary pharmacology & therapeutics, 2008, Oct-01, Volume: 28, Issue:7 Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Antiviral Agents; Aspartate Aminotransferases; Betaretrovirus; Cholagogues and Choleretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamivudine; Liver Cirrhosis, Biliary; Male; Middle Aged; Retroviridae Infections; Treatment Outcome; Tumor Virus Infections; Ursodeoxycholic Acid; Zidovudine	2008
Portal hypertension in primary biliary cirrhosis: a potentially reversible harbinger of demise. Gastroenterology, 2008, Volume: 135, Issue:5 Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Cirrhosis, Biliary; Male; Middle Aged; Portal Pressure; Prevalence; Prognosis; Quebec; Retrospective Studies; Severity of Illness Index; Survival Rate; Time Factors; Ursodeoxycholic Acid	2008
[Observation on therapeutic alliance with UDCA and glucocorticoids in AIH-PBC overlap syndrome]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2011, Volume: 19, Issue:5 Topics: Adult; Alanine Transaminase; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2011
Colchicine or methotrexate, with ursodiol, are effective after 20 years in a subset of patients with primary biliary cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2011, Volume: 9, Issue:9 Topics: Aged; Antimetabolites; Bile Acids and Salts; Colchicine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2011
Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:2 Topics: Adult; Alkaline Phosphatase; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; B-Lymphocytes; CD4 Lymphocyte Count; Cholagogues and Choleretics; Female; Humans; Immunologic Factors; Immunophenotyping; Liver; Liver Cirrhosis, Biliary; Middle Aged; Rituximab; RNA, Messenger; T-Lymphocytes; Treatment Failure; Ursodeoxycholic Acid	2012
Efficacy of ursodeoxycholic acid combined with Tongdan Decoction () on immunological indices and histopathological changes in primary biliary cirrhosis patients. Chinese journal of integrative medicine, 2012, Volume: 18, Issue:1 Topics: Antigens, CD; Biomarkers; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Immunoglobulin G; Inflammation; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2012
Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health. Journal of hepatology, 2012, Volume: 57, Issue:1 Topics: Adult; Bile Acids and Salts; Biliary Tract; Carrier Proteins; Cholagogues and Choleretics; Cholestasis; Cytochrome P-450 CYP3A; Duodenum; Female; Gene Expression Profiling; Glycine; Humans; Inactivation, Metabolic; Intestinal Mucosa; Liver Cirrhosis, Biliary; Middle Aged; Taurine; Ursodeoxycholic Acid	2012
Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy. Journal of digestive diseases, 2012, Volume: 13, Issue:4 Topics: Asian People; Biomarkers; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2012
Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bezafibrate; Carcinoma, Hepatocellular; Cell Line, Tumor; Cholagogues and Choleretics; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Lipids; Liver; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Middle Aged; PPAR alpha; Pregnane X Receptor; Receptors, Steroid; Treatment Failure; Treatment Outcome; Ursodeoxycholic Acid	2013
[The clinical observation of different therapeutic strategies in combined primary biliary cirrhosis and Sjögren syndrome]. Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:11 Topics: Adult; Azathioprine; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisolone; Sjogren's Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2012
[Clinical observation on the safety and efficacy of ursodeoxycholic acid and fuzheng huayu capsule in the treatment of primary biliary cirrhosis]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2012, Volume: 32, Issue:11 Topics: Adult; Capsules; Drugs, Chinese Herbal; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Phytotherapy; Ursodeoxycholic Acid; Young Adult	2012
Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial. The American journal of gastroenterology, 2002, Volume: 97, Issue:8 Topics: Chi-Square Distribution; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Statistics, Nonparametric; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2002
Improved liver tests and greater biliary enrichment with high dose ursodeoxycholic acid in early stage primary biliary cirrhosis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002, Volume: 34, Issue:7 Topics: Alkaline Phosphatase; Bile Acids and Salts; Biomarkers; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Time Factors; Transaminases; Treatment Outcome; Ursodeoxycholic Acid	2002
Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. The American journal of gastroenterology, 2002, Volume: 97, Issue:10 Topics: Adult; Aged; Cholagogues and Choleretics; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Randomized Controlled Trials as Topic; Survival Rate; Ursodeoxycholic Acid	2002
Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. Journal of hepatology, 2003, Volume: 39, Issue:1 Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2003
Bezafibrate treatment: a new medical approach for PBC patients? Journal of gastroenterology, 2003, Volume: 38, Issue:6 Topics: Alkaline Phosphatase; Bezafibrate; Bile Acids and Salts; Cholagogues and Choleretics; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Time Factors; Ursodeoxycholic Acid	2003
Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis. Journal of clinical gastroenterology, 2003, Volume: 37, Issue:2 Topics: Body Mass Index; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid; Weight Gain	2003
Natural history of pruritus in primary biliary cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2003, Volume: 1, Issue:4 Topics: Adult; Alkaline Phosphatase; Antipruritics; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cholagogues and Choleretics; Cholestyramine Resin; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Incidence; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Minnesota; Multivariate Analysis; Predictive Value of Tests; Pruritus; Rifampin; Risk Factors; Serum Albumin; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2003
Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World journal of gastroenterology, 2004, Mar-15, Volume: 10, Issue:6 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retreatment; Treatment Failure; Treatment Outcome; Ursodeoxycholic Acid	2004
Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis. The American journal of gastroenterology, 2004, Volume: 99, Issue:2 Topics: Cholagogues and Choleretics; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Survival Analysis; Treatment Outcome; United States; Ursodeoxycholic Acid	2004
A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results. Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:4 Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Colchicine; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Methotrexate; Middle Aged; Referral and Consultation; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2004
[Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:3 Topics: Adult; Antipruritics; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pruritus; S-Adenosylmethionine; Ursodeoxycholic Acid	2004
[Clinical features of primary biliary cirrhosis and treatment of it by integrated traditional Chinese and western medicine]. Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine, 2003, Volume: 1, Issue:2 Topics: Adult; Alanine Transaminase; Arthralgia; Cholagogues and Choleretics; Drug Therapy, Combination; Drugs, Chinese Herbal; Fatigue; Female; gamma-Glutamyltransferase; Humans; Jaundice; Liver Cirrhosis, Biliary; Male; Middle Aged; Phytotherapy; Pruritus; Splenomegaly; Treatment Outcome; Ursodeoxycholic Acid	2003
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Alkaline Phosphatase; Autoantibodies; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria, Liver; Mycophenolic Acid; Pilot Projects; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2005
No relevant effect of ursodeoxycholic acid on cytochrome P450 3A metabolism in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2005, Volume: 41, Issue:3 Topics: Adult; Aged; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Budesonide; Cytochrome P-450 CYP3A; Female; Humans; Hydrocortisone; Liver Cirrhosis, Biliary; Male; Middle Aged; Oxidoreductases, N-Demethylating; Ursodeoxycholic Acid	2005
Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial. Hepatology (Baltimore, Md.), 2005, Volume: 41, Issue:4 Topics: Adult; Aged; Budesonide; Drug Therapy, Combination; Glucocorticoids; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	2005
Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:5 Topics: Adult; Aged; Bile; Bile Acids and Salts; Cholagogues and Choleretics; Drug Therapy, Combination; Endoscopy; Female; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Prevalence; Survival Analysis; Treatment Failure; Ursodeoxycholic Acid; Varicose Veins	2005
Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:6 Topics: Anti-Inflammatory Agents; Aspartate Aminotransferases; Bile Acids and Salts; Biomarkers; Biopsy; Budesonide; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Peptide Fragments; Predictive Value of Tests; Procollagen; Prospective Studies; ROC Curve; Ursodeoxycholic Acid	2008
[Comparative study of superoxide production of monocytes in primary biliary cirrhosis]. Orvosi hetilap, 1995, Oct-29, Volume: 136, Issue:44 Topics: Anions; Cholagogues and Choleretics; Cholelithiasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Monocytes; Superoxides; Tetradecanoylphorbol Acetate; Ursodeoxycholic Acid	1995
The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:4 Pt 1 Topics: Adult; Autoantibodies; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Mitochondria; Pilot Projects; Placebos; Prospective Studies; Ursodeoxycholic Acid	1995
Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut, 1995, Volume: 36, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Bile; Bilirubin; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	1995
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1995, Volume: 22, Issue:3 Topics: Adult; Bile; Bilirubin; Double-Blind Method; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Time Factors; Treatment Failure; Ursodeoxycholic Acid	1995
Prevention of biliary cirrhosis following hepatic arterial thrombosis after liver transplantation in children by using ursodeoxycholic acid. Journal of pediatric surgery, 1995, Volume: 30, Issue:1 Topics: Adolescent; Biopsy; Child; Child, Preschool; Combined Modality Therapy; Follow-Up Studies; Graft Occlusion, Vascular; Hepatic Artery; Humans; Infant; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Postoperative Care; Reoperation; Thrombosis; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	1995
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology, 1995, Volume: 108, Issue:5 Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholesterol; Colchicine; Double-Blind Method; Female; Finland; gamma-Glutamyltransferase; Humans; Immunoglobulin G; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Procollagen; Ursodeoxycholic Acid	1995
Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:5 Topics: Alkaline Phosphatase; Bilirubin; Cholestanol; Cholesterol; Colchicine; Humans; Liver Cirrhosis, Biliary; Middle Aged; Phytosterols; Placebos; Ursodeoxycholic Acid	1995
Ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:5 Topics: Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Placebos; Treatment Outcome; Ursodeoxycholic Acid	1995
Prolonged treatment with ursodeoxycholic acid for primary biliary cirrhosis. La Clinica terapeutica, 1995, Volume: 146, Issue:5 Topics: Adult; Cholestasis; Drug Evaluation; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Pruritus; Treatment Outcome; Ursodeoxycholic Acid	1995
Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis. Journal of hepatology, 1994, Volume: 21, Issue:4 Topics: Adult; Biopsy; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Time Factors; Ursodeoxycholic Acid	1994
Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference? Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:2 Topics: Adult; Bone Density; Bone Diseases; Double-Blind Method; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1995
Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. Mayo Clinic proceedings, 1994, Volume: 69, Issue:10 Topics: Adult; Bilirubin; Cholesterol; Cholesterol, HDL; Chronic Disease; Female; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Triglycerides; Ursodeoxycholic Acid	1994
The natural history of abdominal pain associated with primary biliary cirrhosis. The American journal of gastroenterology, 1994, Volume: 89, Issue:10 Topics: Abdominal Pain; Endoscopy, Gastrointestinal; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Ursodeoxycholic Acid	1994
Predictive factors in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: role of serum markers of connective tissue. Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:3 Topics: Adult; Aged; Biomarkers; Connective Tissue; Female; Forecasting; Humans; Hyperbilirubinemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Multivariate Analysis; Placebos; Survival Analysis; Ursodeoxycholic Acid	1994
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. The New England journal of medicine, 1994, May-12, Volume: 330, Issue:19 Topics: Double-Blind Method; Female; Humans; Liver Cirrhosis, Biliary; Liver Failure; Liver Transplantation; Male; Middle Aged; Regression Analysis; Risk Factors; Treatment Failure; Treatment Outcome; Ursodeoxycholic Acid	1994
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology, 1994, Volume: 106, Issue:5 Topics: Adult; Bilirubin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1994
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1994, Volume: 19, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Bilirubin; Canada; Cholestasis; Cholesterol; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Transaminases; Ursodeoxycholic Acid	1994
[Therapy of primary biliary cirrhosis with ursodeoxycholic acid]. Zeitschrift fur Gastroenterologie, 1993, Volume: 31, Issue:10 Topics: Double-Blind Method; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1993
[Taurodeoxycholic acid in the treatment of primary biliary cirrhosis. A controlled study in comparison to ursodeoxycholic acid]. La Clinica terapeutica, 1993, Volume: 143, Issue:4 Topics: Adolescent; Adult; Aged; Drug Tolerance; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Taurodeoxycholic Acid; Time Factors; Ursodeoxycholic Acid	1993
Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function. European journal of clinical pharmacology, 1993, Volume: 45, Issue:3 Topics: Bile Acids and Salts; Cholic Acid; Cholic Acids; Deoxycholic Acid; Feces; Female; Glutamate Dehydrogenase; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Ursodeoxycholic Acid	1993
Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease. Digestive diseases and sciences, 1994, Volume: 39, Issue:1 Topics: Cholestyramine Resin; Clinical Enzyme Tests; Female; Follow-Up Studies; Humans; Hyaluronic Acid; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Peptide Fragments; Procollagen; Prospective Studies; Pruritus; Time Factors; Ursodeoxycholic Acid	1994
Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multicenter trial. Italian Multicenter Group for the Study of UDCA in PBC. Journal of hepatology, 1993, Volume: 17, Issue:3 Topics: Bilirubin; Double-Blind Method; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid	1993
Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1993, Volume: 17, Issue:4 Topics: Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Middle Aged; Placebos; Time Factors; Ursodeoxycholic Acid	1993
Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy. Hepatology (Baltimore, Md.), 1993, Volume: 17, Issue:4 Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Deoxycholic Acid; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Ursodeoxycholic Acid	1993
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology, 1996, Volume: 110, Issue:5 Topics: Adult; Double-Blind Method; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Survival Rate; Ursodeoxycholic Acid	1996
Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:5 Topics: Adult; Aged; Bilirubin; Canada; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Middle Aged; Models, Theoretical; Predictive Value of Tests; Prognosis; Risk Factors; Survival Rate; Ursodeoxycholic Acid	1996
Combined treatment with methotrexate and ursodeoxycholic acid in non-cirrhotic primary biliary cirrhosis. Acta clinica Belgica, 1996, Volume: 51, Issue:1 Topics: Adult; Aged; Blood Chemical Analysis; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	1996
Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. Gut, 1996, Volume: 38, Issue:3 Topics: Administration, Oral; Adult; Aged; Bile; Bile Acids and Salts; Chromatography, High Pressure Liquid; Drug Administration Schedule; Gas Chromatography-Mass Spectrometry; Humans; Intestinal Mucosa; Lithocholic Acid; Liver Cirrhosis, Biliary; Middle Aged; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid	1996
Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis. Journal of molecular medicine (Berlin, Germany), 1996, Volume: 74, Issue:5 Topics: Antibodies; Autoimmune Diseases; Enzyme-Linked Immunosorbent Assay; Humans; Immunoblotting; Liver Cirrhosis, Biliary; Pyruvate Dehydrogenase (Lipoamide); Pyruvate Dehydrogenase Complex; Ursodeoxycholic Acid	1996
Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study. Journal of hepatology, 1996, Volume: 24, Issue:1 Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Colchicine; Drug Therapy, Combination; Female; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	1996
Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. Journal of hepatology, 1996, Volume: 25, Issue:1 Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunoglobulin G; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisolone; Prospective Studies; Ursodeoxycholic Acid	1996
A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group. Hepatology (Baltimore, Md.), 1996, Volume: 24, Issue:5 Topics: Adult; Aged; Colchicine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Peptide Fragments; Procollagen; Ursodeoxycholic Acid	1996
Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis. The American journal of gastroenterology, 1996, Volume: 91, Issue:11 Topics: Bilirubin; Biopsy; Cholagogues and Choleretics; Cohort Studies; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Time Factors; Ursodeoxycholic Acid	1996
Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response. Journal of hepatology, 1996, Volume: 25, Issue:6 Topics: Adult; Alkaline Phosphatase; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Chromatography, Gas; Cross-Over Studies; Deoxycholic Acid; Dose-Response Relationship, Drug; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Regression Analysis; Transaminases; Treatment Outcome; Ursodeoxycholic Acid	1996
Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scandinavian journal of gastroenterology, 1997, Volume: 32, Issue:2 Topics: Bile Acids and Salts; Blood Chemical Analysis; Cholagogues and Choleretics; Double-Blind Method; Drug Administration Schedule; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Survival Rate; Ursodeoxycholic Acid	1997
Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy. European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:2 Topics: Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Cholagogues and Choleretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prednisone; Receptors, Interleukin-2; Ursodeoxycholic Acid	1997
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:2 Topics: Cholagogues and Choleretics; Cross-Over Studies; Humans; Lipids; Liver; Liver Cirrhosis, Biliary; Middle Aged; Pilot Projects; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid	1997
Ursocholic acid, a hydrophilic bile acid, fails to improve liver function parameters in primary biliary cirrhosis: comparison with ursodeoxycholic acid. The American journal of gastroenterology, 1997, Volume: 92, Issue:6 Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile; Bile Acids and Salts; Cholic Acids; Chromatography, Gas; Deoxycholic Acid; Fasting; Female; Humans; Liver; Liver Cirrhosis, Biliary; Placebos; Taurocholic Acid; Ursodeoxycholic Acid	1997
Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1 Topics: Adult; Aged; Autoantibodies; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Mitochondria; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	1997
Expression and therapeutic response related to apolipoprotein E polymorphism in primary biliary cirrhosis. Journal of hepatology, 1997, Volume: 27, Issue:1 Topics: Adult; Alleles; Apolipoproteins E; Cholagogues and Choleretics; Colchicine; Humans; Immunoglobulins; Liver Cirrhosis, Biliary; Middle Aged; Phenotype; Polymorphism, Genetic; Ursodeoxycholic Acid	1997
The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone. Journal of hepatology, 1997, Volume: 27, Issue:1 Topics: Adult; Aged; Cholagogues and Choleretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Liver; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Necrosis; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid	1997
Serial quantitative liver function tests in patients with primary biliary cirrhosis: a prospective long-term study. Digestion, 1997, Volume: 58, Issue:4 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prognosis; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	1997
Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis. Mayo Clinic proceedings, 1997, Volume: 72, Issue:12 Topics: Aged; Cholagogues and Choleretics; Double-Blind Method; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid	1997
Autoimmune conditions associated with primary biliary cirrhosis: response to ursodeoxycholic acid therapy. The American journal of gastroenterology, 1998, Volume: 93, Issue:6 Topics: Arthritis; Autoimmune Diseases; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Raynaud Disease; Sjogren's Syndrome; Thyroiditis, Autoimmune; Ursodeoxycholic Acid	1998
Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis. The American journal of gastroenterology, 1998, Volume: 93, Issue:9 Topics: Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholic Acids; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Patient Compliance; Ursodeoxycholic Acid	1998
Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Journal of hepatology, 1998, Volume: 29, Issue:3 Topics: Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Epithelial Cells; Female; Humans; Immunohistochemistry; Kupffer Cells; Lipid A; Lipopolysaccharides; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1998
A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group. Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:10 Topics: Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Time Factors; Ursodeoxycholic Acid	1998
Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 1998, Volume: 106, Issue:9 Topics: Adult; Aged; Albumins; Autoantibodies; Bilirubin; Colchicine; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin A; Immunoglobulin G; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Pyruvate Dehydrogenase Complex; Ursodeoxycholic Acid	1998
Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. Journal of hepatology, 1998, Volume: 29, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Autoimmunity; Azathioprine; Cholagogues and Choleretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisone; Treatment Outcome; Ursodeoxycholic Acid	1998
Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:1 Topics: Canada; Cholagogues and Choleretics; Cost-Benefit Analysis; Double-Blind Method; Drug Costs; Female; Health Care Costs; Humans; Life Expectancy; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; United States; Ursodeoxycholic Acid	1999
Clinical significance of serum bilirubin levels under ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:1 Topics: Bilirubin; Canada; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Survival Analysis; Treatment Outcome; United States; Ursodeoxycholic Acid	1999
Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:2 Topics: Absorption; Adult; Aged; Bile; Bile Acids and Salts; Cross-Over Studies; Duodenum; Feces; Female; Gas Chromatography-Mass Spectrometry; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Middle Aged; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid	1999
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:3 Topics: Adult; Aged; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Middle Aged; Penicillamine; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	1999
Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:4 Topics: Bile Ducts; Biopsy; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Prognosis; Treatment Outcome; Ursodeoxycholic Acid	1999
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver, 1999, Volume: 19, Issue:2 Topics: Adult; Aged; Cholagogues and Choleretics; Double-Blind Method; Esophageal and Gastric Varices; Humans; Liver Cirrhosis, Biliary; Middle Aged; Outcome Assessment, Health Care; Prognosis; Prospective Studies; Reproducibility of Results; Risk Factors; Survival Analysis; Ursodeoxycholic Acid	1999
Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:6 Topics: Bile; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Chromatography, Gas; Chromatography, High Pressure Liquid; Deoxycholic Acid; Double-Blind Method; Drug Administration Schedule; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Placebos; Regression Analysis; Reproducibility of Results; Time Factors; Ursodeoxycholic Acid	1999
Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:6 Topics: Bilirubin; Cohort Studies; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prothrombin Time; Risk Assessment; Serum Albumin; Survival Analysis; Time Factors; Ursodeoxycholic Acid	1999
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial. Journal of hepatology, 1999, Volume: 30, Issue:5 Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Time Factors; Ursodeoxycholic Acid	1999
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:1 Topics: Blood Proteins; Cell Degranulation; Cholestasis; Eosinophil Granule Proteins; Eosinophil-Derived Neurotoxin; Eosinophils; Female; Hepatitis, Autoimmune; Hepatitis, Viral, Human; Humans; Immunohistochemistry; Leukocyte Count; Liver; Liver Cirrhosis, Biliary; Male; Placebos; Proteins; Radioimmunoassay; Ribonucleases; Ursodeoxycholic Acid	1999
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999, Volume: 5, Issue:4 Topics: Age Factors; Aged; Bacterial Infections; Bilirubin; Cholagogues and Choleretics; Creatinine; Female; Follow-Up Studies; Graft Rejection; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Placebos; Premedication; Retrospective Studies; Risk Factors; Sex Factors; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	1999
The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1999, Volume: 30, Issue:3 Topics: Bile Ducts; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1999
Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial. Gastroenterology, 1999, Volume: 117, Issue:4 Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid	1999
A pilot study on the hemodynamic effect of short-term ursodeoxycholic acid therapy in patients with stable liver cirrhosis. The American journal of gastroenterology, 1999, Volume: 94, Issue:10 Topics: Adult; Aged; Blood Pressure; Cardiac Output; Cholagogues and Choleretics; Clinical Enzyme Tests; Female; Heart Rate; Hemodynamics; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Stroke Volume; Ursodeoxycholic Acid; Vascular Resistance	1999
Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:10 Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Bile Acids and Salts; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Double-Blind Method; Female; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Multivariate Analysis; Ursodeoxycholic Acid	1999
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. Journal of hepatology, 2000, Volume: 32, Issue:4 Topics: Cholagogues and Choleretics; Double-Blind Method; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2000
Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:5 Topics: Administration, Oral; Adult; Aged; Cholagogues and Choleretics; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Protective Agents; Retreatment; Silymarin; Treatment Failure; Ursodeoxycholic Acid	2000
Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid. The American journal of gastroenterology, 2000, Volume: 95, Issue:10 Topics: Aged; Autoimmune Diseases; Bezafibrate; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid	2000
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:6 Topics: Disease Progression; Double-Blind Method; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Markov Chains; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2000
Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis. Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:12 Topics: Adult; Aged; Biopsy; Colchicine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2000
[Treatment of primary biliary cirrhosis with ursodeoxycholic acid]. Vutreshni bolesti, 2000, Volume: 32, Issue:1 Topics: Administration, Oral; Adult; Biopsy; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Time Factors; Ultrasonography; Ursodeoxycholic Acid	2000
Cholesterol metabolism in primary biliary cirrhosis during simvastatin and UDCA administration. Journal of lipid research, 2001, Volume: 42, Issue:3 Topics: Aged; Anticholesteremic Agents; Cholagogues and Choleretics; Cholesterol; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Middle Aged; Simvastatin; Ursodeoxycholic Acid	2001
Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis. Journal of lipid research, 2001, Volume: 42, Issue:5 Topics: Bile Acids and Salts; Bilirubin; Female; Gas Chromatography-Mass Spectrometry; Humans; Isomerism; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Prodrugs; Spectrometry, Mass, Electrospray Ionization; Ursodeoxycholic Acid	2001
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:9 Topics: Colchicine; Double-Blind Method; Drug Therapy, Combination; Female; Gout Suppressants; Humans; Italy; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2001
Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile? The American journal of gastroenterology, 2001, Volume: 96, Issue:11 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2001
Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:2 Topics: Adult; Antibodies, Antinuclear; Biopsy; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Survival Analysis; Ursodeoxycholic Acid	2002
Tumor necrosis factor-alpha and transforming growth factor-beta reflect severity of liver damage in primary biliary cirrhosis. Journal of gastroenterology and hepatology, 2002, Volume: 17, Issue:2 Topics: Adult; Biomarkers; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Double-Blind Method; Female; Hepatitis C; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases, Alcoholic; Male; Middle Aged; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid	2002
An electron microscopic and morphometric study of ursodeoxycholic effect in primary biliary cirrhosis. Liver, 2002, Volume: 22, Issue:3 Topics: Adult; Aged; Apoptosis; Cell Count; Cholagogues and Choleretics; Collagen; Double-Blind Method; Female; Fibrosis; Hepatocytes; Humans; Liver; Liver Cirrhosis, Biliary; Male; Microscopy, Electron; Middle Aged; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid treatment in primary biliary cirrhosis with the emphasis on late stage disease. The Netherlands journal of medicine, 1992, Volume: 41, Issue:1-2 Topics: Adult; Aged; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Nausea; Prospective Studies; Pruritus; Time Factors; Ursodeoxycholic Acid	1992
Treatment of chronic active hepatitis and primary biliary cirrhosis with ursodeoxycholic acid. Zeitschrift fur Gastroenterologie, 1992, Volume: 30 Suppl 1 Topics: Adult; Caroli Disease; Cholangitis, Sclerosing; Cholelithiasis; Double-Blind Method; Female; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Long-Term Care; Male; Membrane Lipids; Middle Aged; Ursodeoxycholic Acid	1992
[Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study]. Zeitschrift fur Gastroenterologie, 1992, Volume: 30 Suppl 1 Topics: Colchicine; Double-Blind Method; Drug Therapy, Combination; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Pilot Projects; Ursodeoxycholic Acid	1992
Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease. The Italian journal of gastroenterology, 1992, Volume: 24, Issue:1 Topics: Bile Acids and Salts; Cell Membrane; Cholestasis, Intrahepatic; Chronic Disease; Hepatitis, Chronic; Humans; In Vitro Techniques; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. The New England journal of medicine, 1991, May-30, Volume: 324, Issue:22 Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholesterol; Double-Blind Method; Drug Evaluation; Drug Tolerance; Female; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Patient Compliance; Ursodeoxycholic Acid	1991
Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study. European journal of clinical pharmacology, 1991, Volume: 40, Issue:5 Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Double-Blind Method; Female; gamma-Glutamyltransferase; Hepatitis, Chronic; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1991
Therapeutic effect of ursodeoxycholic acid on early-stage primary biliary cirrhosis. Journal of the Formosan Medical Association = Taiwan yi zhi, 1991, Volume: 90, Issue:10 Topics: Adult; Biomarkers; Drug Administration Schedule; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Time Factors; Ursodeoxycholic Acid	1991
Ursodeoxycholic acid (UDCA) in the treatment of chronic cholestatic diseases. Biochimie, 1991, Volume: 73, Issue:10 Topics: Animals; Cholestasis; Chronic Disease; Histocompatibility Antigens Class I; Humans; In Vitro Techniques; Liver Cirrhosis, Biliary; Major Histocompatibility Complex; Ursodeoxycholic Acid	1991
Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group. Journal of hepatology, 1990, Volume: 11, Issue:1 Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cholesterol; Deoxycholic Acid; Double-Blind Method; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	1990
A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis. Gastroenterologia Japonica, 1990, Volume: 25, Issue:6 Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Double-Blind Method; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid	1990
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: first controlled data. Hepatology (Baltimore, Md.), 1990, Volume: 12, Issue:1 Topics: Clinical Trials as Topic; Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Ursodeoxycholic Acid	1990
[Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study]. Zeitschrift fur Gastroenterologie. Verhandlungsband, 1989, Volume: 24 Topics: Adult; Clinical Trials as Topic; Deoxycholic Acid; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Prospective Studies; Ursodeoxycholic Acid	1989
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology, 1989, Volume: 97, Issue:5 Topics: Deoxycholic Acid; Double-Blind Method; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Randomized Controlled Trials as Topic; Time Factors; Ursodeoxycholic Acid	1989
Effect of different doses of ursodeoxycholic acid in chronic liver disease. Digestive diseases and sciences, 1989, Volume: 34, Issue:12 Suppl Topics: Bile; Bilirubin; Cholangitis, Sclerosing; Deoxycholic Acid; Dose-Response Relationship, Drug; Female; Hepatitis, Chronic; Humans; Lipid Metabolism; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Random Allocation; Time Factors; Ursodeoxycholic Acid	1989
[Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases]. Klinische Wochenschrift, 1989, Feb-15, Volume: 67, Issue:4 Topics: Cholangitis, Sclerosing; Clinical Trials as Topic; Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Pilot Projects; Prospective Studies; Ursodeoxycholic Acid	1989
Ursodeoxycholic acid for chronic liver diseases. Journal of clinical gastroenterology, 1988, Volume: 10 Suppl 2 Topics: Chronic Disease; Clinical Trials as Topic; Deoxycholic Acid; Hepatitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1988

Other Studies

569 other study(ies) available for ursodeoxycholic acid and Biliary Cirrhosis

Article	Year
Retrieval and treatment of patients with primary biliary cholangitis who are lost in the health system. Revista espanola de enfermedades digestivas, 2021, Volume: 113, Issue:11 Topics: Aged; Alkaline Phosphatase; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA. Digestive diseases and sciences, 2022, Volume: 67, Issue:8 Topics: Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Treatment Outcome; Ursodeoxycholic Acid	2022
Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis. Hepatology communications, 2021, Volume: 5, Issue:12 Topics: Adult; Bile Acids and Salts; Cholangitis, Sclerosing; Cholestasis; Drug Therapy, Combination; Female; Fenofibrate; Glucuronides; Hepatocytes; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; PPAR alpha; Retrospective Studies; Treatment Outcome; Up-Regulation; Ursodeoxycholic Acid; Young Adult	2021
Bezafibrate therapy in primary biliary cholangitis refractory to ursodeoxycholic acid: a longitudinal study of paired liver biopsies at 5 years of follow up. Alimentary pharmacology & therapeutics, 2021, Volume: 54, Issue:9 Topics: Bezafibrate; Biopsy; Cholagogues and Choleretics; Drug Therapy, Combination; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Longitudinal Studies; Ursodeoxycholic Acid	2021
Practical management of primary biliary cholangitis. Revista espanola de enfermedades digestivas, 2022, Volume: 114, Issue:7 Topics: Adult; Cholangitis; End Stage Liver Disease; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Quality of Life; Ursodeoxycholic Acid	2022
Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2021, 10-25, Volume: 78, Issue:4 Topics: Benzoxazoles; Butyrates; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2022, Volume: 54, Issue:8 Topics: Antibodies; Cholangitis; Humans; Liver Cirrhosis, Biliary; Prognosis; Retrospective Studies; Ursodeoxycholic Acid	2022
Alterations in gut microbiota and elevated serum bilirubin in primary biliary cholangitis patients treated with ursodeoxycholic acid. European journal of clinical investigation, 2022, Volume: 52, Issue:2 Topics: Adult; Aged; Bilirubin; Cholagogues and Choleretics; Female; Gastrointestinal Microbiome; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	2022
Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment. The Australasian journal of dermatology, 2022, Volume: 63, Issue:1 Topics: Cholagogues and Choleretics; Female; Humans; Keratoderma, Palmoplantar; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2022
Machine learning in primary biliary cholangitis: A novel approach for risk stratification. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:3 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Machine Learning; Prognosis; Risk Assessment; Ursodeoxycholic Acid	2022
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Authors' reply. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:2 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis-are we there yet? Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:2 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Review of Medical Management of Primary Biliary Cholangitis. South Dakota medicine : the journal of the South Dakota State Medical Association, 2021, Volume: 74, Issue:12 Topics: Cholagogues and Choleretics; Cholestasis; Disease Progression; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Reciprocal alterations in circulating and hepatic gamma-delta T cells in patients with primary biliary cholangitis. Hepatology international, 2022, Volume: 16, Issue:1 Topics: Humans; Intraepithelial Lymphocytes; Liver Cirrhosis, Biliary; Receptors, Antigen, T-Cell, gamma-delta; Ursodeoxycholic Acid	2022
[Bioinformatic analysis of differentially expressed genes and immune cell infiltration in primary biliary cholangitis patients with poor response to ursodeoxycholic acid therapy]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2022, Volume: 38, Issue:1 Topics: Computational Biology; Humans; Liver Cirrhosis, Biliary; Phosphatidylinositol 3-Kinases; Protein Interaction Maps; Ursodeoxycholic Acid	2022
Primary biliary cholangitis first demonstrated in pregnancy: a case report. Journal of medical case reports, 2022, Jan-31, Volume: 16, Issue:1 Topics: Adult; Cesarean Section; Cholestasis; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Ursodeoxycholic Acid	2022
[Primary biliary cholangitis]. La Revue du praticien, 2021, Volume: 71, Issue:8 Topics: Autoimmune Diseases; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2021
Immunoglobulin M: A Neglected Serum Biomarker in Treatment-Naive Primary Biliary Cholangitis With Normal Alkaline Phosphatase. Hepatology communications, 2022, Volume: 6, Issue:6 Topics: Adult; Alkaline Phosphatase; Biomarkers; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Retrospective Studies; Ursodeoxycholic Acid	2022
Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis. Nutrients, 2022, Feb-19, Volume: 14, Issue:4 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Treatment Outcome; Ursodeoxycholic Acid; Vitamin D	2022
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis. Hepatology (Baltimore, Md.), 2022, Volume: 76, Issue:2 Topics: Canada; Carcinoma, Hepatocellular; Cholangitis; Ethnicity; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Quality of Life; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2022
Seladelpar in patients with primary biliary cholangitis: Need for a closer look! Journal of hepatology, 2022, Volume: 77, Issue:5 Topics: Acetates; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study. EBioMedicine, 2022, Volume: 80 Topics: Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2022
Clinical Patterns of Primary Biliary Cholangitis: Comparison Between Two European Case Series. Reviews on recent clinical trials, 2022, Volume: 17, Issue:2 Topics: Bilirubin; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Serum Albumin; Ursodeoxycholic Acid	2022
NUDT1 promotes the accumulation and longevity of CD103 Journal of hepatology, 2022, Volume: 77, Issue:5 Topics: Animals; Autoantigens; CD8-Positive T-Lymphocytes; Immunodominant Epitopes; Liver Cirrhosis, Biliary; Mice; Oxidoreductases; Pyruvates; Transforming Growth Factor beta; Ursodeoxycholic Acid	2022
A change of paradigm in PBC: Pursuing normal alkaline phosphatase. EBioMedicine, 2022, Volume: 82 Topics: Alkaline Phosphatase; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:6 Topics: Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Primary biliary cholangitis presenting with Fanconi syndrome: an important phenotype. BMJ case reports, 2022, Aug-16, Volume: 15, Issue:8 Topics: Fanconi Syndrome; Female; Humans; Liver Cirrhosis, Biliary; Nephritis, Interstitial; Phenotype; Ursodeoxycholic Acid	2022
Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis. Digestive diseases and sciences, 2023, Volume: 68, Issue:2 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid	2023
Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitis. Scandinavian journal of gastroenterology, 2023, Volume: 58, Issue:1 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Retrospective Studies; Sick Leave; Sweden; Treatment Outcome; Ursodeoxycholic Acid	2023
Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC. Digestive diseases and sciences, 2023, Volume: 68, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:9 Topics: Alkaline Phosphatase; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2022
Suppression of Hepatic PPARα in Primary Biliary Cholangitis Is Modulated by miR-155. Cells, 2022, 09-15, Volume: 11, Issue:18 Topics: Bile Acids and Salts; Glycodeoxycholic Acid; Humans; Ligands; Lipopolysaccharides; Lithocholic Acid; Liver Cirrhosis, Biliary; MicroRNAs; PPAR alpha; Transcription Factors; Ursodeoxycholic Acid	2022
Predicting liver-related serious adverse events in patients with primary biliary cholangitis-related cirrhosis treated with obeticholic acid. Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:11 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Efficacy and safety of fenofibrate addition therapy in patients with cirrhotic primary biliary cholangitis with incomplete response to ursodeoxycholic acid. Hepatology communications, 2022, Volume: 6, Issue:12 Topics: Alkaline Phosphatase; Cholagogues and Choleretics; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2022
The Evolving Landscape of Primary Biliary Cholangitis. Clinics in liver disease, 2022, Volume: 26, Issue:4 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid. The American journal of case reports, 2022, Oct-23, Volume: 23 Topics: Abdominal Pain; Aged; Alkaline Phosphatase; Autoimmune Diseases; Budesonide; Crohn Disease; Female; Humans; Ileitis; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2022
[Evaluation of therapeutic efficiency of various drugs of ursodeoxycholic acid in the treatment of biliary sludge]. Terapevticheskii arkhiv, 2021, Dec-15, Volume: 93, Issue:12 Topics: Bile; Cholagogues and Choleretics; Cholelithiasis; Humans; Liver Cirrhosis, Biliary; Pain; Sewage; Ursodeoxycholic Acid	2021
[Ursodeoxycholic acid: history and clinical implications]. Nederlands tijdschrift voor geneeskunde, 2022, 09-28, Volume: 166 Topics: Bicarbonates; Bile Acids and Salts; Chlorides; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2022
Coexistence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome and membranous nephropathy: A case report. Clinical nephrology, 2023, Volume: 99, Issue:1 Topics: Azathioprine; Glomerulonephritis, Membranous; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2023
Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients. Medicine, 2022, Nov-18, Volume: 101, Issue:46 Topics: Albumins; Alkaline Phosphatase; Cholagogues and Choleretics; Glucocorticoids; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Retrospective Studies; Survival Rate; Ursodeoxycholic Acid	2022
Primary biliary cholangitis: personalized medicine for optimal therapeutic opportunities. Science bulletin, 2022, 12-31, Volume: 67, Issue:24 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Precision Medicine; Ursodeoxycholic Acid	2022
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis. The American journal of gastroenterology, 2023, 07-01, Volume: 118, Issue:7 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2023
Fenofibrate normalizes alkaline phosphatase and improves long-term outcomes in patients with advanced primary biliary cholangitis refractory to ursodeoxycholic acid. Gastroenterologia y hepatologia, 2023, Volume: 46, Issue:9 Topics: Alkaline Phosphatase; Cholagogues and Choleretics; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2023
Application of the Latest Advances in Evidence-Based Medicine in Primary Biliary Cholangitis. The American journal of gastroenterology, 2023, 02-01, Volume: 118, Issue:2 Topics: Cholangitis; Cholestasis; Evidence-Based Medicine; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2023
Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2023, Volume: 34, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2023
Primary biliary cholangitis-cause or association with psoriasis: a case report. Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2023, Volume: 32, Issue:1 Topics: Aged; Autoimmune Diseases; Female; Humans; Liver Cirrhosis, Biliary; Psoriasis; Skin; Ursodeoxycholic Acid	2023
The association between soluble CD163, disease severity, and ursodiol treatment in patients with primary biliary cholangitis. Hepatology communications, 2023, 04-01, Volume: 7, Issue:4 Topics: Aged; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Patient Acuity; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid	2023
Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study. Gut and liver, 2023, Jul-15, Volume: 17, Issue:4 Topics: Cholagogues and Choleretics; Cohort Studies; Humans; Liver Cirrhosis, Biliary; Republic of Korea; Treatment Outcome; Ursodeoxycholic Acid	2023
Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis. Journal of internal medicine, 2023, Volume: 293, Issue:5 Topics: COVID-19; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Retrospective Studies; SARS-CoV-2; Ursodeoxycholic Acid	2023
Regulation of immune responses in primary biliary cholangitis: a transcriptomic analysis of peripheral immune cells. Hepatology communications, 2023, 04-01, Volume: 7, Issue:4 Topics: Humans; Immunity; Leukocytes, Mononuclear; Liver Cirrhosis, Biliary; Transcriptome; Ursodeoxycholic Acid	2023
Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports. Journal of medical case reports, 2023, Apr-28, Volume: 17, Issue:1 Topics: Cholangitis, Sclerosing; Connective Tissue Diseases; Constriction, Pathologic; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Syndrome; Ursodeoxycholic Acid	2023
[Interpretation of key points of the technical guidelines for clinical trials of drugs for the treatment of primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2023, Mar-20, Volume: 31, Issue:3 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Pharmaceutical Preparations; Ursodeoxycholic Acid	2023
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival. Liver international : official journal of the International Association for the Study of the Liver, 2023, Volume: 43, Issue:7 Topics: Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2023
Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019. Journal of gastroenterology, 2023, Volume: 58, Issue:7 Topics: Aged; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Longitudinal Studies; Male; Republic of Korea; State Medicine; Ursodeoxycholic Acid	2023
Plasma lipidomics of primary biliary cholangitis and its comparison with Sjögren's syndrome. Frontiers in immunology, 2023, Volume: 14 Topics: Humans; Lipidomics; Lipids; Liver Cirrhosis, Biliary; Sjogren's Syndrome; Ursodeoxycholic Acid	2023
Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatology communications, 2023, 06-01, Volume: 7, Issue:6 Topics: Cholangitis; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Male; Prognosis; Ursodeoxycholic Acid	2023
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years. European journal of gastroenterology & hepatology, 2023, 08-01, Volume: 35, Issue:8 Topics: Bilirubin; Cholagogues and Choleretics; Cohort Studies; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2023
A case report of primary biliary cholangitis combined with ankylosing spondylitis. Medicine, 2023, Oct-13, Volume: 102, Issue:41 Topics: Antirheumatic Agents; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Spondylitis, Ankylosing; Ursodeoxycholic Acid	2023
[Primary biliary cholangitis. Experience in 179 patients]. Revista medica de Chile, 2022, Volume: 150, Issue:7 Topics: Adult; Aged; Autoantibodies; Autoimmune Diseases; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid; Young Adult	2022
High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study. BMC gastroenterology, 2023, Nov-17, Volume: 23, Issue:1 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Neutrophils; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2023
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:3 Topics: Alanine Transaminase; Bilirubin; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2020
A Brief Reflection on Continuous vs Binary Risk Indicators in Primary Biliary Cholangitis. The American journal of gastroenterology, 2019, Volume: 114, Issue:10 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Longitudinal Studies; Risk Factors; Ursodeoxycholic Acid	2019
Fatigue in Primary Biliary Cholangitis: No Place for Rituximab. Hepatology (Baltimore, Md.), 2019, Volume: 70, Issue:5 Topics: Fatigue; Humans; Liver Cirrhosis, Biliary; Rituximab; Ursodeoxycholic Acid	2019
Application of Risk Scores in the Daily Management of Primary Biliary Cholangitis: Response to Corpechot and Chazouillères. The American journal of gastroenterology, 2019, Volume: 114, Issue:10 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response. Alimentary pharmacology & therapeutics, 2019, Volume: 50, Issue:10 Topics: Adult; Biomarkers, Pharmacological; Biopsy; Cohort Studies; Disease Progression; Female; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Predictive Value of Tests; Prognosis; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2019
IgM response is a prognostic biomarker of primary biliary cholangitis treated with ursodeoxycholic acid and bezafibrate. Journal of gastroenterology and hepatology, 2020, Volume: 35, Issue:4 Topics: Bezafibrate; Biomarkers; Drug Therapy, Combination; Female; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2020
Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis. Clinical rheumatology, 2020, Volume: 39, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; China; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Male; Middle Aged; Prognosis; Retrospective Studies; Ursodeoxycholic Acid; Young Adult	2020
Increased p16 Journal of autoimmunity, 2020, Volume: 107 Topics: Animals; bcl-X Protein; Bile Ducts; Biomarkers; Case-Control Studies; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p16; Disease Models, Animal; Disease Susceptibility; Epithelial Cells; Gene Expression; Humans; Liver Cirrhosis, Biliary; Mice; Ursodeoxycholic Acid	2020
Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis. Gut, 2020, Volume: 69, Issue:8 Topics: Adult; Aged; Alkaline Phosphatase; Cholagogues and Choleretics; Chronic Disease; Databases, Factual; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Numbers Needed To Treat; Proportional Hazards Models; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2020
Editorial: rapid assessment of health-related quality of life in primary biliary cholangitis-no excuse not to ask. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Quality of Life; Ursodeoxycholic Acid	2020
Letter: histology is relevant for risk stratification in primary biliary cholangitis. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Risk Assessment; Ursodeoxycholic Acid	2020
Editorial: biochemical responses do not tell the whole story in primary biliary cholangitis. Alimentary pharmacology & therapeutics, 2020, Volume: 51, Issue:1 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2020
Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC). Digestive diseases and sciences, 2020, Volume: 65, Issue:10 Topics: Aged; Cholagogues and Choleretics; Cross-Sectional Studies; Female; Germany; Health Status; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Quality of Life; Symptom Assessment; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2020
Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study. Croatian medical journal, 2019, Dec-31, Volume: 60, Issue:6 Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Catchment Area, Health; Cholagogues and Choleretics; Croatia; Female; Humans; Incidence; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prevalence; Progression-Free Survival; Retrospective Studies; Ursodeoxycholic Acid; Young Adult	2019
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis. The American journal of gastroenterology, 2020, Volume: 115, Issue:2 Topics: Adult; Aged; Alanine Transaminase; Asian; Aspartate Aminotransferases; Bilirubin; Black or African American; Cholagogues and Choleretics; Female; Hispanic or Latino; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Proportional Hazards Models; Survival Rate; Ursodeoxycholic Acid; White People	2020
[Autoimmune mediated cholestatic liver diseases]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:5 Topics: Autoimmune Diseases; Cholagogues and Choleretics; Cholangiography; Cholangitis, Sclerosing; Fibric Acids; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2020
Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience. Journal of hepatology, 2020, Volume: 72, Issue:6 Topics: Bezafibrate; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2020
Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit. Gut, 2020, Volume: 69, Issue:8 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2020
Reply to: "Switching vs. add-on strategy in PBC treatment: Lessons from UDCA and bezafibrate experience". Journal of hepatology, 2020, Volume: 72, Issue:6 Topics: Bezafibrate; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2020
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis. Journal of hepatology, 2020, Volume: 73, Issue:3 Topics: Aged; Cholagogues and Choleretics; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Risk; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2020
Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators. Clinics and research in hepatology and gastroenterology, 2020, Volume: 44, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Autoantibodies; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Drug Therapy, Combination; Female; Globulins; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Nuclear Pore Complex Proteins; Prednisolone; Prognosis; Severity of Illness Index; Ursodeoxycholic Acid	2020
A validation study of the Ursodeoxycholic Acid Response Score in Japanese patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver, 2020, Volume: 40, Issue:8 Topics: Aged; Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Female; Humans; Japan; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2020
Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis. The American journal of gastroenterology, 2020, Volume: 115, Issue:10 Topics: Adaptor Proteins, Signal Transducing; Adult; Antigens, Nuclear; Autoantibodies; Autoantigens; Cholagogues and Choleretics; Disease Progression; Female; Hexokinase; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Mitochondrial Proteins; Nuclear Pore Complex Proteins; Prognosis; Ursodeoxycholic Acid	2020
Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol. Clinical pharmacology and therapeutics, 2020, Volume: 108, Issue:6 Topics: Adult; Aged; Bile Acids and Salts; Biomarkers; Cholangitis, Sclerosing; Cytokines; Drug Therapy, Combination; Female; Fenofibrate; Humans; Inflammation Mediators; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; PPAR alpha; Principal Component Analysis; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2020
Effective treatment of autoimmune hepatitis-primary biliary cholangitis overlap syndrome with obeticholic acid. Revista espanola de enfermedades digestivas, 2020, Volume: 112, Issue:9 Topics: Adult; Chenodeoxycholic Acid; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2020
Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia. International journal of public health, 2020, Volume: 65, Issue:5 Topics: Aged; Cholagogues and Choleretics; Female; Humans; Incidence; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Slovakia; Ursodeoxycholic Acid	2020
UDCA prophylaxis for post-transplant PBC recurrence prevention: Time to change practice. Journal of hepatology, 2020, Volume: 73, Issue:3 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Recurrence; Ursodeoxycholic Acid	2020
Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study. BMC complementary medicine and therapies, 2020, Aug-01, Volume: 20, Issue:1 Topics: Adult; Cholagogues and Choleretics; Combined Modality Therapy; Female; Humans; Inflammation; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Sympathetic Nervous System; Transcutaneous Electric Nerve Stimulation; Ursodeoxycholic Acid; Vagus Nerve	2020
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All. Digestive diseases and sciences, 2021, Volume: 66, Issue:5 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Racial Groups; Ursodeoxycholic Acid	2021
Understanding Fatigue in Primary Biliary Cholangitis. Digestive diseases and sciences, 2021, Volume: 66, Issue:7 Topics: Aged; Cholagogues and Choleretics; Cohort Studies; Fatigue; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2021
A nomogram based on pretreatment clinical parameters for the prediction of inadequate biochemical response in primary biliary cholangitis. Journal of clinical laboratory analysis, 2020, Volume: 34, Issue:11 Topics: Adult; Disease Progression; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Nomograms; Predictive Value of Tests; Prognosis; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2020
Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis. Vnitrni lekarstvi, 2020,Spring, Volume: 66, Issue:5 Topics: Bile Ducts; Cholangitis, Sclerosing; Cholestasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2020
Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:3 Topics: Antibodies, Antinuclear; Autoantibodies; Glycoproteins; Humans; Liver Cirrhosis, Biliary; Retrospective Studies; Ursodeoxycholic Acid	2021
Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine: A protocol for systematic review and meta analysis. Medicine, 2020, Nov-13, Volume: 99, Issue:46 Topics: Cholagogues and Choleretics; Combined Modality Therapy; Humans; Liver Cirrhosis, Biliary; Medicine, Chinese Traditional; Meta-Analysis as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Ursodeoxycholic Acid	2020
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines. Journal of autoimmunity, 2021, Volume: 116 Topics: Adult; Aged; Alkaline Phosphatase; Autoantibodies; Cholangitis; Cohort Studies; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Practice Guidelines as Topic; Prognosis; Treatment Outcome; Ursodeoxycholic Acid	2021
Worse Response to Ursodeoxycholic Acid in Primary Biliary Cholangitis Patients with Autoimmune Hepatitis Features. Digestive diseases (Basel, Switzerland), 2021, Volume: 39, Issue:4 Topics: Adult; Cholagogues and Choleretics; Drug Monitoring; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2021
Management of primary biliary cholangitis: results from a large real-life observational study in France and Belgium. European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1 Topics: Albumins; Belgium; Bilirubin; Cholagogues and Choleretics; Female; France; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid	2021
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:4 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Spain; Ursodeoxycholic Acid	2021
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool. European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1 Topics: Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Critical Pathways; Humans; Liver Cirrhosis, Biliary; Middle Aged; Risk Assessment; Ursodeoxycholic Acid	2021
Is Ursodeoxycholic Acid Really a Posttransplant Panacea? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2021, Volume: 27, Issue:6 Topics: Biliary Tract; Humans; Incidence; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2021
Chronic fatigue should not be overlooked in primary biliary cholangitis. Journal of hepatology, 2021, Volume: 75, Issue:3 Topics: Cholagogues and Choleretics; Fatigue Syndrome, Chronic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Ursodeoxycholic acid impairs liver-infiltrating T-cell chemotaxis through IFN-γ and CX3CL1 production in primary biliary cholangitis. European journal of immunology, 2021, Volume: 51, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Chemokine CX3CL1; Chemotaxis; Cholagogues and Choleretics; Epithelial Cells; Female; Humans; Immunosuppression Therapy; Interferon-gamma; Jurkat Cells; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; T-Lymphocytes; Ursodeoxycholic Acid	2021
Primary Biliary Cholangitis-associated Palmar Keratosis. Internal medicine (Tokyo, Japan), 2021, Sep-01, Volume: 60, Issue:17 Topics: Cholagogues and Choleretics; Cholangitis; Humans; Keratosis; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
A case of episodic angioedema with eosinophilia in an elderly woman with primary biliary cholangitis. Clinical journal of gastroenterology, 2021, Volume: 14, Issue:3 Topics: Angioedema; Eosinophilia; Female; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis. Alimentary pharmacology & therapeutics, 2021, Volume: 53, Issue:10 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Retrospective Studies; Ursodeoxycholic Acid	2021
Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in Japan. Hepatology international, 2021, Volume: 15, Issue:2 Topics: Cholagogues and Choleretics; Humans; Japan; Liver Cirrhosis, Biliary; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2021
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis. The American journal of gastroenterology, 2021, 07-01, Volume: 116, Issue:7 Topics: Adult; Aged; Cholagogues and Choleretics; Cohort Studies; End Stage Liver Disease; Female; Humans; Hyperbilirubinemia; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prognosis; Severity of Illness Index; Ursodeoxycholic Acid	2021
Fenofibrate improves GLOBE and UK-PBC scores and histological features in primary biliary cholangitis. Minerva medica, 2022, Volume: 113, Issue:6 Topics: Cholagogues and Choleretics; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Retrospective Studies; Ursodeoxycholic Acid	2022
Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis. The American journal of gastroenterology, 2021, 09-01, Volume: 116, Issue:9 Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2021
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome in a patient with paroxysmal nocturnal hemoglobinuria: a case report. The Journal of international medical research, 2021, Volume: 49, Issue:5 Topics: Adult; Female; Hemoglobinuria, Paroxysmal; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Prednisolone; Ursodeoxycholic Acid	2021
Identification of a Latitude Gradient in the Prevalence of Primary Biliary Cholangitis. Clinical and translational gastroenterology, 2021, 05-18, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Child; Child, Preschool; Cholagogues and Choleretics; Female; Geography; Humans; Infant; Infant, Newborn; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Sex Distribution; Sunlight; Ultraviolet Rays; Ursodeoxycholic Acid; Young Adult	2021
Combination antiretroviral therapy improves recurrent primary biliary cholangitis following liver transplantation. Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:8 Topics: Anti-Retroviral Agents; Cholangitis; HIV Infections; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2021
Letter to the Editor: Is Male Sex Associated With Increased Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis? Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:4 Topics: Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2021
Simplified 6-month prediction scores for primary biliary cholangitis patients treated with ursodeoxycholic acid. European journal of gastroenterology & hepatology, 2022, 04-01, Volume: 34, Issue:4 Topics: Adult; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Prognosis; Proportional Hazards Models; Ursodeoxycholic Acid	2022
Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease. United European gastroenterology journal, 2021, Volume: 9, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Disease Progression; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Logistic Models; Male; Middle Aged; Multivariate Analysis; Portugal; Predictive Value of Tests; Registries; Risk Factors; Severity of Illness Index; Treatment Failure; Ursodeoxycholic Acid	2021
Reply to: "Chronic fatigue should not be overlooked in primary biliary cholangitis". Journal of hepatology, 2021, Volume: 75, Issue:3 Topics: Cholangitis; Fatigue Syndrome, Chronic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2021
Specific considerations for the management of primary biliary cholangitis: are the drug treatment options good enough? Expert opinion on pharmacotherapy, 2021, Volume: 22, Issue:15 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Pharmaceutical Preparations; Ursodeoxycholic Acid	2021
The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis. Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:6 Topics: Aged; Biliary Tract; Biomarkers; Case-Control Studies; Chemokines; Epithelial Cells; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Proteome; Treatment Failure; Ursodeoxycholic Acid	2021
Anti-mitochondrial Antibody-Negative Primary Biliary Cholangitis Is Part of the Same Spectrum of Classical Primary Biliary Cholangitis. Digestive diseases and sciences, 2022, Volume: 67, Issue:7 Topics: Autoantibodies; Cholestasis; Diabetes Mellitus, Type 2; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Ursodeoxycholic Acid	2022
External Validation of UDCA Response Score in Slovak and Croatian Patients with Primary Biliary Cholangitis. Canadian journal of gastroenterology & hepatology, 2021, Volume: 2021 Topics: Cholagogues and Choleretics; Cohort Studies; Humans; Liver Cirrhosis, Biliary; Middle Aged; Slovakia; Ursodeoxycholic Acid	2021
Omega-3 Polyunsaturated Fatty Acid: A Pharmaco-Nutraceutical Approach to Improve the Responsiveness to Ursodeoxycholic Acid. Nutrients, 2021, Jul-29, Volume: 13, Issue:8 Topics: Apoptosis; Autoimmune Diseases; Bile Acids and Salts; Carcinoma, Hepatocellular; Caspase 3; Cholangitis, Sclerosing; Cholestanetriol 26-Monooxygenase; Cholestasis; Cholesterol 7-alpha-Hydroxylase; Dietary Supplements; Down-Regulation; Drug Therapy, Combination; Endoplasmic Reticulum Stress; Fatty Acids, Omega-3; Gene Expression; Hep G2 Cells; Humans; Inflammation; Liver; Liver Cirrhosis, Biliary; Liver Diseases; THP-1 Cells; Ursodeoxycholic Acid	2021
Poor performance of anti-mitochondrial antibodies for the diagnosis of primary biliary cholangitis in female Colombian patients: A single-center study. World journal of gastroenterology, 2021, Aug-07, Volume: 27, Issue:29 Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Colombia; Female; Humans; Liver Cirrhosis, Biliary; Mitochondria; Ursodeoxycholic Acid	2021
Finding the cure for primary biliary cholangitis - Still waiting. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:4 Topics: Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Gut microbial profile in primary biliary cholangitis: Towards bioindicators. Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:5 Topics: Cholangitis; Cholangitis, Sclerosing; Environmental Biomarkers; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis. BMJ case reports, 2017, Sep-25, Volume: 2017 Topics: Aged; Autoantibodies; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Colitis, Ulcerative; Diagnosis, Differential; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Treatment Outcome; Ursodeoxycholic Acid	2017
Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response. The American journal of gastroenterology, 2018, Volume: 113, Issue:1 Topics: Alkaline Phosphatase; Bezafibrate; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Elasticity Imaging Techniques; Female; Humans; Hypolipidemic Agents; Jaundice; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prognosis; Pruritus; Ursodeoxycholic Acid; Visual Analog Scale	2018
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018, Volume: 16, Issue:8 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cholagogues and Choleretics; Cohort Studies; Facilities and Services Utilization; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Race Factors; Sex Factors; United States; Ursodeoxycholic Acid; Young Adult	2018
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:5 Topics: Adult; Aged; Cholagogues and Choleretics; Databases, Factual; Europe; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; North America; Retrospective Studies; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2018
Evolving role of obeticholic acid in primary biliary cholangitis. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:5 Topics: Chenodeoxycholic Acid; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome. The American journal of gastroenterology, 2018, Volume: 113, Issue:2 Topics: Adult; Aged; Ascites; Aspartate Aminotransferases; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Esophageal and Gastric Varices; Europe; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Incidence; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; North America; Platelet Count; Population Growth; Prognosis; Proportional Hazards Models; Risk Factors; Ursodeoxycholic Acid	2018
Editorial: Itching to Know: Role of Fibrates in PBC. The American journal of gastroenterology, 2018, Volume: 113, Issue:1 Topics: Bezafibrate; Cholangitis; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2018
[Research advances in primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017, Nov-20, Volume: 25, Issue:11 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Mitochondria; Ursodeoxycholic Acid	2017
[Advances in the treatment of primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017, Nov-20, Volume: 25, Issue:11 Topics: Autoimmune Diseases; Bile Ducts, Intrahepatic; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Serum levels of a cell death biomarker predict the development of cirrhosis-related conditions in primary biliary cholangitis. Medical molecular morphology, 2018, Volume: 51, Issue:3 Topics: Biomarkers; Biopsy; Cell Death; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Follow-Up Studies; Humans; Keratin-18; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Peptide Fragments; Retrospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2018
The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: Regulation by cholic acid-induced Interleukin-7. Journal of autoimmunity, 2018, Volume: 90 Topics: Adult; Cell Movement; Cells, Cultured; Cholagogues and Choleretics; Cohort Studies; Female; Humans; Immunophenotyping; Interleukin-7; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Mucosal-Associated Invariant T Cells; Ursodeoxycholic Acid	2018
Primary cutaneous amyloidosis associated with autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Sjögren syndrome: A case report. Medicine, 2018, Volume: 97, Issue:8 Topics: Amyloidosis, Familial; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Sjogren's Syndrome; Skin Diseases, Genetic; Treatment Outcome; Undifferentiated Connective Tissue Diseases; Ursodeoxycholic Acid	2018
The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut, 2018, Volume: 67, Issue:9 Topics: Alanine Transaminase; Alkaline Phosphatase; Autoantibodies; Bilirubin; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Disease Progression; Gastroenterology; Humans; Liver Cirrhosis, Biliary; Mitochondria; Predictive Value of Tests; Risk Assessment; Risk Factors; Sensitivity and Specificity; Societies, Medical; Treatment Outcome; United Kingdom; Ursodeoxycholic Acid	2018
Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness. Digestive diseases and sciences, 2018, Volume: 63, Issue:10 Topics: Chenodeoxycholic Acid; Cholagogues and Choleretics; Clinical Competence; Disease Progression; Early Diagnosis; Gastroenterologists; Humans; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid	2018
Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA. Revista espanola de enfermedades digestivas, 2018, Volume: 110, Issue:9 Topics: Adult; Aged; Cholagogues and Choleretics; Cholangitis; Cohort Studies; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid	2018
Influence factors and a predictive scoring model for measuring the biochemical response of primary biliary cholangitis to ursodeoxycholic acid treatment. European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:11 Topics: Aged; Alanine Transaminase; Bilirubin; Biomarkers; Cholagogues and Choleretics; Clinical Decision-Making; Decision Support Techniques; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Retrospective Studies; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2018
IgG4-related retroperitoneal fibrosis overlapping with primary biliary cirrhosis and primary Sjögren's syndrome: A case report. Medicine, 2018, Volume: 97, Issue:26 Topics: Aged; Antibodies, Antinuclear; Cholagogues and Choleretics; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Retroperitoneal Fibrosis; Sjogren's Syndrome; Ursodeoxycholic Acid	2018
Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital. Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Colombia; Disease Progression; Female; Follow-Up Studies; Hepatitis, Autoimmune; Hospitals, University; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Syndrome; Ursodeoxycholic Acid	2018
Ensuring timely treatment of patients with primary biliary cholangitis. The lancet. Gastroenterology & hepatology, 2018, Volume: 3, Issue:9 Topics: Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. The lancet. Gastroenterology & hepatology, 2018, Volume: 3, Issue:9 Topics: Age of Onset; Alkaline Phosphatase; Area Under Curve; Bilirubin; Cholagogues and Choleretics; Decision Support Techniques; Female; Humans; Linear Models; Liver Cirrhosis, Biliary; Male; Middle Aged; Risk Factors; ROC Curve; Time-to-Treatment; Transaminases; Treatment Outcome; Ursodeoxycholic Acid	2018
Management of primary biliary cholangitis prior to obeticholic acid availability. Minerva medica, 2018, Volume: 109, Issue:6 Topics: Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2018
Efficacy and Safety of Immunosuppressive Therapy for PBC-AIH Overlap Syndrome Accompanied by Decompensated Cirrhosis: A Real-World Study. Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018 Topics: Adult; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Image-Guided Biopsy; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Treatment Outcome; Undifferentiated Connective Tissue Diseases; Ursodeoxycholic Acid	2018
[Primary biliary cholangitis : an update]. Revue medicale suisse, 2018, Aug-29, Volume: 14, Issue:616 Topics: Autoimmune Diseases; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2018
Bezafibrate in Primary Biliary Cholangitis. The New England journal of medicine, 2018, 09-06, Volume: 379, Issue:10 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study. Journal of gastrointestinal and liver diseases : JGLD, 2018, Volume: 27, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Cholagogues and Choleretics; Cholesterol; Fatigue; Female; gamma-Glutamyltransferase; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Pilot Projects; Poland; Proof of Concept Study; Prospective Studies; Pruritus; Quality of Life; S-Adenosylmethionine; Surveys and Questionnaires; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2018
Analysis of predictive response scores to treatment with ursodeoxycholic acid in patients with primary biliary cholangitis. Medicina clinica, 2019, 05-17, Volume: 152, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Area Under Curve; Body Mass Index; Cholesterol; Comorbidity; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Retrospective Studies; ROC Curve; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2019
Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases. La Tunisie medicale, 2018, Volume: 96, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2018
In primary biliary cholangitis, adding bezafibrate to ursodeoxycholic acid increased complete biochemical response. Annals of internal medicine, 2018, 10-16, Volume: 169, Issue:8 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
[Bezafibrate for primary biliary cholangitis : Bezafibrate in combination with ursodeoxycholic acid in primary biliary cholangitis (BEZURSO) trial]. Der Internist, 2018, Volume: 59, Issue:12 Topics: Bezafibrate; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2018
Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from China. Journal of gastroenterology and hepatology, 2019, Volume: 34, Issue:7 Topics: China; Cholagogues and Choleretics; Female; Follow-Up Studies; Hepatitis B; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Longitudinal Studies; Male; Progression-Free Survival; Retrospective Studies; Risk Factors; Sex Factors; Time Factors; Ursodeoxycholic Acid	2019
Primary biliary cirrhosis with refractory hypokalemia: A case report. Medicine, 2018, Volume: 97, Issue:48 Topics: Adult; Calcium; Dietary Supplements; Female; Humans; Hypokalemia; Liver Cirrhosis, Biliary; Potassium Citrate; Ursodeoxycholic Acid	2018
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:3 Topics: Cholagogues and Choleretics; Europe; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Patient Selection; Ursodeoxycholic Acid	2019
Past hepatitis B virus infection was not associated with poorer response or the UK-PBC risk score in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:2 Topics: China; Cholagogues and Choleretics; Hepatitis B; Humans; Liver Cirrhosis, Biliary; Risk Factors; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2019
Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:5 Topics: Adult; Aged; Cholagogues and Choleretics; Comorbidity; Databases, Factual; End Stage Liver Disease; Female; Humans; Incidence; Italy; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2019
Letter: reduction in projected mortality or need for liver transplantation associated with bezafibrate add-on in primary biliary cholangitis with incomplete UDCA response. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:2 Topics: Bezafibrate; Cholangitis; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Ursodeoxycholic Acid	2019
[Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019, Jan-20, Volume: 27, Issue:1 Topics: Cholagogues and Choleretics; Cholangitis; Cholestasis; Humans; Liver Cirrhosis, Biliary; Risk Factors; Ursodeoxycholic Acid	2019
Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions. PloS one, 2019, Volume: 14, Issue:2 Topics: Adult; Brain Mapping; Case-Control Studies; Cerebral Cortex; Cholagogues and Choleretics; Female; Humans; Interoception; Iron; Linear Models; Liver; Liver Cirrhosis, Biliary; Magnetic Resonance Imaging; Middle Aged; Organ Size; Severity of Illness Index; Thalamus; Ursodeoxycholic Acid	2019
Long-term outcomes with obeticholic acid in primary biliary cholangitis: reassuring, but still an itch we need to scratch. The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:6 Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. Journal of hepatology, 2019, Volume: 71, Issue:2 Topics: Adult; Aged; Cholagogues and Choleretics; Cholangitis; Disease Progression; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Risk; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2019
Clinical Trials in PBC Going Forward. Seminars in liver disease, 2019, Volume: 39, Issue:3 Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2019
Biliary features in liver histology of children with autoimmune liver disease. Hepatology international, 2019, Volume: 13, Issue:4 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Lymphocytes; Male; Prednisone; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2019
Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study. Scandinavian journal of gastroenterology, 2019, Volume: 54, Issue:5 Topics: Aged; Aged, 80 and over; Albumins; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Female; Humans; Iceland; Liver Cirrhosis, Biliary; Male; Middle Aged; Severity of Illness Index; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2019
Alteration of liver-infiltrated and peripheral blood double-negative T-cells in primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:9 Topics: Adult; Aged; Case-Control Studies; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; T-Lymphocytes, Regulatory; Ursodeoxycholic Acid	2019
Unusual presentation of pica in iron-deficiency anaemia associated with primary biliary cholangitis. BMJ case reports, 2019, May-29, Volume: 12, Issue:5 Topics: Administration, Oral; Anemia, Iron-Deficiency; Blood Transfusion; Cholagogues and Choleretics; Diagnosis, Differential; Digestive System Surgical Procedures; Esophageal and Gastric Varices; Female; Humans; Hypertension, Portal; Iron; Liver Cirrhosis, Biliary; Middle Aged; Pica; Ultrasonography; Ursodeoxycholic Acid	2019
Pediatric-onset primary biliary cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:7 Topics: Adolescent; Age of Onset; Cholagogues and Choleretics; Disease Progression; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Ursodeoxycholic Acid	2019
Additional fibrate treatment in UDCA-refractory PBC patients. Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:9 Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ursodeoxycholic Acid	2019
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis. The American journal of gastroenterology, 2019, Volume: 114, Issue:7 Topics: Adult; Age Factors; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Internationality; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2019
Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis. Canadian journal of gastroenterology & hepatology, 2019, Volume: 2019 Topics: Adult; China; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Sjogren's Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2019
A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis. Clinical journal of gastroenterology, 2020, Volume: 13, Issue:1 Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Cholagogues and Choleretics; Cholestasis; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunoglobulin M; Liver Cirrhosis, Biliary; Mitochondrial Proteins; Prednisolone; Ursodeoxycholic Acid	2020
RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis. Digestive diseases and sciences, 2020, Volume: 65, Issue:2 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antigens, CD; Aspartate Aminotransferases; B7-1 Antigen; Bile Ducts, Intrahepatic; Cadherins; Cholagogues and Choleretics; Epithelial Cells; Female; gamma-Glutamyltransferase; Humans; Immunohistochemistry; In Vitro Techniques; Intercellular Adhesion Molecule-1; Interleukin-6; Liver Cirrhosis, Biliary; Male; Middle Aged; RANK Ligand; Real-Time Polymerase Chain Reaction; Receptor Activator of Nuclear Factor-kappa B; Severity of Illness Index; Transfection; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid; Vascular Cell Adhesion Molecule-1	2020
Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: results of a 14-year cohort study. Hepatology (Baltimore, Md.), 2013, Volume: 58, Issue:1 Topics: Adult; Female; Humans; Liver Cirrhosis, Biliary; Longitudinal Studies; Male; Middle Aged; Predictive Value of Tests; Prognosis; Ursodeoxycholic Acid	2013
Risk factors for hepatic decompensation in patients with primary biliary cirrhosis. World journal of gastroenterology, 2013, Feb-21, Volume: 19, Issue:7 Topics: Adult; Biomarkers; Chi-Square Distribution; China; Cholagogues and Choleretics; Disease Progression; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Liver Failure; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2013
CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid. Clinical and experimental immunology, 2013, Volume: 172, Issue:1 Topics: Adult; Biopsy; Case-Control Studies; Chemokine CXCL10; Chemokine CXCL11; Chemokine CXCL9; Chemotaxis; Cholagogues and Choleretics; Female; Gene Expression; Humans; Leukocytes, Mononuclear; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Protein Isoforms; Receptors, CXCR3; RNA, Messenger; Ursodeoxycholic Acid	2013
Clinicopathological significance of serum fractalkine in primary biliary cirrhosis. Digestive diseases and sciences, 2013, Volume: 58, Issue:10 Topics: Biomarkers; Chemokine CX3CL1; Cholagogues and Choleretics; Cholangitis; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2013
Effects of hepatocellular carcinoma on the survival of patients with primary biliary cirrhosis in the era of ursodeoxycholic acid therapy. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:14 Topics: Carcinoma, Hepatocellular; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2013
Ursodeoxycholic acid improves bilirubin but not albumin in primary biliary cirrhosis: further evidence for nonefficacy. BioMed research international, 2013, Volume: 2013 Topics: Bilirubin; Clinical Trials as Topic; Cohort Studies; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Models, Biological; Serum Albumin; Treatment Outcome; Ursodeoxycholic Acid	2013
Bezafibrate normalizes alkaline phosphatase in primary biliary cirrhosis patients with incomplete response to ursodeoxycholic acid. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:2 Topics: Alkaline Phosphatase; Bezafibrate; Elasticity Imaging Techniques; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Pilot Projects; Prospective Studies; Statistics, Nonparametric; Treatment Outcome; Ursodeoxycholic Acid	2014
Identification of a primary biliary cirrhosis associated protein as lysosome-associated membrane protein-2. Journal of proteomics, 2013, Oct-08, Volume: 91 Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cell Differentiation; Dogs; Gene Expression Regulation; Humans; Hybridomas; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Lysosomal-Associated Membrane Protein 2; Madin Darby Canine Kidney Cells; Molecular Sequence Data; Prognosis; Protein Binding; Recombinant Proteins; RNA, Messenger; Tissue Distribution; Ursodeoxycholic Acid	2013
Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:5 Topics: Adult; Aged; Antibodies, Antinuclear; Case-Control Studies; Cholagogues and Choleretics; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Receptors, Tumor Necrosis Factor, Member 6b; Tumor Necrosis Factor Ligand Superfamily Member 15; Ursodeoxycholic Acid	2014
Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholagogues and Choleretics; Cohort Studies; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2014
Biochemical criteria at 1 year are not robust indicators of response to ursodeoxycholic acid in early primary biliary cirrhosis: results from a 29-year cohort study. Alimentary pharmacology & therapeutics, 2013, Volume: 38, Issue:11-12 Topics: Adult; Aged; Albumins; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2013
A 62-year-old female patient with left-sided pleural effusion. Expert review of respiratory medicine, 2013, Volume: 7, Issue:5 Topics: Biopsy; Drug Therapy, Combination; Female; Furosemide; Humans; Hydrothorax; Liver Cirrhosis, Biliary; Middle Aged; Pleural Effusion; Spironolactone; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ursodeoxycholic Acid	2013
Metabolic syndrome associated with primary biliary cirrhosis. Journal of clinical gastroenterology, 2015, Volume: 49, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Angina, Stable; Cholagogues and Choleretics; Female; Humans; Ischemic Attack, Transient; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Survival Rate; Ursodeoxycholic Acid	2015
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients. Journal of gastroenterology, 2014, Volume: 49, Issue:10 Topics: Alkaline Phosphatase; Biomarkers; Cholagogues and Choleretics; Clinical Enzyme Tests; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Pruritus; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2014
Letter: biochemical response to combination anti-retroviral therapy in patients with primary biliary cirrhosis. Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:2 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2014
Hispanics with primary biliary cirrhosis are more likely to have features of autoimmune hepatitis and reduced response to ursodeoxycholic acid than non-Hispanics. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:8 Topics: Adolescent; Adult; Aged; Cholagogues and Choleretics; Cross-Sectional Studies; Ethnicity; Female; Hepatitis, Autoimmune; Hispanic or Latino; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2014
New therapeutics in primary biliary cirrhosis: will there ever be light? Liver international : official journal of the International Association for the Study of the Liver, 2014, Volume: 34, Issue:2 Topics: Alkaline Phosphatase; Fibric Acids; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2014
Effectiveness of fenofibrate in comparison to bezafibrate for patients with asymptomatic primary biliary cirrhosis. Fukuoka igaku zasshi = Hukuoka acta medica, 2013, Volume: 104, Issue:10 Topics: Adult; Aged; Asymptomatic Diseases; Bezafibrate; Cardiovascular Diseases; Cholesterol, LDL; Cohort Studies; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; PPAR alpha; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Uric Acid; Ursodeoxycholic Acid	2013
Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response. Journal of hepatology, 2014, Volume: 60, Issue:6 Topics: Adult; Aspartate Aminotransferases; Cholagogues and Choleretics; Databases, Factual; Disease-Free Survival; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Ursodeoxycholic Acid	2014
Sequential presentation of primary biliary cirrhosis and autoimmune hepatitis. European journal of gastroenterology & hepatology, 2014, Volume: 26, Issue:5 Topics: Adolescent; Adult; Aged; Biomarkers; Disease Progression; Drug Therapy, Combination; Europe; Female; Gastrointestinal Agents; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Remission Induction; Retrospective Studies; Risk Factors; Syndrome; Time Factors; Treatment Outcome; United States; Ursodeoxycholic Acid; Young Adult	2014
Primary biliary cirrhosis in 2014. Current opinion in gastroenterology, 2014, Volume: 30, Issue:3 Topics: Cholagogues and Choleretics; Fibric Acids; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Sex Characteristics; Ursodeoxycholic Acid	2014
Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:2 Topics: Adult; Alkaline Phosphatase; Autoantibodies; Blotting, Western; Cohort Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Fatigue; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Italy; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; Pruritus; Transaminases; Ursodeoxycholic Acid	2015
Ursodeoxycholic acid influences the expression of p27kip1 but not FoxO1 in patients with non-cirrhotic primary biliary cirrhosis. Journal of immunology research, 2014, Volume: 2014 Topics: Adult; Animals; Biopsy; Case-Control Studies; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cyclin-Dependent Kinase Inhibitor p27; Female; Forkhead Box Protein O1; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Liver Cirrhosis, Biliary; Liver Diseases, Alcoholic; Male; Mice; Mice, Knockout; Middle Aged; RNA, Messenger; Ursodeoxycholic Acid	2014
The therapeutic effect of UDCA is a factor in determining the prognosis of primary biliary cirrhosis. Journal of gastroenterology, 2014, Volume: 49, Issue:10 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2014
Overlap of IgG4-related sclerosing cholangitis and primary biliary cirrhosis. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:13 Topics: Bezafibrate; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2014
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:2 Topics: Adult; B-Lymphocytes; Case-Control Studies; Cholagogues and Choleretics; Female; Humans; Interleukins; Liver Cirrhosis, Biliary; Male; Middle Aged; Receptors, CXCR5; T-Lymphocytes, Helper-Inducer; Ursodeoxycholic Acid; Young Adult	2015
Co-occurrence of idiopathic granulomatous hepatitis and primary biliary cirrhosis. Digestive diseases and sciences, 2014, Volume: 59, Issue:11 Topics: Adult; Cholagogues and Choleretics; Colchicine; Female; Folic Acid Antagonists; Hepatitis; Humans; Liver Cirrhosis, Biliary; Methotrexate; Tubulin Modulators; Ursodeoxycholic Acid	2014
Reply to: "AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis". Journal of hepatology, 2014, Volume: 61, Issue:6 Topics: Aspartate Aminotransferases; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Platelet Count; Ursodeoxycholic Acid	2014
AST/platelet ratio index associates with progression to hepatic failure and correlates with histological fibrosis stage in Japanese patients with primary biliary cirrhosis. Journal of hepatology, 2014, Volume: 61, Issue:6 Topics: Aspartate Aminotransferases; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Platelet Count; Ursodeoxycholic Acid	2014
Biochemical responses to bezafibrate improve long-term outcome in asymptomatic patients with primary biliary cirrhosis refractory to UDCA. Journal of gastroenterology, 2015, Volume: 50, Issue:6 Topics: Adult; Aged; Alanine Transaminase; Bezafibrate; Databases, Factual; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2015
[Is ursodeoxycholic acid effective in primary biliary cirrhosis?]. Medwave, 2014, Sep-24, Volume: 14, Issue:8 Topics: Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2014
Case-control study on prednisolone combined with ursodeoxycholic acid and azathioprine in pure primary biliary cirrhosis with high levels of immunoglobulin G and transaminases: efficacy and safety analysis. Medicine, 2014, Volume: 93, Issue:20 Topics: Adult; Azathioprine; Case-Control Studies; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunoglobulin G; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisolone; Transaminases; Treatment Outcome; Ursodeoxycholic Acid	2014
The association between bile salt export pump single-nucleotide polymorphisms and primary biliary cirrhosis susceptibility and ursodeoxycholic acid response. Disease markers, 2014, Volume: 2014 Topics: Adolescent; Adult; Aged; Aged, 80 and over; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Case-Control Studies; Child; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Polymorphism, Single Nucleotide; Ursodeoxycholic Acid	2014
Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis. Journal of clinical pathology, 2015, Volume: 68, Issue:2 Topics: Aged; Alkaline Phosphatase; Bile Ducts, Intrahepatic; Bilirubin; Biomarkers; Biopsy; Case-Control Studies; Disease Progression; Female; Humans; Immunohistochemistry; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Stem Cells; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2015
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment. Le infezioni in medicina, 2014, Volume: 22, Issue:4 Topics: Adult; Cholagogues and Choleretics; Epstein-Barr Virus Infections; Fingolimod Hydrochloride; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Multiple Sclerosis; Recurrence; Treatment Outcome; Ursodeoxycholic Acid; Withholding Treatment	2014
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international study. Gut, 2016, Volume: 65, Issue:2 Topics: Aspartate Aminotransferases; Carcinoma, Hepatocellular; Europe; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Liver Neoplasms; Logistic Models; Male; North America; Proportional Hazards Models; Risk; Risk Factors; Sex Factors; Thrombocytopenia; Ursodeoxycholic Acid	2016
[Lung involvement in patients with primary biliary cirrhosis]. Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Female; Humans; Liver Cirrhosis, Biliary; Lung; Lung Diseases, Interstitial; Mitochondria; Respiratory Function Tests; Tomography, X-Ray Computed; Ursodeoxycholic Acid	2015
Autoimmune hepatitis-primary biliary cirrhosis concurrent with biliary stricture after liver transplantation. World journal of gastroenterology, 2015, Feb-21, Volume: 21, Issue:7 Topics: Cholagogues and Choleretics; Cholestasis; Fatty Liver, Alcoholic; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Prednisone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid	2015
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:5 Topics: Arthritis, Psoriatic; Autoantibodies; Cholangitis, Sclerosing; Comorbidity; Female; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria; Syndrome; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid	2015
A decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis. Scientific reports, 2015, Apr-20, Volume: 5 Topics: Adult; Aged; Area Under Curve; Demography; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Lysosomal-Associated Membrane Protein 2; Male; Middle Aged; Retrospective Studies; ROC Curve; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2015
Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. The American journal of gastroenterology, 2015, Volume: 110, Issue:6 Topics: Antigens, Neoplasm; Case-Control Studies; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Female; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Membrane Glycoproteins; Middle Aged; Plant Lectins; Prognosis; Proportional Hazards Models; Receptors, N-Acetylglucosamine; Retrospective Studies; Ursodeoxycholic Acid	2015
Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:2 Topics: Adult; Aged; Alkaline Phosphatase; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Ursodeoxycholic Acid; Vitamin D; Vitamin D Deficiency	2015
[In Process Citation]. MMW Fortschritte der Medizin, 2015, Volume: 157 Suppl 2 Topics: Chenodeoxycholic Acid; Cholangitis, Sclerosing; Hope; Humans; Life Expectancy; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid	2015
Combination Therapy of Ursodeoxycholic Acid and Bezafibrate in Patients With Primary Biliary Cirrhosis: The End of the Steroid Era in Autoimmune Liver Diseases? The American journal of gastroenterology, 2015, Volume: 110, Issue:7 Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid	2015
Response to Licinio et al. The American journal of gastroenterology, 2015, Volume: 110, Issue:7 Topics: Bezafibrate; Dyslipidemias; Female; Humans; Liver Cirrhosis, Biliary; Male; Myalgia; Renal Insufficiency; Ursodeoxycholic Acid	2015
Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes. Clinical and molecular hepatology, 2015, Volume: 21, Issue:2 Topics: Adult; Aged; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Republic of Korea; Retrospective Studies; Steroids; Treatment Outcome; Ursodeoxycholic Acid	2015
Delayed Development of Primary Biliary Cirrhosis in a Patient with Acute Glomerulonephritis: A Possible Pitfall of a Self-limiting Disease. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:15 Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cholagogues and Choleretics; Diuretics; Female; Glomerulonephritis; Humans; Kidney; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2015
Letter: serum vitamin D levels in primary biliary cirrhosis. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:5 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid; Vitamin D	2015
Letter: serum vitamin D levels in primary biliary cirrhosis--authors' reply. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:5 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid; Vitamin D	2015
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence. Journal of hepatology, 2015, Volume: 63, Issue:6 Topics: Adult; Cholagogues and Choleretics; Cohort Studies; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Secondary Prevention; Treatment Outcome; Ursodeoxycholic Acid	2015
Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Alimentary pharmacology & therapeutics, 2016, Volume: 43, Issue:2 Topics: Adult; Aged; Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ursodeoxycholic Acid	2016
[Hashimoto's encephalopaty associated with primary biliary cirrhosis and vitiligo]. Medicina clinica, 2016, Mar-18, Volume: 146, Issue:6 Topics: Anti-Inflammatory Agents; Autoantibodies; Dementia; Diagnosis, Differential; Electroencephalography; Encephalitis; Hashimoto Disease; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Magnetic Resonance Imaging; Prednisone; Ursodeoxycholic Acid; Vitiligo	2016
Primary biliary cholangitis associated with warm autoimmune hemolytic anemia. Journal of digestive diseases, 2016, Volume: 17, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Biopsy; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Prednisolone; Ursodeoxycholic Acid	2016
Surrogate Endpoints for Optimal Therapeutic Response to UDCA in Primary Biliary Cholangitis. Digestive diseases (Basel, Switzerland), 2015, Volume: 33 Suppl 2 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Prognosis; Risk Assessment; Treatment Outcome; Ursodeoxycholic Acid	2015
Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid. Digestive diseases (Basel, Switzerland), 2015, Volume: 33 Suppl 2 Topics: Antibodies, Monoclonal; Chenodeoxycholic Acid; Cholagogues and Choleretics; Fibric Acids; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Treatment Failure; Treatment Outcome; Ursodeoxycholic Acid	2015
Decreased expression of TIPE2 contributes to the hyperreactivity of monocyte to Toll-like receptor ligands in primary biliary cirrhosis. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:6 Topics: Adult; Case-Control Studies; Cells, Cultured; Cholagogues and Choleretics; Cytokines; Down-Regulation; Female; Humans; Inflammation Mediators; Intracellular Signaling Peptides and Proteins; Ligands; Lipopolysaccharides; Liver Cirrhosis, Biliary; Male; Middle Aged; Monocytes; NF-kappa B; RNA Interference; RNA, Messenger; Signal Transduction; Teichoic Acids; Toll-Like Receptors; Transfection; Ursodeoxycholic Acid	2016
Editorial: fenofibrate as second-line therapy in high risk PBC--more answers or more questions? Alimentary pharmacology & therapeutics, 2016, Volume: 43, Issue:5 Topics: Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2016
Editorial: fenofibrate as second-line therapy in high risk PBC--more answers or more questions? Authors' reply. Alimentary pharmacology & therapeutics, 2016, Volume: 43, Issue:5 Topics: Female; Fenofibrate; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2016
Primary biliary cirrhosis associated with Graves' disease in a male patient. Clinical journal of gastroenterology, 2016, Volume: 9, Issue:2 Topics: Cholagogues and Choleretics; Graves Disease; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2016
Biliary Cirrhosis Treated With Ursodeoxycholic Acid. Gastroenterology, 2016, Volume: 150, Issue:7 Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2016
Clonal Characteristics of Circulating B Lymphocyte Repertoire in Primary Biliary Cholangitis. Journal of immunology (Baltimore, Md. : 1950), 2016, 09-01, Volume: 197, Issue:5 Topics: Adult; Aged; Autoimmune Diseases; B-Lymphocytes; Cholangitis; Clone Cells; Female; Genetic Variation; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Mutation; Ursodeoxycholic Acid	2016
Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score. Digestive diseases and sciences, 2016, Volume: 61, Issue:10 Topics: Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Creatinine; Drug Therapy, Combination; Female; Fenofibrate; Glomerular Filtration Rate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Longitudinal Studies; Middle Aged; Prognosis; Retrospective Studies; Serum Albumin; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2016
Identification of microRNA profiles associated with refractory primary biliary cirrhosis. Molecular medicine reports, 2016, Volume: 14, Issue:4 Topics: Adult; Aged; Anti-Inflammatory Agents; Bezafibrate; Cholagogues and Choleretics; Drug Resistance; Female; Gene Expression Regulation; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; MicroRNAs; Middle Aged; Prednisolone; Transcriptome; Ursodeoxycholic Acid	2016
A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis. CPT: pharmacometrics & systems pharmacology, 2016, Volume: 5, Issue:8 Topics: Administration, Oral; Bile Acids and Salts; Cholagogues and Choleretics; Databases, Factual; Humans; Ileum; Liver Cirrhosis, Biliary; Random Allocation; Systems Analysis; Ursodeoxycholic Acid	2016
Primary biliary cholangitis, let's try to keep the new nomenclature correct! The Netherlands journal of medicine, 2016, Volume: 74, Issue:6 Topics: Cholagogues and Choleretics; Cholangitis; Early Diagnosis; Humans; Liver Cirrhosis, Biliary; Prognosis; Terminology as Topic; Ursodeoxycholic Acid	2016
How the concept of biochemical response influenced the management of primary biliary cholangitis over time. The Netherlands journal of medicine, 2016, Volume: 74, Issue:6 Topics: Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Disease Management; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Serum Albumin; Treatment Outcome; Ursodeoxycholic Acid	2016
Therapy: Obeticholic acid for PBC. Nature reviews. Gastroenterology & hepatology, 2016, Volume: 13, Issue:10 Topics: Chenodeoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2016
The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis. Alimentary pharmacology & therapeutics, 2016, Volume: 44, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Quality of Life; Severity of Illness Index; Ursodeoxycholic Acid; Young Adult	2016
Clinical significance of the Scheuer histological staging system for primary biliary cholangitis in Japanese patients. European journal of gastroenterology & hepatology, 2017, Volume: 29, Issue:1 Topics: Aged; Asian People; Biomarkers; Biopsy; Cholagogues and Choleretics; Clinical Enzyme Tests; Decision Support Techniques; Female; gamma-Glutamyltransferase; Humans; Japan; Kaplan-Meier Estimate; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Retrospective Studies; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2017
Obeticholic acid in primary biliary cholangitis. Clinics and research in hepatology and gastroenterology, 2017, Volume: 41, Issue:1 Topics: Chenodeoxycholic Acid; Cholangitis; Double-Blind Method; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2017
Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:6 Topics: Biomarkers; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Interleukin-8; Japan; Lipopolysaccharide Receptors; Liver; Liver Cirrhosis, Biliary; Liver Failure; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Prognosis; Risk Factors; Survival Analysis; Ursodeoxycholic Acid	2017
Interstitial granulomatous dermatitis associated with primary biliary cirrhosis. The Journal of dermatology, 2018, Volume: 45, Issue:1 Topics: Aged; Autoantibodies; Autoimmune Diseases; Biopsy; Cholagogues and Choleretics; Dermatitis; Drugs, Chinese Herbal; Forearm; Humans; Liver Cirrhosis, Biliary; Male; Mitochondria; Skin; Treatment Outcome; Ursodeoxycholic Acid	2018
[Infrequent but serious: autoimmune hepatitis and primary biliary cirrhosis. Early therapy improves long-term prognosis]. MMW Fortschritte der Medizin, 2008, Apr-10, Volume: 150, Issue:15 Topics: Budesonide; Drug Therapy, Combination; Hepatitis, Autoimmune; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Long-Term Care; Prognosis; Ursodeoxycholic Acid	2008
Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology, 2008, Volume: 135, Issue:5 Topics: Adult; Aged; Aspartate Aminotransferases; Cholagogues and Choleretics; Confidence Intervals; Disease Progression; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Cirrhosis, Biliary; Male; Middle Aged; Odds Ratio; Portal Pressure; Prevalence; Prognosis; Quebec; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2008
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Treatment Outcome; Ursodeoxycholic Acid	2008
Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2009, Volume: 49, Issue:1 Topics: Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Drug Synergism; Fenofibrate; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Prognosis; Ursodeoxycholic Acid	2009
Are therapeutic doses of ursodeoxycholic acid in the cure of primary biliary cirrhosis inadequate? Some clinical considerations. Minerva gastroenterologica e dietologica, 2008, Volume: 54, Issue:4 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Treatment Failure; Ursodeoxycholic Acid	2008
A patient with primary biliary cirrhosis and elevated LDL cholesterol. Clinical chemistry, 2009, Volume: 55, Issue:1 Topics: Cholesterol, LDL; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	2009
Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology, 2009, Volume: 136, Issue:4 Topics: Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Multivariate Analysis; Netherlands; Prognosis; Prospective Studies; Serum Albumin; Survival Analysis; Ursodeoxycholic Acid	2009
Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. Digestive diseases and sciences, 2010, Volume: 55, Issue:2 Topics: Administration, Oral; Adult; Aged; Alkaline Phosphatase; Angiotensin-Converting Enzyme Inhibitors; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Quality of Life; Tetrahydroisoquinolines; Treatment Outcome; Ursodeoxycholic Acid	2010
Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol. Hepatology (Baltimore, Md.), 2009, Volume: 50, Issue:2 Topics: Cholagogues and Choleretics; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Treatment Failure; Ursodeoxycholic Acid	2009
Early biochemical response to ursodeoxycholic acid predicts symptom development in patients with asymptomatic primary biliary cirrhosis. Journal of gastroenterology, 2009, Volume: 44, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Multivariate Analysis; Prognosis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2009
Management of autoimmune and cholestatic liver disorders. Clinics in liver disease, 2009, Volume: 13, Issue:2 Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Cholangitis, Sclerosing; Chronic Disease; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Transplantation; Practice Guidelines as Topic; Prednisone; Ursodeoxycholic Acid	2009
Autoimmune hemolityc anemia concomitant with sequential autoimmune hepatitis-primary biliary cirrhosis overlap syndrome and Hashimoto's thyroiditis: a new entity of autoimmune polyendocrine syndrome. Journal of endocrinological investigation, 2009, Volume: 32, Issue:3 Topics: Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Budesonide; Female; Hashimoto Disease; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Middle Aged; Polyendocrinopathies, Autoimmune; Syndrome; Ursodeoxycholic Acid	2009
Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes. Journal of gastroenterology and hepatology, 2010, Volume: 25, Issue:2 Topics: Alanine Transaminase; Alkaline Phosphatase; Biomarkers; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Prednisolone; Retrospective Studies; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2010
Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines. Journal of hepatology, 2009, Volume: 51, Issue:6 Topics: Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary; Practice Guidelines as Topic; Ursodeoxycholic Acid	2009
Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. Antioxidants & redox signaling, 2010, Aug-01, Volume: 13, Issue:3 Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Bile Acids and Salts; Biopsy; Deoxyguanosine; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Middle Aged; NF-E2-Related Factor 2; Oxidative Stress; Thioredoxin Reductase 1; Ursodeoxycholic Acid	2010
Is there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis? Translational research : the journal of laboratory and clinical medicine, 2010, Volume: 155, Issue:3 Topics: Alkaline Phosphatase; Bilirubin; Humans; Liver Cirrhosis, Biliary; Molybdenum; Ursodeoxycholic Acid	2010
[The characteristics of peripheral lymphocytic subsets and cytokines in primary biliary and their changes to drug treatment.]. Zhonghua nei ke za zhi, 2010, Volume: 49, Issue:2 Topics: Cytokines; Humans; Interleukin-4; Interleukin-6; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2010
Learning from the pregnane X receptor: how to fight one aggressor with two strategies. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:2 Topics: Animals; Apoptosis; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Disease Models, Animal; Glycochenodeoxycholic Acid; Hepatocytes; Humans; Liver Cirrhosis, Biliary; Pregnane X Receptor; Rats; Receptors, Steroid; Ursodeoxycholic Acid	2010
Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. The American journal of gastroenterology, 2010, Volume: 105, Issue:10 Topics: Adult; Alkaline Phosphatase; Disease Progression; Female; Humans; Immunoglobulins; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Odds Ratio; Patient Selection; Predictive Value of Tests; Regression Analysis; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2010
Successful treatment of primary Sjögren's syndrome complicated with primary biliary cirrhosis and lung involvement. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2010, Volume: 21, Issue:1 Topics: Adult; Female; Humans; Liver Cirrhosis, Biliary; Lung Diseases, Interstitial; Methylprednisolone; Sjogren's Syndrome; Tomography, X-Ray Computed; Ursodeoxycholic Acid	2010
Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid. Digestive diseases and sciences, 2010, Volume: 55, Issue:11 Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Colchicine; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Methotrexate; Treatment Failure; Ursodeoxycholic Acid	2010
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:3 Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Apoptosis; Apoptosomes; B-Lymphocytes; Case-Control Studies; Cells, Cultured; Cholagogues and Choleretics; Cytokines; Epithelial Cells; Female; Humans; Immunity, Innate; Liver Cirrhosis, Biliary; Macrophages; Middle Aged; Mitochondria; Mitochondrial Proteins; Recurrence; T-Lymphocytes; Ursodeoxycholic Acid	2010
[Prognosis of Korean patients with primary biliary cirrhosis]. The Korean journal of hepatology, 2010, Volume: 16, Issue:2 Topics: Bacterial Proteins; Endopeptidases; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Prognosis; Severity of Illness Index; Survival Rate; Ursodeoxycholic Acid	2010
[Clinical features and prognosis of primary biliary cirrhosis in Korea]. The Korean journal of hepatology, 2010, Volume: 16, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Autoantibodies; Bacterial Proteins; Endopeptidases; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prognosis; Republic of Korea; Retrospective Studies; Severity of Illness Index; Survival Rate; Ursodeoxycholic Acid	2010
Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:12 Topics: Adult; Bile Acids and Salts; Breast Feeding; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Milk, Human; Pregnancy; Ursodeoxycholic Acid	2010
The impact of fatigue and treatment with ursodeoxycholic acid on the prognosis of primary biliary cirrhosis: an extended 9 year follow-up. Journal of hepatology, 2010, Volume: 53, Issue:5 Topics: Fatigue; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Prognosis; Time Factors; Ursodeoxycholic Acid	2010
The independent effects of fatigue and UDCA therapy on mortality in primary biliary cirrhosis: results of a 9 year follow-up. Journal of hepatology, 2010, Volume: 53, Issue:5 Topics: Fatigue; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Proportional Hazards Models; Quality of Life; Ursodeoxycholic Acid	2010
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis. Clinics and research in hepatology and gastroenterology, 2011, Volume: 35, Issue:1 Topics: Cholagogues and Choleretics; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prospective Studies; Time Factors; Ursodeoxycholic Acid	2011
Varices in early histological stage primary biliary cirrhosis. Journal of clinical gastroenterology, 2011, Volume: 45, Issue:7 Topics: Adult; Aged; Cholagogues and Choleretics; Double-Blind Method; Endoscopy, Gastrointestinal; Esophageal and Gastric Varices; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Predictive Value of Tests; Prevalence; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome; Ursodeoxycholic Acid	2011
Methotrexate for primary biliary cirrhosis: who is to be trusted? Digestive diseases and sciences, 2010, Volume: 55, Issue:11 Topics: Cholagogues and Choleretics; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Treatment Outcome; Ursodeoxycholic Acid	2010
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:3 Topics: Cause of Death; Cholagogues and Choleretics; Disease Progression; Female; Follow-Up Studies; Humans; Italy; Liver Cirrhosis, Biliary; Liver Failure; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	2011
[A two-year follow-up study on the efficacy of ursodeoxycholic acid on primary biliary cirrhosis in different stages]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2010, Volume: 18, Issue:10 Topics: Adult; Disease Progression; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2010
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Alimentary pharmacology & therapeutics, 2011, Volume: 33, Issue:2 Topics: Adult; Aged; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Statistics as Topic; Treatment Outcome; Ursodeoxycholic Acid	2011
Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis. The Journal of the Association of Physicians of India, 2010, Volume: 58 Topics: Adult; Autoantibodies; Biopsy; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2010
Discriminant analysis using a multivariate linear mixed model with a normal mixture in the random effects distribution. Statistics in medicine, 2010, Dec-30, Volume: 29, Issue:30 Topics: Biomarkers; Cholagogues and Choleretics; Computer Simulation; Data Interpretation, Statistical; Discriminant Analysis; Disease Progression; Humans; Linear Models; Liver Cirrhosis, Biliary; Longitudinal Studies; Ursodeoxycholic Acid	2010
Trends in liver transplantation for primary biliary cirrhosis in the Netherlands 1988-2008. BMC gastroenterology, 2010, Dec-20, Volume: 10 Topics: Cholagogues and Choleretics; Female; Humans; Linear Models; Liver Cirrhosis, Biliary; Liver Failure; Liver Transplantation; Male; Middle Aged; Netherlands; Retrospective Studies; Ursodeoxycholic Acid	2010
[Budesonide in treatment of patients with cross primary biliary cirrhosis and autoimmune hepatitis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:8 Topics: Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2010
Do fatigue and UDCA therapy truly have independent effects on mortality in PBC? Journal of hepatology, 2011, Volume: 55, Issue:3 Topics: Fatigue; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2011
A case of primary biliary cirrhosis which developed eight years after diagnosis of systemic lupus erythematosus. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:4 Topics: Adult; Autoantibodies; Female; Humans; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Time Factors; Ursodeoxycholic Acid	2011
Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:6 Topics: Adult; Antibodies, Antinuclear; Azathioprine; Biopsy; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis, Autoimmune; Humans; Hydroxychloroquine; Immunoblotting; Immunoglobulin G; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Middle Aged; Prednisolone; Prevalence; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2011
Relatively high risk for hepatocellular carcinoma in patients with primary biliary cirrhosis not responding to ursodeoxycholic acid. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:12 Topics: Adult; Aged; Carcinoma, Hepatocellular; Cause of Death; Cholagogues and Choleretics; Female; Humans; Incidence; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Mass Screening; Middle Aged; Netherlands; Patient Selection; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Survival Rate; Time Factors; Treatment Failure; Ursodeoxycholic Acid	2010
Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:9 Topics: Adult; Aged; Alkaline Phosphatase; Bezafibrate; Biomarkers; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunoglobulin M; Japan; Liver Cirrhosis, Biliary; Logistic Models; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Failure; Ursodeoxycholic Acid	2011
Overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis triggered by fluvastatin. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2011, Volume: 30, Issue:2 Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Anticholesteremic Agents; Autoantibodies; Coronary Artery Disease; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Hepatitis, Autoimmune; Humans; Indoles; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Prednisone; Ursodeoxycholic Acid	2011
Case of primary biliary cirrhosis-autoimmune hepatitis overlap which manifested after delivery. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:12 Topics: Adult; Bezafibrate; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Postpartum Period; Pregnancy; Ursodeoxycholic Acid	2011
Treatment of primary biliary cirrhosis with ursodeoxycholic acid, budesonide and fibrates. Digestive diseases (Basel, Switzerland), 2011, Volume: 29, Issue:1 Topics: Adult; Budesonide; Female; Fibric Acids; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Treatment Outcome; Ursodeoxycholic Acid	2011
A major step towards effective treatment evaluation in primary biliary cirrhosis. Journal of hepatology, 2011, Volume: 55, Issue:6 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2011
Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. Journal of hepatology, 2011, Volume: 55, Issue:6 Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Cholagogues and Choleretics; Cohort Studies; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Serum Albumin; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2011
[No complaints, but constantly elevated cholestatic serum liver tests]. Praxis, 2011, Jul-06, Volume: 100, Issue:14 Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Autoantibodies; Cholangitis, Sclerosing; Cholestasis; Diagnosis, Differential; Female; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Mitochondria, Liver; Ultrasonography; Ursodeoxycholic Acid	2011
No more pilots, a phase III trial of fibrates in primary biliary cirrhosis is long overdue! Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:9 Topics: Bezafibrate; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2011
Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients. Clinical biochemistry, 2011, Volume: 44, Issue:17-18 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Biomarkers; Case-Control Studies; Cholagogues and Choleretics; Female; Humans; Keratin-18; Liver Cirrhosis, Biliary; Male; Middle Aged; Nitroso Compounds; Oxidation-Reduction; Oxidative Stress; Thioredoxins; Tyrosine; Ursodeoxycholic Acid	2011
Optimizing biochemical markers as endpoints for clinical trials in primary biliary cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:5 Topics: Alkaline Phosphatase; Ascites; Bilirubin; Biomarkers; Cholagogues and Choleretics; Clinical Trials as Topic; Disease Progression; Endpoint Determination; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Varicose Veins	2012
Ursodeoxycholic acid is conjugated with taurine to promote secretin-stimulated biliary hydrocholeresis in the normal rat. PloS one, 2011, Volume: 6, Issue:12 Topics: Animals; Anion Transport Proteins; Antiporters; Bile; Cells, Cultured; Choledochal Cyst; Dehydrocholic Acid; Gene Silencing; Humans; Liver Cirrhosis, Biliary; Male; Microtubules; Mitogen-Activated Protein Kinase Kinases; Models, Biological; Phosphatidylinositol 3-Kinases; Polymerization; Protein Kinase C; Rats; Rats, Wistar; Secretin; SLC4A Proteins; Taurine; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid	2011
The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study. European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:7 Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Cholagogues and Choleretics; Female; Humans; Iceland; Incidence; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Prevalence; Prognosis; Retrospective Studies; Severity of Illness Index; Ursodeoxycholic Acid; Young Adult	2012
[3rd place in the competition of scientific work in hepatology in 2010. Treatment of patients with overlap of primary biliary cirrhosis and autoimmune hepatitis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2011, Issue:9 Topics: Anti-Inflammatory Agents; Budesonide; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Prednisolone; Quality of Life; Surveys and Questionnaires; Ursodeoxycholic Acid	2011
A case of IgG4-related sclerosing cholangitis overlapped with primary biliary cirrhosis. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:13 Topics: Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisolone; Ursodeoxycholic Acid	2012
Keratin 19 demonstration of canal of Hering loss in primary biliary cirrhosis: "minimal change PBC"? Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:2 Topics: Adult; Bile Ducts, Intrahepatic; Biopsy; Female; Humans; Immunohistochemistry; Keratin-19; Liver; Liver Cirrhosis, Biliary; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	2013
[Interstitial lung disease in patients with primary biliary cirrhosis]. Pneumonologia i alergologia polska, 2012, Volume: 80, Issue:5 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Lung Diseases, Interstitial; Middle Aged; Poland; Respiratory Function Tests; Tomography, X-Ray Computed; Ursodeoxycholic Acid	2012
[Therapy for refractory primary biliary cirrhosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2012, Volume: 20, Issue:5 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2012
Analysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis. BMC gastroenterology, 2012, Oct-24, Volume: 12 Topics: Adult; Age of Onset; Autoantibodies; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Longitudinal Studies; Male; Methotrexate; Middle Aged; Mitochondria, Liver; Proton-Translocating ATPases; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2012
Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Bile Acids and Salts; Biliary Tract Diseases; Cholagogues and Choleretics; Cholangitis, Sclerosing; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Treatment Outcome; Ursodeoxycholic Acid	2012
Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:5 Topics: Anticholesteremic Agents; Bezafibrate; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2013
Observation on therapeutic efficacy of ursodeoxycholic acid in Chinese patients with primary biliary cirrhosis: a 2-year follow-up study. Frontiers of medicine, 2013, Volume: 7, Issue:2 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Aspartate Aminotransferases; China; Cholagogues and Choleretics; Fatigue; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pruritus; Severity of Illness Index; Treatment Outcome; Ursodeoxycholic Acid	2013
[A clinical study of bilirubin rise in short-term in patients with primary biliary cirrhosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2012, Volume: 20, Issue:8 Topics: Adult; Bilirubin; Biomarkers; Disease Progression; Drugs, Chinese Herbal; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; S-Adenosylmethionine; Ursodeoxycholic Acid	2012
[Biliary cast syndrome in non-liver surgery patients]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2012, Volume: 60, Issue:6 Topics: Acute Disease; Ascariasis; Bile Duct Diseases; Bile Ducts; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Female; Gallstones; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pancreatitis; Tomography, X-Ray Computed; Ultrasonography; Ursodeoxycholic Acid	2012
Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology, 2013, Volume: 144, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Sex Factors; Treatment Outcome; United Kingdom; Ursodeoxycholic Acid; Young Adult	2013
Autoimmune hepatitis-primary biliary cirrhosis overlap syndrome concomitant with immune hemolytic anemia and immune thrombocytopenic purpura (Evans syndrome). Clinics and research in hepatology and gastroenterology, 2013, Volume: 37, Issue:2 Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Antinuclear; Autoantibodies; Cholagogues and Choleretics; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunoglobulins, Intravenous; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria, Liver; Prednisolone; Thrombocytopenia; Ursodeoxycholic Acid	2013
Value of baseline platelet count for prediction of complications in primary biliary cirrhosis patients treated with ursodeoxycholic acid. Scandinavian journal of clinical and laboratory investigation, 2013, Volume: 73, Issue:1 Topics: Adult; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Platelet Count; Proportional Hazards Models; Ursodeoxycholic Acid	2013
[Management of PBC cases failing to respond to UDCA]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2013, Volume: 110, Issue:1 Topics: Bezafibrate; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2013
Not all PBC is the same! Gastroenterology, 2013, Volume: 144, Issue:3 Topics: Female; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	2013
Turner syndrome associated with acquired von Willebrand disease, primary biliary cirrhosis, and inflammatory bowel disease. American journal of hematology, 2002, Volume: 70, Issue:3 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Esophageal and Gastric Varices; Factor VIII; Female; Gastrointestinal Hemorrhage; Humans; Hypersplenism; Inflammatory Bowel Diseases; Liver Cirrhosis, Biliary; Partial Thromboplastin Time; Platelet Count; Portasystemic Shunt, Surgical; Thrombocytopenia; Turner Syndrome; Ursodeoxycholic Acid; von Willebrand Diseases; von Willebrand Factor	2002
Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:8 Topics: Absorptiometry, Photon; Aged; Bone Density; Bone Diseases, Metabolic; Calcium; Case-Control Studies; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Osteocalcin; Ursodeoxycholic Acid	2002
Fenofibrate treatment in patients with primary biliary cirrhosis. The American journal of gastroenterology, 2002, Volume: 97, Issue:8 Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Statistics, Nonparametric; Treatment Outcome; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis. Hepatology (Baltimore, Md.), 2002, Volume: 36, Issue:4 Pt 1 Topics: Cholagogues and Choleretics; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2002
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years. Gastroenterology, 2002, Volume: 123, Issue:4 Topics: Aged; Cholagogues and Choleretics; Cohort Studies; Disease Progression; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Proportional Hazards Models; Risk Factors; United Kingdom; Ursodeoxycholic Acid	2002
[Clinical analysis of 22 patients with primary biliary cirrhosis]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:5 Topics: Alkaline Phosphatase; Bilirubin; Cholestasis; Female; Hepatomegaly; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid	2002
Markov models in primary biliary cirrhosis. Gastroenterology, 2002, Volume: 123, Issue:5 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Markov Chains; Ursodeoxycholic Acid	2002
[Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis]. Zeitschrift fur Gastroenterologie, 2002, Volume: 40 Suppl 2 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Cholangitis, Sclerosing; Clinical Trials as Topic; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Treatment Outcome; Ursodeoxycholic Acid	2002
The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:12 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Sulindac; Ursodeoxycholic Acid	2002
Idiotype-anti-idiotype-based noncompetitive enzyme-linked immunosorbent assay of ursodeoxycholic acid 7-N-acetylglucosaminides in human urine with subfemtomole range sensitivity. Journal of immunological methods, 2003, Jan-15, Volume: 272, Issue:1-2 Topics: Acetylglucosamine; Antibodies, Anti-Idiotypic; Biomarkers; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Humans; Immunoglobulin Idiotypes; Liver Cirrhosis, Biliary; Male; Reference Values; Sensitivity and Specificity; Ursodeoxycholic Acid	2003
Autoimmune hemolysis associated with primary biliary cirrhosis responding to ursodeoxycholic acid as sole treatment. American journal of hematology, 2003, Volume: 72, Issue:1 Topics: Anemia, Hemolytic, Autoimmune; Autoantibodies; Autoantigens; Bile Acids and Salts; Bone Marrow; Erythrocyte Membrane; Female; Humans; Hyperplasia; Liver Cirrhosis, Biliary; Membrane Proteins; Middle Aged; Mitochondria; Remission Induction; Ursodeoxycholic Acid	2003
[Bronchiolitis obliterans with organizing pneumonia and primary biliary cirrhosis]. Medicina clinica, 2003, Jan-18, Volume: 120, Issue:1 Topics: Aged; Autoantibodies; Biopsy, Needle; Cryptogenic Organizing Pneumonia; Female; Glucocorticoids; Humans; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Prednisolone; Treatment Outcome; Ursodeoxycholic Acid	2003
Methotrexate therapy for primary biliary cirrhosis. The American journal of gastroenterology, 2003, Volume: 98, Issue:1 Topics: Adult; Aged; Cohort Studies; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Survival Rate; Ursodeoxycholic Acid	2003
Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate. The American journal of gastroenterology, 2003, Volume: 98, Issue:1 Topics: Adult; Cholagogues and Choleretics; Colchicine; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Treatment Failure; Ursodeoxycholic Acid	2003
Tumor necrosis factor-alpha and interferon-gamma directly impair epithelial barrier function in cultured mouse cholangiocytes. Liver international : official journal of the International Association for the Study of the Liver, 2003, Volume: 23, Issue:1 Topics: Animals; Bile Ducts; Cell Membrane Permeability; Cells, Cultured; Dose-Response Relationship, Immunologic; Electric Impedance; Epithelium; Immunoblotting; Interferon-gamma; Interleukin-2; Interleukin-4; Liver Cirrhosis, Biliary; Mice; Tight Junctions; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid	2003
[Interview: questions to Professor Raoul Poupon]. Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:3 Pt 1 Topics: Bile Acids and Salts; Biological Transport; Cholagogues and Choleretics; Cholesterol; Humans; Liver Cirrhosis, Biliary; Phospholipids; Prognosis; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid	2003
[Primary biliary cirrhosis and autoimmune hepatitis overlap syndrome: therapeutic features in 5 patients]. Annales de medecine interne, 2003, Volume: 154, Issue:1 Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Time Factors; Ursodeoxycholic Acid	2003
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a cause of resistance to ursodeoxycholic treatment. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:2 Topics: Adult; Cholagogues and Choleretics; Drug Resistance; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Syndrome; Ursodeoxycholic Acid	2003
[Primary biliary cirrhosis. Primary sclerosing cholangitis]. Gastroenterologie clinique et biologique, 2003, Volume: 27, Issue:3 Pt 1 Topics: Anti-Inflammatory Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Risk Factors; Tomography, Emission-Computed; Ursodeoxycholic Acid	2003
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:1 Topics: Adenoma; Adult; Cell Division; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Female; Humans; Intestinal Mucosa; Liver Cirrhosis, Biliary; Male; Middle Aged; Neoplasm Recurrence, Local; Prevalence; Product Surveillance, Postmarketing; Risk Factors; Ursodeoxycholic Acid	2003
New weapon for primary biliary cirrhosis from Japan. Journal of gastroenterology, 2003, Volume: 38, Issue:6 Topics: Bezafibrate; Bile Acids and Salts; Drug Therapy, Combination; Humans; Hypolipidemic Agents; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2003
Intestinal absorption of the bile acid analogue 75Se-homocholic acid-taurine is increased in primary biliary cirrhosis, and reverts to normal during ursodeoxycholic acid administration. Gut, 2003, Volume: 52, Issue:9 Topics: Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Female; Humans; Ileum; Intestinal Absorption; Liver Cirrhosis, Biliary; Middle Aged; Selenium Radioisotopes; Taurine; Taurocholic Acid; Ursodeoxycholic Acid	2003
Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment. European journal of clinical investigation, 2003, Volume: 33, Issue:10 Topics: Adult; Blood Proteins; Cholesterol; Erythrocyte Membrane; Female; Follow-Up Studies; Humans; Lipids; Liver Cirrhosis, Biliary; Middle Aged; Oxidation-Reduction; Severity of Illness Index; Ursodeoxycholic Acid	2003
[The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases]. La Tunisie medicale, 2003, Volume: 81, Issue:7 Topics: Adult; Antibodies, Antinuclear; Autoantibodies; Azathioprine; Cholagogues and Choleretics; Clinical Enzyme Tests; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Retrospective Studies; Syndrome; Time Factors; Ursodeoxycholic Acid	2003
Pediatric-onset primary biliary cirrhosis. Gastroenterology, 2003, Volume: 125, Issue:5 Topics: Adolescent; Age of Onset; Autoantibodies; Biopsy; Child; Cholagogues and Choleretics; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Microsomes, Liver; Mitochondria, Liver; Retreatment; Ursodeoxycholic Acid	2003
[Primary biliary cirrhosis and pregnancy: benefit of ursodeoxycholic acid therapy]. Gastroenterologia y hepatologia, 2003, Volume: 26, Issue:9 Topics: Adult; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Pregnancy Complications; Ursodeoxycholic Acid	2003
Ursodeoxycholic acid and histological progression in primary biliary cirrhosis. Journal of hepatology, 2003, Volume: 39, Issue:6 Topics: Disease Progression; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2003
Ursodeoxycholic acid therapy attenuated expression of adhesion molecule in primary biliary cirrhosis. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:12 Topics: Female; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Liver; Liver Cirrhosis, Biliary; Lymphocyte Function-Associated Antigen-1; Middle Aged; Ursodeoxycholic Acid	2003
Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases. Journal of autoimmunity, 2004, Volume: 22, Issue:2 Topics: Adult; Aged; Antigens, Bacterial; Autoimmune Diseases; Female; Humans; Immunity; Immunoglobulin M; Lipopolysaccharides; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2004
Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology (Baltimore, Md.), 2004, Volume: 39, Issue:3 Topics: Animals; Cardiolipins; Cholestasis; Chronic Disease; Cystathionine gamma-Lyase; Glutamate-Cysteine Ligase; Glutathione; Hepatocytes; Liver; Liver Cirrhosis, Biliary; Male; Membrane Potentials; Mitochondria; Oxidation-Reduction; Oxidative Stress; Peroxides; Rats; Rats, Wistar; Ursodeoxycholic Acid	2004
Studying pruritus in the 21st century. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2003, Volume: 1, Issue:4 Topics: Alkaline Phosphatase; Antipruritics; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cholagogues and Choleretics; Cholestyramine Resin; Dose-Response Relationship, Drug; Enzyme Inhibitors; History, 21st Century; Humans; Liver Cirrhosis, Biliary; Pruritus; Rifampin; Serum Albumin; Ursodeoxycholic Acid	2003
Primary biliary cirrhosis presented as peripheral eosinophilia in asymptomatic women with or without elevated alkaline phosphatase. European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:4 Topics: Adult; Alkaline Phosphatase; Antibodies; Cholagogues and Choleretics; Eosinophilia; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria, Liver; Ursodeoxycholic Acid	2004
Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis. The American journal of gastroenterology, 2004, Volume: 99, Issue:2 Topics: Cholagogues and Choleretics; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Liver Cirrhosis, Biliary; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2004
[Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:2 Topics: Adult; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; S-Adenosylmethionine; Treatment Outcome; Ursodeoxycholic Acid	2004
Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2004, Volume: 24, Issue:3 Topics: Aspartate Aminotransferases; Bile Ducts, Intrahepatic; Bilirubin; Biomarkers; Cholagogues and Choleretics; Female; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Lymphocytes; Male; Middle Aged; Necrosis; Predictive Value of Tests; Sensitivity and Specificity; Ursodeoxycholic Acid	2004
Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis with unusual initial presentation as fulminant hepatic failure. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:6 Topics: Cholagogues and Choleretics; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Failure; Middle Aged; Prednisolone; Ursodeoxycholic Acid	2004
Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations. Gastroenterology, 2004, Volume: 127, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Cholagogues and Choleretics; Data Collection; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Transients and Migrants; Ursodeoxycholic Acid; Victoria	2004
Reversal of portal hypertension in a patient with primary biliary cirrhosis: disappearance of esophageal varices and thrombocytopenia. The American journal of gastroenterology, 2004, Volume: 99, Issue:9 Topics: Biopsy, Needle; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Function Tests; Middle Aged; Propranolol; Risk Assessment; Severity of Illness Index; Thrombocytopenia; Treatment Outcome; Ursodeoxycholic Acid	2004
[Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?]. Ugeskrift for laeger, 2004, Aug-02, Volume: 166, Issue:32 Topics: Biopsy; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2004
Quality of life in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2004, Volume: 40, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cholagogues and Choleretics; Emotions; Energy Metabolism; Fatigue; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Quality of Life; Sickness Impact Profile; Ursodeoxycholic Acid	2004
Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment. Digestive diseases and sciences, 2004, Volume: 49, Issue:7-8 Topics: Antibodies; Antibodies, Antinuclear; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Risk Assessment; Survival Analysis; Ursodeoxycholic Acid	2004
[Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis]. Deutsche medizinische Wochenschrift (1946), 2004, Nov-05, Volume: 129, Issue:45 Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Autoimmune Diseases; Biopsy; Cholagogues and Choleretics; Cholangitis; Female; Glomerulonephritis, IGA; Humans; Immunohistochemistry; Kidney; Leg Ulcer; Liver; Liver Cirrhosis, Biliary; Middle Aged; Thyroiditis, Autoimmune; Treatment Outcome; Ursodeoxycholic Acid	2004
[Treatment of autoimmune hepatic diseases]. Klinicheskaia meditsina, 2004, Volume: 82, Issue:10 Topics: Adult; Autoimmune Diseases; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Drug Therapy, Combination; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Diseases; Prognosis; Risk Factors; Syndrome; Time Factors; Ursodeoxycholic Acid	2004
[Clinical features of 35 cases of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2005, Volume: 13, Issue:1 Topics: Adult; Autoantibodies; Cholagogues and Choleretics; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid	2005
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology, 2005, Volume: 128, Issue:2 Topics: Adult; Aged; Cholagogues and Choleretics; Disease Progression; Female; Humans; Liver Cirrhosis, Biliary; Male; Markov Chains; Middle Aged; Models, Biological; Multivariate Analysis; Survival Analysis; Ursodeoxycholic Acid	2005
Examining the increased IgM production and ursodeoxycholic acid treatment in PBC. Gastroenterology, 2005, Volume: 128, Issue:2 Topics: Cholagogues and Choleretics; Humans; Immunoglobulin M; Immunologic Memory; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2005
Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis. Alimentary pharmacology & therapeutics, 2005, Feb-01, Volume: 21, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cholagogues and Choleretics; Endothelin-1; Endothelin-2; Endothelin-3; Female; Hepatic Veins; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Nitric Oxide; Ursodeoxycholic Acid	2005
Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis. Journal of hepatology, 2005, Volume: 42, Issue:3 Topics: Antibodies; Biomarkers; Disease-Free Survival; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Membrane Glycoproteins; Middle Aged; Nuclear Pore Complex Proteins; Nuclear Proteins; Peptide Fragments; Probability; Retrospective Studies; Survival Analysis; Treatment Outcome; Ursodeoxycholic Acid	2005
Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis. Journal of hepatology, 2005, Volume: 42, Issue:3 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Safety; Ursodeoxycholic Acid	2005
Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Digestive diseases and sciences, 2005, Volume: 50, Issue:1 Topics: Cholagogues and Choleretics; Colchicine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Prednisone; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2005
[Case of primary biliary cirrhosis patient with anti-p97/VCP antibodies presenting a mild clinical course]. Rinsho byori. The Japanese journal of clinical pathology, 2005, Volume: 53, Issue:1 Topics: Adenosine Triphosphatases; Autoantibodies; Cell Cycle Proteins; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria; Severity of Illness Index; Ursodeoxycholic Acid; Valosin Containing Protein	2005
Two successive pregnancies after ursodeoxycholic acid therapy in a previously infertile woman with antimitochondrial antibody-negative primary biliary cirrhosis. Fertility and sterility, 2005, Volume: 83, Issue:3 Topics: Adult; Autoantibodies; Cholagogues and Choleretics; Female; Humans; Infertility, Female; Liver Cirrhosis, Biliary; Mitochondria; Pregnancy; Pregnancy Outcome; Ursodeoxycholic Acid	2005
Soluble CD40L in plasma of patients with primary biliary cirrhosis. Annals of the New York Academy of Sciences, 2005, Volume: 1051 Topics: Adult; Aged; CD40 Ligand; Enzyme-Linked Immunosorbent Assay; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2005
Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:9 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Mycophenolic Acid; Ursodeoxycholic Acid	2005
Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:10 Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Cholagogues and Choleretics; Female; Humans; Immunosuppression Therapy; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Time Factors; Ursodeoxycholic Acid	2005
Post-liver transplantation de novo hepatitis with overlap features. Pathology international, 2005, Volume: 55, Issue:10 Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prednisone; Treatment Outcome; Ursodeoxycholic Acid	2005
Steroids in the management of PBC: why do we need them? Gastroenterology, 2005, Volume: 129, Issue:4 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Budesonide; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2005
Reflections on therapeutic trials in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2005, Volume: 42, Issue:5 Topics: Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2005
Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort. Gut, 2006, Volume: 55, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Cholagogues and Choleretics; Fatigue; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Phenotype; Severity of Illness Index; Survival Analysis; Ursodeoxycholic Acid	2006
Patients and patience: the pitfalls of primary biliary cirrhosis trials. Nature clinical practice. Gastroenterology & hepatology, 2005, Volume: 2, Issue:12 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Multicenter Studies as Topic; Physician-Patient Relations; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2005
Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Journal of hepatology, 2006, Volume: 44, Issue:2 Topics: Adult; Aged; Biopsy; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2006
Primary biliary cirrhosis. The New England journal of medicine, 2005, Dec-22, Volume: 353, Issue:25 Topics: Cholagogues and Choleretics; Colchicine; Humans; Liver Cirrhosis, Biliary; Meta-Analysis as Topic; Methotrexate; Selection Bias; Ursodeoxycholic Acid	2005
[Primary biliary cirrhosis and eosinophilia: regression after treatment with ursodeoxycholic acid]. Gastroenterologia y hepatologia, 2006, Volume: 29, Issue:1 Topics: Adult; Cholagogues and Choleretics; Eosinophilia; Female; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2006
Fenofibrate-induced liver injury. World journal of gastroenterology, 2005, Dec-28, Volume: 11, Issue:48 Topics: Aged; Female; Fenofibrate; Humans; Liver; Liver Cirrhosis, Biliary; PPAR alpha; Ursodeoxycholic Acid	2005
Methotrexate for treatment of primary biliary cirrhosis. Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:3 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Methotrexate; Ursodeoxycholic Acid	2006
Reflections on therapeutic trials in primary biliary cirrhosis: a quality of life oriented counter-view. Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:3 Topics: Cholagogues and Choleretics; Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary; Methotrexate; Quality of Life; Ursodeoxycholic Acid	2006
Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid. Gastroenterology, 2006, Volume: 130, Issue:3 Topics: Alkaline Phosphatase; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Survival Rate; Ursodeoxycholic Acid	2006
Primary biliary cirrhosis: when and why does the disease develop? Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2006, Volume: 38, Issue:4 Topics: Adolescent; Autoantibodies; Borrelia burgdorferi; Cholagogues and Choleretics; Female; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Mitochondria; Ursodeoxycholic Acid	2006
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid. Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:4 Topics: Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2006
[Primary biliary cirrhosis: a thirteen years experience]. Revista medica de Chile, 2006, Volume: 134, Issue:4 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Hypothyroidism; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Sjogren's Syndrome; Survival Rate; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2006
Ursodeoxycholic acid in primary biliary cirrhosis improves glutathione status but fails to reduce lipid peroxidation. Redox report : communications in free radical research, 2006, Volume: 11, Issue:3 Topics: Adult; Aged; Antioxidants; Dinoprost; Disease Progression; Female; gamma-Glutamyltransferase; Glutathione; Humans; Lipid Peroxidation; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	2006
Prognosis of ursodeoxycholic Acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. The American journal of gastroenterology, 2006, Volume: 101, Issue:9 Topics: Bilirubin; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Netherlands; Prognosis; Prospective Studies; Serum Albumin; Survival Rate; Time Factors; Ursodeoxycholic Acid	2006
Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy. Alimentary pharmacology & therapeutics, 2006, Sep-01, Volume: 24, Issue:5 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Cholagogues and Choleretics; Drug Administration Schedule; Enzyme Inhibitors; Fatigue; Female; gamma-Glutamyltransferase; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Pruritus; Rifampin; Treatment Outcome; Ursodeoxycholic Acid	2006
Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease. Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Female; France; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Medical Records; Middle Aged; Retrospective Studies; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	2007
The long-term beneficial effects of ursodeoxycholic acid in primary biliary cirrhosis are highly questionable. The American journal of gastroenterology, 2007, Volume: 102, Issue:2 Topics: Cholagogues and Choleretics; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Meta-Analysis as Topic; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2007
Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. The American journal of gastroenterology, 2007, Volume: 102, Issue:6 Topics: Ascites; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatitis, Autoimmune; Humans; Hypertension, Portal; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Syndrome; Ursodeoxycholic Acid	2007
Clinicolaboratory characteristics of Japanese patients with primary biliary cirrhosis-autoimmune hepatitis overlap. Fukushima journal of medical science, 2006, Volume: 52, Issue:2 Topics: Adult; Aged; Alanine Transaminase; Female; Hepatitis, Autoimmune; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Retrospective Studies; Ursodeoxycholic Acid	2006
Guidelines for therapy of autoimmune liver disease. Seminars in liver disease, 2007, Volume: 27, Issue:2 Topics: Animals; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Liver Transplantation; Practice Guidelines as Topic; Treatment Outcome; Ursodeoxycholic Acid	2007
[Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard]. MMW Fortschritte der Medizin, 2007, May-24, Volume: 149, Issue:21 Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Budesonide; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Disease-Free Survival; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Syndrome; Ursodeoxycholic Acid	2007
Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:3 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Biomarkers; Cholagogues and Choleretics; Cholestasis; Cholesterol; Female; Heptanoic Acids; Humans; Lipoproteins, LDL; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Pyrroles; Single-Blind Method; Transaminases; Ursodeoxycholic Acid	2007
Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study. Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cholagogues and Choleretics; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Liver Cirrhosis, Biliary; Liver Neoplasms; Longitudinal Studies; Male; Middle Aged; Odds Ratio; Risk Factors; Severity of Illness Index; United Kingdom; Ursodeoxycholic Acid	2007
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:9 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Probability; Recurrence; Retrospective Studies; Survival Analysis; Survivors; Ursodeoxycholic Acid	2007
How, why, and when does primary biliary cirrhosis recur after liver transplantation? Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2007, Volume: 13, Issue:9 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Recurrence; Survivors; Treatment Outcome; Ursodeoxycholic Acid	2007
Development of autoimmune hepatitis in primary biliary cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2007, Volume: 27, Issue:8 Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Middle Aged; Prednisone; Retrospective Studies; Syndrome; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2007
Incidence, prevalence and clinical course of primary biliary cirrhosis in a Spanish community. European journal of gastroenterology & hepatology, 2007, Volume: 19, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Cholagogues and Choleretics; Epidemiologic Methods; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Severity of Illness Index; Spain; Treatment Outcome; Ursodeoxycholic Acid	2007
A patient with primary biliary cirrhosis accompanied by Graves disease and Hurthle cell adenoma. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2007, Volume: 18, Issue:3 Topics: Adenoma, Oxyphilic; Cholagogues and Choleretics; Female; Graves Disease; Humans; Liver Cirrhosis, Biliary; Middle Aged; Thyroid Neoplasms; Ursodeoxycholic Acid	2007
Geotherapeutics of primary biliary cirrhosis: bright and sunny around the Mediterranean but still cloudy and foggy in the United Kingdom. Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:4 Topics: Cholagogues and Choleretics; France; Humans; Liver Cirrhosis, Biliary; Liver Neoplasms; Liver Transplantation; Risk Factors; United Kingdom; Ursodeoxycholic Acid	2007
Transplantation trends in primary biliary cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:11 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Retrospective Studies; United States; Ursodeoxycholic Acid; Waiting Lists	2007
Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Alimentary pharmacology & therapeutics, 2008, Mar-01, Volume: 27, Issue:5 Topics: Adult; Aged; Alkaline Phosphatase; Antibodies, Antinuclear; Area Under Curve; Biopsy, Needle; Cholagogues and Choleretics; Elasticity Imaging Techniques; Female; Fibrosis; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Prospective Studies; ROC Curve; Ursodeoxycholic Acid	2008
Left ventricular aneurysms developed in a patient with systemic sclerosis. Modern rheumatology, 2007, Volume: 17, Issue:6 Topics: Antihypertensive Agents; Coronary Aneurysm; Coronary Angiography; Diuretics; Drug Therapy, Combination; Endomyocardial Fibrosis; Female; Heart Ventricles; Humans; Liver Cirrhosis, Biliary; Middle Aged; Platelet Aggregation Inhibitors; Prednisolone; Pulmonary Fibrosis; Scleroderma, Systemic; Treatment Outcome; Ursodeoxycholic Acid	2007
Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells. The Journal of clinical investigation, 2008, Volume: 118, Issue:2 Topics: Animals; Anion Transport Proteins; Antiporters; Cell Line; Cholagogues and Choleretics; Chromatin Immunoprecipitation; Dexamethasone; Drug Therapy, Combination; Gene Expression Regulation; Glucocorticoids; Hepatocyte Nuclear Factor 1-alpha; Hepatocyte Nuclear Factor 1-beta; Hepatocytes; Humans; Liver Cirrhosis, Biliary; Mice; Mutation; p300-CBP Transcription Factors; Promoter Regions, Genetic; SLC4A Proteins; Transcription, Genetic; Up-Regulation; Ursodeoxycholic Acid	2008
Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:2 Topics: Autoantibodies; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Humans; Immunoblotting; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Statistics, Nonparametric; T-Lymphocytes, Regulatory; Ursodeoxycholic Acid	2008
Primary biliary cirrhosis following chemotherapy for Hodgkin's lymphoma. Internal medicine (Tokyo, Japan), 2008, Volume: 47, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholagogues and Choleretics; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid; Vinblastine	2008
Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes. Hepatology (Baltimore, Md.), 2008, Volume: 47, Issue:4 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Practice Patterns, Physicians'; Treatment Outcome; Ursodeoxycholic Acid	2008
Association of primary biliary cirrhosis with idiopathic thrombocytopenic purpura. World journal of gastroenterology, 2008, Apr-21, Volume: 14, Issue:15 Topics: Aged; Cholagogues and Choleretics; HLA-DQ Antigens; HLA-DQ beta-Chains; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunoglobulins, Intravenous; Liver Cirrhosis, Biliary; Male; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Steroids; Ursodeoxycholic Acid	2008
Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7 Topics: Cholagogues and Choleretics; Down-Regulation; Female; Gene Expression; Gene Expression Profiling; Hepatitis B; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Ursodeoxycholic Acid	2008
Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival. Alimentary pharmacology & therapeutics, 2008, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Ursodeoxycholic Acid	2008
Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. Clinical science (London, England : 1979), 2009, Volume: 116, Issue:1 Topics: Animals; Antioxidants; Collagen Type III; Drug Administration Schedule; Drug Evaluation, Preclinical; Gene Expression Regulation; Hemodynamics; Hypertension, Portal; Lipid Peroxidation; Liver; Liver Circulation; Liver Cirrhosis, Biliary; Male; Peptide Fragments; Portal Pressure; Procollagen; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ursodeoxycholic Acid; Vascular Resistance	2009
[Dipeptidyl-peptidase IV of human lymphocytes in patients with primary biliary cirrhosis and UDCA therapy]. Zeitschrift fur Gastroenterologie, 1993, Volume: 31 Suppl 2 Topics: Cholangitis, Sclerosing; Dipeptidyl Peptidase 4; Fluorescent Antibody Technique, Indirect; Humans; Liver Cirrhosis, Biliary; Lymphocyte Count; Lymphocytes; Ursodeoxycholic Acid	1993
The ursodeoxycholic acid story in primary biliary cirrhosis. Gut, 1995, Volume: 37, Issue:3 Topics: Cholagogues and Choleretics; Double-Blind Method; Forecasting; Histocompatibility Antigens Class I; Humans; Liver; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	1995
Can ursodeoxycholic acid induce disease remission in primary biliary cirrhosis? The Dutch Multicentre PBC Study Group. Journal of hepatology, 1995, Volume: 22, Issue:3 Topics: Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Remission Induction; Ursodeoxycholic Acid	1995
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A. Digestive diseases and sciences, 1995, Volume: 40, Issue:5 Topics: Adult; Autoimmune Diseases; Cyclosporine; Female; Hepatitis; Humans; Liver Cirrhosis, Biliary; Prednisolone; Syndrome; Ursodeoxycholic Acid	1995
Colchicine and ursodeoxycholic acid for primary biliary cirrhosis: emerging results. Gastroenterology, 1995, Volume: 108, Issue:5 Topics: Colchicine; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1995
[Significance of subtype pattern of antimitochondrial antibodies in primary biliary cirrhosis for prognostic parameters and response to ursodeoxycholic acid]. Schweizerische medizinische Wochenschrift, 1995, Apr-15, Volume: 125, Issue:15 Topics: Adult; Aged; Autoantibodies; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Prognosis; Ursodeoxycholic Acid	1995
[Conjugated bile acid profiles in serum, urine, and bile of patients with primary biliary cirrhosis under the ursodeoxycholic acid treatment]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science, 1995, Volume: 70, Issue:1 Topics: Aged; Bile; Female; Glucuronates; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Sulfates; Ursodeoxycholic Acid	1995
Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling. Journal of hepatology, 1995, Volume: 22, Issue:1 Topics: Cell Division; Female; Follow-Up Studies; Humans; Ki-67 Antigen; Liver; Liver Cirrhosis, Biliary; Male; Neoplasm Proteins; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Ursodeoxycholic Acid	1995
Primary biliary cirrhosis trials and Mayo risk score. Gastroenterology, 1994, Volume: 107, Issue:5 Topics: Clinical Trials as Topic; Humans; Liver Cirrhosis, Biliary; Risk; Ursodeoxycholic Acid	1994
Therapeutic trials in primary biliary cirrhosis. QJM : monthly journal of the Association of Physicians, 1994, Volume: 87, Issue:11 Topics: Bilirubin; Clinical Trials as Topic; Colchicine; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Humans; Liver; Liver Cirrhosis, Biliary; Methotrexate; Prognosis; Ursodeoxycholic Acid	1994
Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Journal of hepatology, 1993, Volume: 18, Issue:3 Topics: Adjuvants, Immunologic; Adult; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Female; Flow Cytometry; Humans; Immunohistochemistry; Interleukin-2; Liver Cirrhosis, Biliary; Lymphocyte Activation; Male; Pokeweed Mitogens; Receptors, Interleukin-2; T-Lymphocytes; Ursodeoxycholic Acid	1993
Primary biliary cirrhosis: how should we evaluate new treatments? Lancet (London, England), 1994, May-28, Volume: 343, Issue:8909 Topics: Clinical Trials as Topic; Colchicine; Cyclosporine; Humans; Liver Cirrhosis, Biliary; Methotrexate; Prognosis; Survival Analysis; Ursodeoxycholic Acid	1994
Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis. Journal of gastroenterology, 1994, Volume: 29, Issue:1 Topics: Chronic Disease; DNA; Female; Humans; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Ursodeoxycholic Acid	1994
Evaluation of new treatment for primary biliary cirrhosis. Lancet (London, England), 1994, Jul-02, Volume: 344, Issue:8914 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
Evaluation of new treatment for primary biliary cirrhosis. Lancet (London, England), 1994, Jul-02, Volume: 344, Issue:8914 Topics: Colchicine; Drug Therapy, Combination; Humans; Liver Cirrhosis, Biliary; Methotrexate; Ursodeoxycholic Acid	1994
Ursodeoxycholic acid: from dissolution of gallstones to lipid-lowering agent. Mayo Clinic proceedings, 1994, Volume: 69, Issue:10 Topics: Cholelithiasis; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
[Primary biliary cirrhosis. Immunological aggression and aggression by biliary acids]. La Revue du praticien, 1994, May-15, Volume: 44, Issue:10 Topics: Bile Acids and Salts; Humans; Immune System Diseases; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology, 1994, Volume: 107, Issue:6 Topics: Antibodies, Antinuclear; Autoantibodies; Autoantigens; Autoimmune Diseases; Bile Duct Diseases; Female; Fluorescent Antibody Technique; Follow-Up Studies; Hepatitis; Humans; Immunoblotting; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria, Liver; Prednisone; Ursodeoxycholic Acid	1994
[Immunosuppression caused by ursodeoxycholic acid]. Zeitschrift fur Gastroenterologie, 1994, Volume: 32, Issue:8 Topics: Cholangitis, Sclerosing; Cytokines; Humans; Immune Tolerance; Immunoglobulins; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
[Dipeptidyl peptidase IV of peripheral blood lymphocytes in patients with primary biliary cirrhosis]. Zeitschrift fur Gastroenterologie, 1993, Volume: 31, Issue:2 Topics: Adult; Antigens, Differentiation, T-Lymphocyte; CD4-CD8 Ratio; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Female; Fluorescent Antibody Technique; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; T-Lymphocytes; Ursodeoxycholic Acid	1993
Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. Journal of hepatology, 1993, Volume: 18, Issue:1 Topics: Adult; Alkaline Phosphatase; Bile Acids and Salts; Drug Therapy, Combination; Female; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Methotrexate; Middle Aged; Pilot Projects; Ursodeoxycholic Acid	1993
Ursodeoxycholate in primary biliary cirrhosis any--different from the rest? Journal of clinical gastroenterology, 1994, Volume: 18, Issue:1 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
Biochemical and histological changes after more than four years of treatment of ursodeoxycholic acid in primary biliary cirrhosis. Journal of clinical gastroenterology, 1994, Volume: 18, Issue:1 Topics: Adult; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Pruritus; Ursodeoxycholic Acid	1994
Primary biliary cirrhosis--a first step in prolonging survival. The New England journal of medicine, 1994, May-12, Volume: 330, Issue:19 Topics: Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Ursodeoxycholic Acid	1994
Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. The Netherlands journal of medicine, 1994, Volume: 44, Issue:3 Topics: Adult; Aged; Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunoglobulin M; Immunosuppression Therapy; Inflammation; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisone; Retrospective Studies; Severity of Illness Index; Ursodeoxycholic Acid	1994
Intrahepatic cholestasis and biliary cirrhosis associated with extrahepatic Hodgkin's disease. The Netherlands journal of medicine, 1994, Volume: 44, Issue:3 Topics: Adult; Cholestasis, Intrahepatic; Fatal Outcome; Hodgkin Disease; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Male; Neoplasm Staging; Paraneoplastic Syndromes; Remission Induction; Ursodeoxycholic Acid	1994
[Eosinophilia in primary biliary cirrhosis: regression under therapy with ursodeoxycholic acid]. Schweizerische medizinische Wochenschrift, 1994, May-14, Volume: 124, Issue:19 Topics: Adult; Eosinophilia; Eosinophils; Female; Humans; Leukocyte Count; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1994
[Biliary scintigraphy. Application to the study of chronic cholestasis]. Presse medicale (Paris, France : 1983), 1993, Sep-25, Volume: 22, Issue:28 Topics: Aged; Aged, 80 and over; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Chronic Disease; Female; Humans; Indocyanine Green; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Radionuclide Imaging; Sulfobromophthalein; Ursodeoxycholic Acid	1993
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid. Gastroenterology, 1994, Volume: 106, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Cholangitis, Sclerosing; Female; Humans; Kinetics; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Reference Values; Ursodeoxycholic Acid	1994
Progression of primary biliary cirrhosis on ursodeoxycholic acid. Gastroenterology, 1994, Volume: 106, Issue:2 Topics: Aged; Female; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1994
[A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1993, Volume: 90, Issue:9 Topics: Female; Hepatitis C; Hepatitis, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis, Biliary; Middle Aged; Recombinant Proteins; Ursodeoxycholic Acid	1993
Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis. Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians, 1993, Volume: 4, Issue:1 Topics: Adult; Aged; Female; Humans; Liver Cirrhosis, Biliary; Lymphocyte Activation; Middle Aged; Ursodeoxycholic Acid	1993
Abdominal pain after taking ursodiol. The New England journal of medicine, 1993, May-20, Volume: 328, Issue:20 Topics: Abdominal Pain; Colchicine; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	1993
Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis. The American journal of gastroenterology, 1993, Volume: 88, Issue:5 Topics: Bile; Bile Acids and Salts; Double-Blind Method; Female; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Prospective Studies; Time Factors; Ursodeoxycholic Acid	1993
Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis. Digestive diseases and sciences, 1993, Volume: 38, Issue:5 Topics: Adult; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1993
Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy. Digestion, 1995, Volume: 56, Issue:6 Topics: Adult; Aged; Bile Acids and Salts; Cholangitis, Sclerosing; Chronic Disease; Dietary Fiber; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Psyllium; Ursodeoxycholic Acid	1995
Hepatic lymph nodes as follow-up factor in primary biliary cirrhosis. An ultrasound study. Scandinavian journal of gastroenterology, 1995, Volume: 30, Issue:10 Topics: Adult; Aged; Cholestasis; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Lymph Nodes; Male; Middle Aged; Ultrasonography; Ursodeoxycholic Acid	1995
Should we treat cholestatic liver disease with cholesterol synthesis inhibitors? The American journal of gastroenterology, 1996, Volume: 91, Issue:2 Topics: Anticholesteremic Agents; Cholagogues and Choleretics; Cholestasis; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Ursodeoxycholic Acid	1996
Primary biliary cirrhosis clinical research single-topic conference. Hepatology (Baltimore, Md.), 1996, Volume: 23, Issue:3 Topics: 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); Autoantigens; Cholagogues and Choleretics; Humans; Immunosuppressive Agents; Ketone Oxidoreductases; Liver Cirrhosis, Biliary; Methotrexate; Multienzyme Complexes; Research; Ursodeoxycholic Acid	1996
Eosinophilia in primary biliary cirrhosis. The American journal of gastroenterology, 1996, Volume: 91, Issue:3 Topics: Aged; Chronic Disease; Eosinophilia; Eosinophils; Female; Flow Cytometry; Humans; Leukocyte Count; Liver Cirrhosis, Biliary; Male; Middle Aged; Prevalence; Ursodeoxycholic Acid	1996
-Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-. Zeitschrift fur Gastroenterologie, 1996, Volume: 34, Issue:3 Topics: Adult; Breast Feeding; Cholagogues and Choleretics; Female; Humans; Infant, Newborn; Liver Cirrhosis, Biliary; Liver Function Tests; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Ursodeoxycholic Acid	1996
Case in point. Primary biliary cirrhosis. Hospital practice (1995), 1996, Jun-15, Volume: 31, Issue:6 Topics: Adult; Humans; Liver Cirrhosis, Biliary; Male; Ursodeoxycholic Acid	1996
Serum hepatocyte growth factor levels in primary biliary cirrhosis. European journal of gastroenterology & hepatology, 1995, Volume: 7, Issue:11 Topics: Adult; Aged; Cholagogues and Choleretics; Female; Hepatocyte Growth Factor; Humans; Immunohistochemistry; Ki-67 Antigen; Liver Cirrhosis, Biliary; Male; Middle Aged; Neoplasm Proteins; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Retrospective Studies; Ursodeoxycholic Acid	1995
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. Digestive diseases and sciences, 1996, Volume: 41, Issue:7 Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deoxycholic Acid; Dinoprostone; Female; Hepatitis C; Humans; Indomethacin; Killer Cells, Natural; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Ursodeoxycholic Acid	1996
Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology, 1996, Volume: 111, Issue:1 Topics: Administration, Oral; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Bile; Chemical and Drug Induced Liver Injury; Cholangitis; Cholic Acids; Drug Resistance, Multiple; Food, Formulated; Gene Expression; Liver; Liver Cirrhosis, Biliary; Liver Diseases; Mice; Mice, Mutant Strains; Ursodeoxycholic Acid	1996
Improvement of peripheral blood lymphocyte subsets in primary biliary cirrhosis after ursodeoxycholic acid therapy. Journal of gastroenterology and hepatology, 1996, Volume: 11, Issue:4 Topics: Aged; Blood Cells; Female; Humans; Liver Cirrhosis, Biliary; Lymphocyte Subsets; Middle Aged; Ursodeoxycholic Acid	1996
Primary biliary cirrhosis--an uncommon disease in Singapore. Singapore medical journal, 1996, Volume: 37, Issue:1 Topics: Adult; Aged; Alkaline Phosphatase; Autoantibodies; Cholangiopancreatography, Endoscopic Retrograde; Cholelithiasis; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Lung Diseases, Interstitial; Male; Middle Aged; Mitochondria; Singapore; Sjogren's Syndrome; Treatment Outcome; Ursodeoxycholic Acid	1996
Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? Journal of clinical gastroenterology, 1996, Volume: 23, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Autoimmune Diseases; Azathioprine; Cholangitis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria; Prednisone; Ursodeoxycholic Acid	1996
Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology, 1996, Volume: 28, Issue:3 Topics: Antibodies, Antinuclear; Autoimmune Diseases; Cholangitis; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique; Gastrointestinal Agents; Humans; Immunoblotting; Liver Cirrhosis, Biliary; Middle Aged; Pyruvate Dehydrogenase Complex; Syndrome; Ursodeoxycholic Acid	1996
[Hemolytic anemia as cause of a marked bilirubin increase in primary biliary cirrhosis]. Deutsche medizinische Wochenschrift (1946), 1996, Oct-04, Volume: 121, Issue:40 Topics: Alkaline Phosphatase; Anemia, Hemolytic; Diagnosis, Differential; Female; gamma-Glutamyltransferase; Humans; Hyperbilirubinemia; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Ursodeoxycholic Acid	1996
Lipoprotein(a) concentration and phenotypes in primary biliary cirrhosis. Clinica chimica acta; international journal of clinical chemistry, 1996, Nov-29, Volume: 255, Issue:2 Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Female; Humans; Lipoprotein(a); Lipoproteins, HDL; Liver Cirrhosis, Biliary; Middle Aged; Phenotype; Ursodeoxycholic Acid	1996
Survival in ursodeoxycholic acid-treated patients with biliary cirrhosis. Gastroenterology, 1996, Volume: 111, Issue:6 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1996
[Primary biliary cirrhosis with polymyositis successfully treated with prednisolone and ursodeoxycholic acid]. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1996, Volume: 33, Issue:10 Topics: Aged; Anti-Inflammatory Agents; Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Polymyositis; Prednisolone; Ursodeoxycholic Acid	1996
Effects of chenodeoxycholic and ursodeoxycholic acids on interferon-gamma production by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Journal of gastroenterology, 1995, Volume: 30, Issue:6 Topics: Case-Control Studies; Cells, Cultured; Chenodeoxycholic Acid; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; In Vitro Techniques; Interferon-gamma; Leukocytes, Mononuclear; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1995
Bile acid research and applications. Lancet (London, England), 1997, Jan-04, Volume: 349, Issue:9044 Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholelithiasis; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Pregnancy; Pregnancy Complications; Research; Ursodeoxycholic Acid	1997
Bile acid therapy and markers of immune-mediated damage in primary biliary cirrhosis. European journal of gastroenterology & hepatology, 1997, Volume: 9, Issue:2 Topics: Anti-Inflammatory Agents; Azathioprine; Biomarkers; Cholagogues and Choleretics; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Liver Cirrhosis, Biliary; Prednisone; Ursodeoxycholic Acid	1997
Clonal accumulation of V beta 5.1-positive cells in the liver of a patient with autoimmune cholangiopathy. Liver, 1997, Volume: 17, Issue:1 Topics: Adult; Antibodies, Antinuclear; Autoimmune Diseases; Biopsy; Cholangitis; Female; Hepatitis; Humans; Immunoglobulin G; Immunoglobulin M; Immunohistochemistry; Liver; Liver Cirrhosis, Biliary; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Ursodeoxycholic Acid	1997
[Autoimmune cholangitis or primary biliary cirrhosis without antimitochondrial antibodies?]. Gastroenterologia y hepatologia, 1997, Volume: 20, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Cholagogues and Choleretics; Cholangitis; Female; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Mitochondria; Prednisone; Retrospective Studies; Ursodeoxycholic Acid	1997
Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Annals of internal medicine, 1997, May-01, Volume: 126, Issue:9 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Bilirubin; Cholagogues and Choleretics; Colchicine; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Prospective Studies; Remission Induction; Ursodeoxycholic Acid	1997
Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:5 Topics: Apoptosis; DNA Damage; Humans; Liver Cirrhosis, Biliary; Proto-Oncogene Proteins c-bcl-2; Ursodeoxycholic Acid	1997
Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis. Journal of hepatology, 1997, Volume: 26, Issue:6 Topics: alpha-2-HS-Glycoprotein; Biomarkers; Blood Proteins; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Liver Cirrhosis, Biliary; Liver Function Tests; Reference Values; Regression Analysis; Ursodeoxycholic Acid; Vitamins	1997
Early primary biliary cirrhosis: just delayed or different? Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1 Topics: Autoantibodies; Humans; Liver Cirrhosis, Biliary; Middle Aged; Mitochondria; Ursodeoxycholic Acid	1997
[Ursodeoxycholic acid in the treatment of primary biliary cirrhosis]. Casopis lekaru ceskych, 1997, Apr-02, Volume: 136, Issue:7 Topics: Adult; Aged; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	1997
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology, 1997, Volume: 113, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Female; Forecasting; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Postoperative Care; Randomized Controlled Trials as Topic; Severity of Illness Index; Survival Analysis; Ursodeoxycholic Acid	1997
[Unusual diagnosis in recurrent arthritis, erythema nodosum and arrhythmia]. Deutsche medizinische Wochenschrift (1946), 1997, Dec-05, Volume: 122, Issue:49 Topics: Adult; Arrhythmias, Cardiac; Arthritis; Biopsy; Cholangitis; Chronic Disease; Diagnosis, Differential; Erythema Nodosum; Female; Follow-Up Studies; Humans; Liver; Liver Cirrhosis, Biliary; Recurrence; Time Factors; Tomography, X-Ray Computed; Ursodeoxycholic Acid	1997
[Cholestatic liver diseases--diagnosis and therapy. 3: Therapy of primary biliary cirrhosis]. Fortschritte der Medizin, 1998, Jan-20, Volume: 116, Issue:1-2 Topics: Cholagogues and Choleretics; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Treatment Outcome; Ursodeoxycholic Acid	1998
[Cholestasis: therapeutic options]. Therapeutische Umschau. Revue therapeutique, 1998, Volume: 55, Issue:2 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Cholestasis, Intrahepatic; Female; Humans; Liver Cirrhosis, Biliary; Male; Pregnancy; Treatment Outcome; Ursodeoxycholic Acid	1998
Primary biliary cirrhosis: ursodiol effective, but think transplantation sooner. Cleveland Clinic journal of medicine, 1998, Volume: 65, Issue:4 Topics: Cholagogues and Choleretics; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Middle Aged; Ursodeoxycholic Acid	1998
Production and characterization of group-specific monoclonal antibodies recognizing nonamidated, glycine- and taurine-amidated ursodeoxycholic acid 7-N-acetylglucosaminides. The Journal of steroid biochemistry and molecular biology, 1998, Volume: 64, Issue:3-4 Topics: Acetylglucosamine; Animals; Antibodies, Monoclonal; Bile Acids and Salts; Enzyme-Linked Immunosorbent Assay; Female; Hybridomas; Liver Cirrhosis, Biliary; Mice; Mice, Inbred BALB C; Molecular Structure; Protein Binding; Ursodeoxycholic Acid	1998
Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis. Digestive diseases and sciences, 1998, Volume: 43, Issue:6 Topics: Adult; Cholagogues and Choleretics; Cholesterol; Cholic Acids; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Sarcosine; Ursodeoxycholic Acid	1998
Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology (Baltimore, Md.), 1998, Volume: 28, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Aged; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Male; Middle Aged; Syndrome; Treatment Outcome; Ursodeoxycholic Acid	1998
[Primary biliary cirrhosis associated with pericardial effusion]. Annales de cardiologie et d'angeiologie, 1998, Volume: 47, Issue:8 Topics: Cholagogues and Choleretics; Echocardiography; Electrocardiography; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Organic Chemicals; Pericardial Effusion; Recurrence; Treatment Outcome; Ursodeoxycholic Acid	1998
[Cholestasis: drug therapy]. Praxis, 1998, Nov-11, Volume: 87, Issue:46 Topics: Cholagogues and Choleretics; Cholestasis; Diagnosis, Differential; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Ursodeoxycholic Acid	1998
Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome. Haematologica, 1998, Volume: 83, Issue:11 Topics: Adult; Bile Ducts; Biopsy; Cholestasis, Intrahepatic; Fatal Outcome; Female; Hodgkin Disease; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Middle Aged; Syndrome; Ursodeoxycholic Acid	1998
Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival. Postgraduate medical journal, 1998, Volume: 74, Issue:874 Topics: Adult; Aged; Aged, 80 and over; Cholagogues and Choleretics; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Medical Audit; Middle Aged; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	1998
Primary biliary cirrhosis associated with membranous glomerulonephritis. Internal medicine (Tokyo, Japan), 1999, Volume: 38, Issue:1 Topics: Adult; Azathioprine; Biopsy; Cholagogues and Choleretics; Diagnosis, Differential; Dipyridamole; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Glomerulus; Liver Cirrhosis, Biliary; Phosphodiesterase Inhibitors; Prednisolone; Ursodeoxycholic Acid	1999
Search for medical treatment for primary biliary cirrhosis. Lancet (London, England), 1997, Oct-11, Volume: 350, Issue:9084 Topics: Cholagogues and Choleretics; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Ursodeoxycholic Acid	1997
Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology, 1999, Volume: 117, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Bicarbonates; Bile Ducts; Biliary Tract Diseases; Cholestasis, Extrahepatic; Female; Gastrointestinal Agents; Humans; Injections, Intravenous; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Reference Values; Secretin; Sodium Bicarbonate; Tomography, Emission-Computed; Ursodeoxycholic Acid	1999
Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win? Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1999, Volume: 5, Issue:4 Topics: Bilirubin; Cholagogues and Choleretics; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Placebos; Premedication; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid	1999
Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol. Gastroenterology, 1999, Volume: 117, Issue:2 Topics: Adult; Alkaline Phosphatase; Bilirubin; Colchicine; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Ursodeoxycholic Acid	1999
Methotrexate in the treatment of primary biliary cirrhosis: the hype and the hope. Gastroenterology, 1999, Volume: 117, Issue:2 Topics: Humans; Liver Cirrhosis, Biliary; Methotrexate; Ursodeoxycholic Acid	1999
[The influence of ursodeoxycholic acid on some biochemical, immunologic and histopathologic parameters in patients with primary biliary cirrhosis]. Przeglad lekarski, 1999, Volume: 56, Issue:3 Topics: Acute-Phase Proteins; Bilirubin; Cholagogues and Choleretics; Humans; Immunoglobulins; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1999
Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-Centre PBC Study Group. Journal of hepatology, 1999, Volume: 31, Issue:2 Topics: Bilirubin; Cholagogues and Choleretics; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Ursodeoxycholic Acid	1999
Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochemical and biophysical research communications, 1999, Sep-24, Volume: 263, Issue:2 Topics: Animals; Antioxidants; Cholangitis, Sclerosing; Glutamate-Cysteine Ligase; Glutathione; Liver; Liver Cirrhosis, Biliary; Male; Metallothionein; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Sulfhydryl Compounds; Ursodeoxycholic Acid	1999
Prescribing habits in primary biliary cirrhosis: a national survey. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:8 Topics: Cholagogues and Choleretics; Cholestyramine Resin; Disease Management; Drug Prescriptions; Gastroenterology; Health Care Surveys; Humans; Liver Cirrhosis, Biliary; United Kingdom; Ursodeoxycholic Acid	1999
Combination therapy with mycophenolate mofetil and ursodeoxycholic acid for primary biliary cirrhosis. European journal of gastroenterology & hepatology, 1999, Volume: 11, Issue:10 Topics: Alkaline Phosphatase; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammation; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Middle Aged; Mycophenolic Acid; Ursodeoxycholic Acid	1999
Time course of histological progression in primary sclerosing cholangitis. The American journal of gastroenterology, 1999, Volume: 94, Issue:11 Topics: Adolescent; Adult; Aged; Biopsy; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Female; Follow-Up Studies; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Markov Chains; Middle Aged; Necrosis; Penicillamine; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	1999
Ursodeoxycholic acid in serum and liver tissue in patients with end-stage cholestatic liver cirrhosis. Transplantation proceedings, 1999, Volume: 31, Issue:7 Topics: Adolescent; Adult; Alagille Syndrome; Bile Acids and Salts; Biliary Atresia; Child; Child, Preschool; Cholagogues and Choleretics; Female; Humans; Infant; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Ursodeoxycholic Acid	1999
UDCA, PBC and biochemistry: what does normal mean? Gut, 2000, Volume: 46, Issue:1 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Reference Values; Ursodeoxycholic Acid	2000
Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment. Gut, 2000, Volume: 46, Issue:1 Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Cholagogues and Choleretics; Discriminant Analysis; Female; Follow-Up Studies; gamma-Glutamyltransferase; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Prognosis; Retrospective Studies; Treatment Outcome; Ursodeoxycholic Acid	2000
Low-dose methotrexate in primary biliary cirrhosis. Gastroenterology, 1999, Volume: 117, Issue:6 Topics: Arthritis, Rheumatoid; Cholagogues and Choleretics; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Ursodeoxycholic Acid	1999
Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study. The American journal of gastroenterology, 2000, Volume: 95, Issue:1 Topics: Aged; Alkaline Phosphatase; Bezafibrate; Cholagogues and Choleretics; Drug Therapy, Combination; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Immunoglobulin M; Liver Cirrhosis, Biliary; Middle Aged; Pilot Projects; Ursodeoxycholic Acid	2000
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid. Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:2 Topics: Administration, Oral; Administration, Topical; Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Bilirubin; Bone Density; Budesonide; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Osteoporosis; Pilot Projects; Retreatment; Treatment Failure; Ursodeoxycholic Acid	2000
Ursodeoxycholic acid for primary biliary cirrhosis. Lancet (London, England), 2000, Feb-19, Volume: 355, Issue:9204 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Meta-Analysis as Topic; Ursodeoxycholic Acid	2000
Ursodeoxycholic acid reduces expression of heat shock proteins in primary biliary cirrhosis. Liver, 2000, Volume: 20, Issue:1 Topics: Adult; Aged; Bile Ducts, Intrahepatic; Cell Count; Cholagogues and Choleretics; Cholangitis, Sclerosing; Epithelial Cells; Female; Fluorescent Antibody Technique, Indirect; Hepatitis C, Chronic; HSP70 Heat-Shock Proteins; Humans; Immunoblotting; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ubiquitins; Ursodeoxycholic Acid	2000
Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology (Baltimore, Md.), 2000, Volume: 31, Issue:4 Topics: Autoantibodies; Biopsy; Humans; Hyperbilirubinemia; Hypercholesterolemia; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Mitochondria; Osteoporosis; Ursodeoxycholic Acid	2000
Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future. Journal of hepatology, 2000, Volume: 32, Issue:4 Topics: Cholagogues and Choleretics; Forecasting; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2000
Serum interferon gamma in primary biliary cirrhosis: effect of ursodeoxycholic acid and prednisone therapy alone and in combination. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:4 Topics: Drug Therapy, Combination; Female; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Liver Cirrhosis, Biliary; Male; Middle Aged; Prednisone; Ursodeoxycholic Acid	2000
Mycophenolate mofetil for primary biliary cirrhosis--convergent thinking. European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:5 Topics: Cholagogues and Choleretics; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Mycophenolic Acid; Ursodeoxycholic Acid	2000
Blood fetal microchimerism in primary biliary cirrhosis. Clinical and experimental immunology, 2000, Volume: 122, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Autoimmune Diseases; Chimera; DNA-Binding Proteins; Female; Fetal Blood; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Nuclear Proteins; Pregnancy; Sex-Determining Region Y Protein; Transcription Factors; Ursodeoxycholic Acid	2000
Clinical studies with silymarin: fibrosis progression is the end point. Hepatology (Baltimore, Md.), 2001, Volume: 33, Issue:2 Topics: Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Fibrosis; Humans; Liver Cirrhosis, Biliary; Protective Agents; Retreatment; Silymarin; Ursodeoxycholic Acid	2001
UDCA, PBC, and biochemistry, what does normal mean? Gut, 2000, Volume: 47, Issue:4 Topics: Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Treatment Outcome; Ursodeoxycholic Acid	2000
Ursodeooxycholic acid for primary biliary cirrhosis. Journal of hepatology, 2001, Volume: 34, Issue:2 Topics: Humans; Liver Cirrhosis, Biliary; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid	2001
The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology, 2001, Volume: 120, Issue:6 Topics: Adolescent; Adult; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Transporters; Bile; Child; Child, Preschool; Cholestasis, Intrahepatic; Female; Genotype; Humans; Immunohistochemistry; Infant; Liver; Liver Cirrhosis, Biliary; Male; Mutation; Phenotype; Phospholipids; Polymorphism, Genetic; Ursodeoxycholic Acid	2001
Differences in the efficacy of ursodeoxycholic acid and bile acid metabolism between viral liver diseases and primary biliary cirrhosis. Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:5 Topics: Adult; Aged; Aspartate Aminotransferases; Bile Acids and Salts; Cholic Acids; Female; gamma-Glutamyltransferase; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid	2001
Effect of bezafibrate in primary biliary cirrhosis: a pilot study. Liver, 2001, Volume: 21, Issue:3 Topics: Adult; Aged; Alanine Transaminase; Alkaline Phosphatase; Bezafibrate; Female; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Pilot Projects; Time Factors; Treatment Outcome; Ursodeoxycholic Acid	2001
Ursodeoxycholic acid for primary biliary cirrhosis: lesson for the future? Journal of hepatology, 2001, Volume: 34, Issue:5 Topics: Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2001
Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis? Journal of hepatology, 2001, Volume: 35, Issue:3 Topics: Alanine Transaminase; Apolipoproteins E; Aspartate Aminotransferases; Biomarkers; Cross-Sectional Studies; Humans; Liver Cirrhosis, Biliary; Polymorphism, Genetic; Retrospective Studies; Ursodeoxycholic Acid	2001
The natural history of primary biliary cirrhosis: of genes and cooperation. Journal of hepatology, 2001, Volume: 35, Issue:3 Topics: Alleles; Genetic Linkage; Genetic Predisposition to Disease; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2001
Benefit of transplantation in primary biliary cirrhosis between 1985-1997. Transplantation, 2002, Jan-27, Volume: 73, Issue:2 Topics: Adult; Aged; Female; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Male; Middle Aged; Time Factors; Ursodeoxycholic Acid	2002
A female with asymptomatic primary biliary cirrhosis associated with pernicious anemia. Journal of gastroenterology and hepatology, 2001, Volume: 16, Issue:12 Topics: Anemia, Pernicious; Autoantibodies; Biopsy; Cholagogues and Choleretics; Female; Gastritis, Atrophic; Humans; Liver Cirrhosis, Biliary; Middle Aged; Transaminases; Ursodeoxycholic Acid; Vitamin B 12; Vitamin B Complex	2001
Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology, 2002, Volume: 122, Issue:3 Topics: Bilirubin; Cholagogues and Choleretics; Disease Progression; Female; Humans; Incidence; Liver; Liver Cirrhosis, Biliary; Male; Markov Chains; Middle Aged; Multivariate Analysis; Necrosis; Predictive Value of Tests; Prognosis; Risk Factors; Serum Albumin; Ursodeoxycholic Acid	2002
[Clinical characteristics of primary biliary cirrhosis with Sjögren's syndrome of 20 cases]. Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:11 Topics: Adult; Aged; Female; Humans; Jaundice; Keratoconjunctivitis Sicca; Liver Cirrhosis, Biliary; Middle Aged; Pruritus; Retrospective Studies; Sjogren's Syndrome; Splenomegaly; Ursodeoxycholic Acid; Xerostomia	2001
The UDCA dosage deficit: a fate shared with CDCA. European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:3 Topics: Chenodeoxycholic Acid; Cholelithiasis; Cholestasis; Dose-Response Relationship, Drug; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	2002
Autoimmune cholangiopathy associated with systemic lupus erythematosus. Liver, 2002, Volume: 22, Issue:2 Topics: Adult; Anemia, Pernicious; Antibodies, Antinuclear; Antibodies, Antiphospholipid; Antirheumatic Agents; Autoimmune Diseases; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Treatment Outcome; Ursodeoxycholic Acid	2002
Ursodeoxycholic acid: a second look. Primary biliary cirrhosis: dashed hopes. Prescrire international, 2002, Volume: 11, Issue:59 Topics: Cholagogues and Choleretics; Cholangitis; Follow-Up Studies; France; Humans; Liver Cirrhosis, Biliary; Meta-Analysis as Topic; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2002
Bile acid therapy in the 1990s. Lancet (London, England), 1992, Nov-21, Volume: 340, Issue:8830 Topics: Chenodeoxycholic Acid; Cholelithiasis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
Ursodeoxycholate has no beneficial effect on liver function or histology in biliary cirrhosis in the rat. Journal of hepatology, 1992, Volume: 16, Issue:3 Topics: Animals; Liver; Liver Cirrhosis, Biliary; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Ursodeoxycholic Acid	1992
[Drug therapy of cholestatic hepatopathies]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1992, Aug-18, Volume: 81, Issue:34 Topics: Cholangitis, Sclerosing; Cholestasis; Humans; Liver Cirrhosis, Biliary; Long-Term Care; Ursodeoxycholic Acid	1992
Ursodeoxycholic acid therapy: the baby and the bathwater. Hospital practice (Office ed.), 1992, Mar-15, Volume: 27, Issue:3 Topics: Animals; Chemical and Drug Induced Liver Injury; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. Gastroenterology, 1992, Volume: 102, Issue:4 Pt 1 Topics: Aged; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	1992
Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease. Hepatology (Baltimore, Md.), 1992, Volume: 15, Issue:4 Topics: Adult; Bile Acids and Salts; Cholangitis, Sclerosing; Chronic Disease; Female; Humans; Kinetics; Liver Cirrhosis, Biliary; Male; Middle Aged; Reference Values; Ursodeoxycholic Acid	1992
Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted? Hepatology (Baltimore, Md.), 1992, Volume: 15, Issue:5 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1992
The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids. Gastroenterologia Japonica, 1992, Volume: 27, Issue:2 Topics: Adult; Aged; Bile Acids and Salts; Cholangitis, Sclerosing; Cholestasis; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Ursodeoxycholic Acid	1992
Immunomodulatory effects of ursodeoxycholic acid on immune responses. Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:2 Topics: Adjuvants, Immunologic; Adult; Cytokines; Female; Humans; Immunoglobulins; Interleukin-1; Liver Cirrhosis, Biliary; Lymphocyte Activation; Male; Middle Aged; Taurocholic Acid; Tumor Cells, Cultured; Ursodeoxycholic Acid	1992
[The treatment of primary biliary cirrhosis with ursodeoxycholic acid. The short- and median-term results and their relation to the study of the disease]. Revista espanola de enfermedades digestivas, 1991, Volume: 80, Issue:5 Topics: Administration, Oral; Drug Evaluation; Drug Tolerance; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Remission Induction; Time Factors; Ursodeoxycholic Acid	1991
[The treatment of primary biliary liver cirrhosis with ursodeoxycholic acid (preliminary report)]. Vutreshni bolesti, 1991, Volume: 30, Issue:1 Topics: Cholestasis, Intrahepatic; Drug Evaluation; Drug Tolerance; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Time Factors; Ursodeoxycholic Acid	1991
Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy. The American journal of gastroenterology, 1991, Volume: 86, Issue:9 Topics: Adult; Aged; Biliary Tract; Female; HLA Antigens; Humans; Immunoenzyme Techniques; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1991
[Hepatic expression of Class-I and Class-II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid]. Zeitschrift fur Gastroenterologie, 1991, Volume: 29, Issue:8 Topics: Fluorescent Antibody Technique; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1991
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. Hepatology (Baltimore, Md.), 1991, Volume: 14, Issue:6 Topics: Bile; Bile Acids and Salts; Humans; Liver; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid	1991
Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis. The American journal of gastroenterology, 1990, Volume: 85, Issue:1 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Bilirubin; Deoxycholic Acid; Drug Administration Schedule; Female; gamma-Glutamyltransferase; Humans; Immunoglobulin M; Liver Cirrhosis, Biliary; Male; Middle Aged; Pruritus; Ursodeoxycholic Acid	1990
[Bile acids in the treatment of cholestatic lesions of the liver]. Casopis lekaru ceskych, 1991, Mar-15, Volume: 130, Issue:11 Topics: Female; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1991
Ursodeoxycholic acid treatment in a patient with primary biliary cirrhosis. The Netherlands journal of medicine, 1990, Volume: 37, Issue:1-2 Topics: Alanine Transaminase; Alkaline Phosphatase; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	1990
New directions in primary biliary cirrhosis. BMJ (Clinical research ed.), 1990, Dec-08, Volume: 301, Issue:6764 Topics: Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1990
Is oriental folk use of bear bile vindicated (yet)? Gastroenterology, 1990, Volume: 98, Issue:4 Topics: Bile Acids and Salts; Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Medicine, East Asian Traditional; Pruritus; Ursodeoxycholic Acid	1990
Expression of HLA molecules on hepatocytes: does ursodeoxycholic acid prevent immunologic injury? Gastroenterology, 1990, Volume: 99, Issue:2 Topics: Deoxycholic Acid; HLA Antigens; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1990
Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III. Journal of hepatology, 1990, Volume: 10, Issue:3 Topics: Aged; Aminopyrine; Bile Acids and Salts; Deoxycholic Acid; Female; Galactose; Humans; Liver; Liver Cirrhosis, Biliary; Male; Middle Aged; Sorbitol; Ursodeoxycholic Acid	1990
[Cholestatic liver diseases and modern bile acid therapy (Medica '89)]. Der Internist, 1990, Volume: 31, Issue:6 Topics: Chenodeoxycholic Acid; Cholelithiasis; Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1990
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1990, Volume: 12, Issue:3 Pt 1 Topics: Bile Acids and Salts; Chromatography, Gas; Deoxycholic Acid; Drug Evaluation; Gas Chromatography-Mass Spectrometry; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1990
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology (Baltimore, Md.), 1990, Volume: 11, Issue:1 Topics: Deoxycholic Acid; Fluorescent Antibody Technique; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Humans; Liver; Liver Cirrhosis, Biliary; Middle Aged; Ursodeoxycholic Acid	1990
[Effect of ursodeoxycholic acid treatment on primary biliary cirrhosis]. Zeitschrift fur Gastroenterologie. Verhandlungsband, 1989, Volume: 24 Topics: Bile Acids and Salts; Bilirubin; Cholestasis, Intrahepatic; Deoxycholic Acid; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Peptide Fragments; Procollagen; Ursodeoxycholic Acid	1989
Ursodeoxycholic acid in primary biliary cirrhosis. Lancet (London, England), 1989, Apr-22, Volume: 1, Issue:8643 Topics: Deoxycholic Acid; Drug Evaluation; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1989
Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis. Digestive diseases and sciences, 1989, Volume: 34, Issue:12 Suppl Topics: Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Deoxycholic Acid; gamma-Glutamyltransferase; Hepatitis, Chronic; Humans; Leucyl Aminopeptidase; Liver Cirrhosis, Biliary; Liver Function Tests; Ursodeoxycholic Acid	1989
Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis. Digestive diseases and sciences, 1989, Volume: 34, Issue:12 Suppl Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Middle Aged; Phospholipids; Ursodeoxycholic Acid	1989
Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: effect of ursodeoxycholic acid treatment. Journal of lipid research, 1989, Volume: 30, Issue:12 Topics: Bile Acids and Salts; Chromatography, Liquid; Chromatography, Thin Layer; Deoxycholic Acid; Female; Gas Chromatography-Mass Spectrometry; Humans; Hydroxylation; Isomerism; Liver Cirrhosis, Biliary; Sulfuric Acids; Ursodeoxycholic Acid	1989
Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment. Gut, 1989, Volume: 30, Issue:8 Topics: Bile Acids and Salts; Chromatography, High Pressure Liquid; Deoxycholic Acid; Female; Glycine; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Taurine; Ursodeoxycholic Acid	1989
High-performance liquid chromatographic determination of tauro- and glyco-conjugated bile acids in human serum. Journal of chromatography, 1989, May-30, Volume: 490, Issue:2 Topics: Bile Acids and Salts; Cholestasis, Extrahepatic; Chromatography, High Pressure Liquid; Glycoconjugates; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1989
Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology (Baltimore, Md.), 1989, Volume: 10, Issue:4 Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Bile Acids and Salts; Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Middle Aged; Pruritus; Ursodeoxycholic Acid	1989
[Ursodeoxycholic acid lowers liver enzymes]. Leber, Magen, Darm, 1989, Volume: 19, Issue:5 Topics: Alanine Transaminase; Aspartate Aminotransferases; Deoxycholic Acid; Hepatitis, Chronic; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1989
Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet (London, England), 1987, Apr-11, Volume: 1, Issue:8537 Topics: Adult; Bile Acids and Salts; Deoxycholic Acid; Drug Evaluation; Female; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Pilot Projects; Prospective Studies; Pruritus; Time Factors; Ursodeoxycholic Acid	1987
Ursodeoxycholic acid for primary biliary cirrhosis. Lancet (London, England), 1987, Aug-15, Volume: 2, Issue:8555 Topics: Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1987
Treatment of primary biliary cirrhosis and cholestatic disorders with ursodeoxycholic acid. Lancet (London, England), 1987, Aug-29, Volume: 2, Issue:8557 Topics: Cholestasis; Deoxycholic Acid; Double-Blind Method; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Prospective Studies; Ursodeoxycholic Acid	1987
Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet (London, England), 1988, May-21, Volume: 1, Issue:8595 Topics: Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Ursodeoxycholic Acid	1988
Deterioration in primary biliary cirrhosis in patient on ursodeoxycholic acid. Lancet (London, England), 1988, Jul-16, Volume: 2, Issue:8603 Topics: Deoxycholic Acid; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1988
[Ursodeoxycholic acid in primary biliary cirrhosis. 2: Prospective long-term study of 21 patients]. Fortschritte der Medizin, 1988, Nov-30, Volume: 106, Issue:34 Topics: Deoxycholic Acid; Female; Humans; Liver Cirrhosis, Biliary; Liver Function Tests; Long-Term Care; Male; Middle Aged; Prospective Studies; Ursodeoxycholic Acid	1988
[A case of primary biliary cirrhosis treated with colchicine and ursodeoxycholic acid]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1988, Volume: 85, Issue:10 Topics: Adult; Colchicine; Deoxycholic Acid; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid	1988